Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOM,Apolipoprotein M,42199,0.109611413275582,0.00270275957744534,0.104314004503789,0.114908822047375,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.136949236469174,0.00313545849473422,0.130803737819495,0.143094735118853,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLR,Low-density lipoprotein receptor,42170,0.312829496587977,0.00439725940961327,0.304210868145135,0.321448125030819,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.217185069422093,0.00265353668154573,0.211984137526263,0.222386001317923,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI,Tissue factor pathway inhibitor,42152,0.120814453963035,0.00296629907131183,0.115000507783264,0.126628400142806,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN1,CCN family member 1,42047,0.257418373969086,0.0068817494701271,0.243930145007637,0.270906602930535,2.02569538582135e-291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0776081626710586,0.00207122826832979,0.0735485552651322,0.0816677700769849,7.24093804679008e-290
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APCS,Serum amyloid P-component,39870,0.113490378427329,0.00312731464950608,0.107360841714297,0.119619915140361,7.97434825710009e-273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPY,Pro-neuropeptide Y,42262,0.219687468669916,0.00611848558187448,0.207695236929442,0.23167970041039,7.08853317892814e-270
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRP,Agouti-related protein,42296,0.174728639767957,0.00498313587297131,0.164961693456933,0.184495586078981,5.10044756277918e-258
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.196054328325261,0.00562134321316271,-0.20707216102306,-0.185036495627463,3.45607208333476e-255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOC1,Apolipoprotein C-I,39959,0.128781841524916,0.00372255739284052,0.121485629034949,0.136078054014884,1.99092061656591e-249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROC,Vitamin K-dependent protein C,42199,0.0852516603193108,0.00248379484974968,0.0803834224138014,0.0901198982248202,1.11461349709738e-247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F7,Coagulation factor VII,42194,0.0909446706634695,0.00302941862048815,0.0850070101673127,0.0968823311596263,8.95646661900739e-192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHR,Growth hormone receptor,39736,0.0821478535807922,0.0027625278248395,0.0767332990441068,0.0875624081174776,4.71003584243915e-187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.072795090516319,0.00249666369547083,0.0679016296731962,0.0776885513594419,2.23667897170051e-181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.120531441042005,0.00419320889524573,0.112312751607323,0.128750130476687,1.87031894139808e-176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCHE,Cholinesterase,39806,0.0732104836552629,0.00263489764823156,0.0680460842647291,0.0783748830457968,2.26947770294107e-164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL27,C-C motif chemokine 27,42145,0.167689654260638,0.00612982468340127,0.155675197881171,0.179704110640104,1.99512293215024e-160
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0511017178980993,0.00190200075128169,0.0473737964255872,0.0548296393706114,6.11588717612564e-155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP1,Neuropilin-1,42230,-0.0715966876938964,0.00268662068759955,-0.0768624642415915,-0.0663309111462013,1.42795517032999e-152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLKB1,Plasma kallikrein,39759,0.0642712587533958,0.00241142477393739,0.0595448661964785,0.0689976513103131,8.80074328350039e-152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.201102060316763,0.00757374928750816,0.186257511713247,0.215946608920279,9.30458332520916e-151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFGE8,Lactadherin,42137,0.117023610379283,0.00446003443018714,0.108281942896117,0.12576527786245,4.74232038457534e-148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0824308657336365,0.00317166599264417,0.0762144003880539,0.0886473310792191,2.20235341151916e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFP,Properdin,39979,0.0604565272565572,0.00233488361449652,0.0558801553721441,0.0650328991409704,1.10942261924163e-143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA5,Plasma serine protease inhibitor,39835,0.0766128127045303,0.00297342213571521,0.0707849053185285,0.0824407200905321,2.76376240431093e-142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROS1,Vitamin K-dependent protein S,39979,0.0636478160980035,0.00250679163035991,0.0587345045024981,0.068561127693509,2.20875801789616e-138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF2,Alpha-2-antiplasmin,39786,0.032434848959725,0.00132601682404216,0.0298358559846024,0.0350338419348477,9.08453220093866e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTR,Transthyretin,39862,0.0596569407545834,0.00245814998460146,0.0548389667847645,0.0644749147244022,7.28875732452241e-127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA4,Kallistatin,39802,0.0561117049459428,0.00231909909566691,0.0515662707184356,0.0606571391734499,4.13352704823443e-126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL23,C-C motif chemokine 23,42185,0.0985347465727944,0.00417410775575252,0.0903534953715194,0.106715997774069,8.85366614045956e-121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0859163533652398,0.00364828966373451,0.0787657056243202,0.0930670011061594,9.25643998061819e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH,Parathyroid hormone,39649,0.192697375044835,0.00823007695574375,0.176566424211577,0.208828325878093,2.28952819902412e-118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAMR1,Inactive serine protease PAMR1,42137,0.060937475099151,0.00261404479087944,0.0558139473090273,0.0660610028892747,6.99886318520471e-118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0743635761777241,0.0031948116018269,0.0681017454381434,0.0806254069173049,1.4709060766214e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.190525964017863,0.00829747492863078,0.174262913157747,0.206789014877979,1.89729395535847e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFH,Complement factor H,39418,0.0535037849728941,0.00232504717844457,0.0489466925031428,0.0580608774426455,1.92943590007176e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0468434808289571,0.00204507671617681,0.0428351304652505,0.0508518311926637,6.8802489308195e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FN1,Fibronectin,39979,0.0614150743262879,0.00270484215142084,0.056113583709503,0.0667165649430727,1.16804280870728e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRN,"Attractin, Isoform 2",39979,0.037499431741841,0.00165375077576571,0.0342580802213402,0.0407407832623418,2.25386636313901e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0541650603160439,0.00241695584110403,0.04942782686748,0.0589022937646078,2.94553203487201e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0870859426183917,0.0038896117918932,-0.0947095817305024,-0.0794623035062811,4.70362511467601e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42181,0.0554434783204982,0.00248340001708818,0.0505760142870054,0.060310942353991,1.84236361875814e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F13B,Coagulation factor XIII B chain,39925,0.0568725523499296,0.00254394076833539,0.0518864284439923,0.061858676255867,2.2837609844165e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42189,0.0758513189659021,0.0034109403846701,0.0691658758119487,0.0825367621198555,1.22246276560903e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB2,Carboxypeptidase B2,39959,0.0495666718046766,0.0022332384129477,0.0451895245152991,0.0539438190940541,7.05017778056389e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42230,0.105922899447887,0.00479043014711306,0.0965336563595451,0.115312142536228,1.81113747926035e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCA,Alpha-synuclein,39736,0.256722907520697,0.0117169242943664,0.233757735903739,0.279688079137655,3.22630692270809e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,P4HB,Protein disulfide-isomerase,42073,0.082832506684392,0.00382759599158946,0.0753304185408766,0.0903345948279073,4.02496908303268e-102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.128297651578179,0.00599792594095503,-0.140053586422451,-0.116541716733907,7.04122252822904e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYAP1,Synapse-associated protein 1,39736,0.123900659764594,0.00582706480350373,0.112479612749726,0.135321706779461,2.2251045978816e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP6,Charged multivesicular body protein 6,39958,0.120617877380803,0.00568600716753664,0.109473303332432,0.131762451429175,5.66875029401587e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.259884885803669,0.0122954984075074,0.235785708924955,0.283984062682384,1.37607832157729e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.178868264194218,0.00847419791492151,0.162258836280972,0.195477692107464,2.54187969550826e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FURIN,Furin,42181,0.0691541680627692,0.00327679923206982,0.0627316415679124,0.0755766945576261,2.63739694582962e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0695524405204458,0.00331615185149068,0.0630527828915241,0.0760520981493676,3.70078371091759e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.165099193951612,0.00794302364079263,0.149530867615658,0.180667520287565,1.77038303461835e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F10,Coagulation factor X,39990,0.0599418319605644,0.00288088696125242,0.0542952935165097,0.0655883704046192,2.11833663269346e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.218254195345219,0.0106062412476723,0.197465962499781,0.239042428190657,1.14534725289136e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN3,Contactin-3,42137,0.0572645058800828,0.00281508717675826,0.0517469350136366,0.0627820767465289,1.23064141253332e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPL,Lipoprotein lipase,42145,-0.0963667898087773,0.00477626406116128,-0.105728267368653,-0.0870053122489012,3.22690448088901e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.221440205205325,0.0109920099839552,-0.242984544773877,-0.199895865636773,5.88510382667039e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0391871943961745,0.00195077812581014,0.0353636692695866,0.0430107195227623,1.76885441331839e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN2,Ficolin-2,42116,0.0809148686419349,0.0040278720194374,0.0730202394838376,0.0888094978000322,1.80170809819513e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL6,C-X-C motif chemokine 6,42296,0.150071757763918,0.00750043154146127,0.135370911942654,0.164772603585182,8.3209613171427e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS4,Galectin-4,42123,-0.111626643123037,0.00560261929982599,-0.122607776950696,-0.100645509295378,4.45257399472198e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFM,Afamin,39979,0.0402343488912425,0.00201707615206004,0.0362808796332048,0.0441878181492802,4.85978911103514e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.288334965943066,0.0145441670662596,0.259828398493197,0.316841533392935,3.1698983880334e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0391940053521506,0.00198248858331726,0.0353083277288487,0.0430796829754524,8.82219002636769e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR5,Cadherin-related family member 5,42145,0.0750051064603507,0.00384988868411867,0.0674593246394781,0.0825508882812233,2.13557543943338e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A5,Zinc transporter ZIP5,42119,0.102264497952111,0.00527177578006398,0.0919318174231858,0.112597178481037,1.05370398446063e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOST,Sclerostin,42129,0.0747106201788248,0.00385197176322928,0.0671607555228955,0.0822604848347542,1.11461218214791e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAT,Tissue-type plasminogen activator,42272,0.0985650521804015,0.00509012684060116,0.0885884035728232,0.10854170078798,1.96767048645021e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES1,Liver carboxylesterase 1,42163,0.162503738856644,0.00845070897225848,0.145940349271018,0.179067128442271,2.52099008302872e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.045787143475716,0.00239048602197945,0.0411017908726363,0.0504724960787957,1.08449873822892e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFI,Complement factor I,39979,0.0371535391439368,0.00193960379601754,0.0333519157037424,0.0409551625841312,1.6098759957723e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAPIN,SNARE-associated protein Snapin,39934,0.111427612499806,0.00582046246741465,0.100019506063674,0.122835718935939,2.00172895665875e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORT1,Sortilin,42129,0.0715254541336167,0.00379481562401304,0.0640876155105511,0.0789632927566822,3.04743665119348e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,41843,0.208561204768663,0.0110964150613348,0.186812231248446,0.230310178288879,8.45251544320944e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.261044214689562,0.0139984733181003,0.233607206986085,0.288481222393038,1.81719150540094e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP10,Stromelysin-2,42124,-0.106647848967887,0.00573531092945171,-0.117889058389613,-0.0954066395461618,3.14085911196072e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFR,Epidermal growth factor receptor,42310,0.029455391943214,0.00159078576112169,0.0263374518514155,0.0325733320350125,1.27308368370436e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG2,Desmoglein-2,42137,-0.0498707649229371,0.0026944090693829,-0.0551518066989276,-0.0445897231469466,1.49151142766454e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.112687278733279,0.0061017499326543,0.100727848865276,0.124646708601281,3.13695493400624e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTD,Biotinidase,39979,0.0378656942012446,0.00205142505373371,0.0338449010959266,0.0418864873065627,5.53804826746337e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUSB,Beta-glucuronidase,42211,0.111785244592562,0.00607670444817804,0.0998749038741327,0.123695585310991,1.13989022817147e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.128963118279169,0.00708825208066862,0.115070144201058,0.142856092357279,6.28235021330522e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBC,Inhibin beta C chain,42137,0.0719404697419901,0.00396060904650202,0.0641776760108462,0.0797032634731341,7.2821527109987e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINC1,Antithrombin-III,39959,0.0262133627239844,0.00144752384197672,0.02337621599371,0.0290505094542588,2.794335515972e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD4,T-cell surface glycoprotein CD4,42100,0.0520503040707808,0.00288915033638762,0.0463875694114611,0.0577130387301006,1.01127087974722e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0395934500938093,0.0022069339211901,0.0352678596082767,0.0439190405793419,5.65902928838101e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUMB,Protein numb homolog,39657,0.150477819353176,0.00839119448046202,0.13403107817147,0.166924560534881,6.57423050433657e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0689541092812886,0.0038516973736789,-0.0765034361336992,-0.0614047824288779,7.33373998768674e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0477626898344805,0.00267519965856671,0.0425192985036898,0.0530060811652713,1.73607395339442e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON2,Spondin-2,42070,-0.0620226229193559,0.00347912389131884,-0.0688417057463408,-0.055203540092371,2.7902231818339e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42070,0.22357356002248,0.0125838009014168,0.198909310255703,0.248237809789257,7.98857566999581e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0787464205820879,0.00445600266688041,-0.0874801858091735,-0.0700126553550023,5.77766625896458e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2,Prothrombin,39979,0.0262687204123512,0.00148864794777217,0.0233509704347178,0.0291864703899847,8.96544542419527e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.120098259372016,0.00684995232354091,0.106672352817876,0.133524165926156,4.58800273732358e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA80,N-alpha-acetyltransferase 80,39649,0.215901293204732,0.0123019289365782,0.191789512489039,0.240013073920425,4.94410824839031e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,39657,0.151927883055414,0.00868309320899959,0.134909020365775,0.168946745745053,1.22687045533867e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42140,0.0683499270863522,0.00394168273646854,0.0606242289228739,0.0760756252498306,1.22341191438706e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO3,Beta-enolase,39638,0.108342240923487,0.00628463265784406,0.0960243609141131,0.120660120932862,9.74958142914382e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1S,Complement C1s subcomponent,39979,0.0363702602194276,0.00211366427354929,0.032227478243271,0.0405130421955842,1.5772874198116e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPIND1,Heparin cofactor 2,39959,0.0501309610859079,0.00292277395772767,0.0444023241287617,0.0558595980430541,4.01152659350741e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11,Coagulation factor XI,39822,0.0540486091359437,0.00315148905708033,0.0478716905840662,0.0602255276878211,4.21927718750347e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRL,Appetite-regulating hormone,42145,0.141713567603712,0.00828854580691437,0.125468017822159,0.157959117385264,7.41044361208401e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.139342897804283,0.00815745913951415,0.123354277890835,0.15533151771773,9.9493520149621e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.124516809665514,0.00729524874604483,0.110218122123266,0.138815497207762,1.22985343672722e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REN,Renin,42145,-0.137898135519753,0.00809979808572716,-0.153773739767778,-0.122022531271728,2.50323368790813e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0701516247912033,0.00413172622804376,0.0620534413842375,0.0782498081981691,7.24896531177517e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKB,Creatine kinase B-type,39966,-0.0969730544905258,0.00574099476291916,-0.108225404225847,-0.0857207047552043,3.07021566542209e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH1,Somatotropin,42129,-0.299002071078297,0.0177266739615411,-0.333746352042918,-0.264257790113677,3.4552895414186e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLTP,Phospholipid transfer protein,42267,-0.0633760462853047,0.00377604831328846,-0.0707771009793501,-0.0559749915912593,1.35849437754389e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0560191253355506,0.00334312925031068,-0.0625716586661596,-0.0494665920049417,2.11805891606459e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0869426122377854,0.00519452717906045,0.0767613389668269,0.0971238855087438,2.92145391987155e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC5,Glypican-5,42016,0.0941140505973922,0.00562358318361041,0.0830918275575158,0.105136273637269,3.08108072651675e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRP,Gastrin-releasing peptide,39638,0.0889738584063093,0.00534272332342437,0.0785021206923976,0.0994455961202211,1.60902208101285e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EEF1D,Elongation factor 1-delta,39958,0.150860393359669,0.00911779230351871,0.132989520444772,0.168731266274565,8.82214893432787e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42181,0.150827522682069,0.00913445747101708,0.132923986038875,0.168731059325262,1.17341161848357e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FYB1,FYN-binding protein 1,42115,0.152543307859938,0.00923884562371392,0.134435170437459,0.170651445282417,1.19757449975397e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0656525579099973,0.00397693252721023,-0.0734473456633293,-0.0578577701566652,1.24929241133496e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5E,5'-nucleotidase,42181,0.0885865880924992,0.00536847594553528,0.0780643752392501,0.0991088009457483,1.39555891028528e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJAP1,Tight junction-associated protein 1,42181,0.136848908017519,0.00829471614989337,0.120591264363728,0.15310655167131,1.46357737725038e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0489603577868591,0.0029755837717417,0.0431282135942453,0.0547925019794728,3.88597949111166e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6A,Ras-related protein Rab-6A,42119,0.0726168677045174,0.00442786214998801,0.0639382578905409,0.0812954775184939,7.23330861855821e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF15,Growth/differentiation factor 15,42310,-0.0749659782744352,0.00457252365923377,-0.0839281246465333,-0.066003831902337,7.71203547360259e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YTHDF3,YTH domain-containing family protein 3,41913,0.140189324896144,0.00855432130805,0.123422855132366,0.156955794659922,8.93704473192944e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOL1,Apolipoprotein L1,39990,0.0875812224093244,0.00534466620292631,0.0771056766515888,0.0980567681670599,1.14463683325242e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0455600294210948,0.00278395745608761,0.0401034728071631,0.0510165860350265,1.24614648358764e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0424829691879113,0.00259717292934047,0.0373925102464039,0.0475734281294186,1.44724928889627e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.111353381679249,0.00680799729616928,0.0980097069787573,0.124697056379741,1.50371583509056e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SARG,Specifically androgen-regulated gene protein,39915,0.178796055609769,0.0110092666214815,0.157217893031665,0.200374218187873,1.19832885698832e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH9,Myosin-9,39966,0.184356888741605,0.0113690286786182,0.162073592531513,0.206640184951697,1.76635792749837e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YES1,Tyrosine-protein kinase Yes,42070,0.184592643087332,0.0114050722056289,0.162238701564299,0.206946584610364,2.27939232872229e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.185130839604902,0.0114295956417115,0.162728832147148,0.207532847062657,2.42602136358131e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA3,Glutathione S-transferase A3,41843,0.1244708164465,0.00769403743740971,0.109390503069177,0.139551129823823,2.62709382182528e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTYMK,Thymidylate kinase,39958,0.108941977495552,0.00672863897026079,0.0957538451138404,0.122130109877263,2.62781101039943e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.128738800090987,0.00795375124643692,0.113149447647971,0.144328152534003,2.85349754145879e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF9,Protein turtle homolog A,39958,0.139178785249619,0.00860973531712877,0.122303704028047,0.156053866471191,3.93957741311486e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC3B,Tetranectin,39726,0.0340523158423606,0.00210746833512054,0.0299216779055244,0.0381829537791969,4.56440050683944e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL3,C-X-C motif chemokine 3,42129,0.153526965474147,0.00951644402211253,0.134874735190807,0.172179195757488,5.21301373255172e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL5,C-X-C motif chemokine 5,42101,0.18113553141649,0.0112389119065376,0.159107264079677,0.203163798753304,6.73684924885634e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C4BPB,C4b-binding protein beta chain,42181,0.0613054414032966,0.00381526833517135,0.0538275154663608,0.0687833673402325,1.43991449868773e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIP2,Cysteine-rich protein 2,42016,0.0583932252825122,0.00363628591187354,0.0512661048952401,0.0655203456697843,1.71106589490878e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THPO,Thrombopoietin,41900,0.0623227283977141,0.0038971197867048,0.0546843736157727,0.0699610831796555,4.93818301361818e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.172369183568565,0.0107755563579706,0.151249093106943,0.193489274030188,5.6706802825291e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZN,Kazrin,39930,0.167473419949991,0.0105084250656245,0.146876906821367,0.188069933078615,1.44058895204002e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS1,Protein MTSS 1,39930,0.177936814816703,0.011172007218903,0.156039680667653,0.199833948965753,1.68556250287591e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.115726572261145,0.00728339178441434,0.101451124363693,0.130002020158597,2.41596544743799e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEFTY2,Left-right determination factor 2,42247,0.081507746399858,0.00514840236502325,0.0714168777644124,0.0915986150353035,5.91988172659656e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLN,Promotilin,42119,0.141009021163127,0.00891825817843243,0.1235292351334,0.158488807192855,8.22303199642859e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.055382260036435,0.00350768282607611,-0.0622573183755441,-0.0485072016973258,1.16012381150274e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFC,Platelet-derived growth factor C,41843,0.0439216248330464,0.00278720491966338,0.0384587031905061,0.0493845464755866,1.91932084634077e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPD52L2,Tumor protein D54,39736,0.172101108729894,0.0109266759793773,0.150684823810314,0.193517393649473,2.68619398704549e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS6,Growth arrest-specific protein 6,42236,-0.0396222115762263,0.00252096235329098,-0.0445632977886766,-0.0346811253637759,3.51997646831756e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAB2,Disabled homolog 2,42262,0.17309145450532,0.0110769887325333,0.151380556589554,0.194802352421085,1.4311647238786e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0519487309752859,0.00333205825571877,0.0454178967940771,0.0584795651564947,2.50581079525182e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFC,Vascular endothelial growth factor C,42181,0.0862264613576524,0.00553463237528332,0.0753785819020971,0.0970743408132077,2.9590977349571e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.0928904432312935,0.00598233554946064,0.0811650655543507,0.104615820908236,6.74906091684834e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.155266518982036,0.0100067000351963,0.135653386913052,0.174879651051021,9.60114738224351e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF2,Growth/differentiation factor 2,42145,0.0546861873470864,0.00353280591811766,0.0477618877475758,0.061610486946597,1.37126030237498e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHBP1,EH domain-binding protein 1,39958,0.115948169542678,0.00750344632953692,0.101241414736786,0.130654924348571,2.52211900688314e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPOCK1,Testican-1,42016,0.0403203308716452,0.00261161590023255,0.0352015637071894,0.045439098036101,2.57627679550334e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.16380455415424,0.010623314855991,0.142982857036498,0.184626251271982,3.43935115227625e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.15399462391186,0.00999099628529636,0.134412271192679,0.173576976631041,3.76833225627533e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0464442882441882,0.00301169733840803,0.0405413614609085,0.052347215027468,4.07215998638694e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC4,Syndecan-4,42145,0.0727045261528119,0.00473376270602102,0.0634263512490107,0.0819827010566131,8.62013678333718e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.079104457996062,0.00515067355116972,0.0690091378357694,0.0891997781563547,1.05630115111915e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOMO1,Nodal modulator 1,42137,0.0356743007592623,0.00232664937784673,0.0311140679786827,0.0402345335398419,1.27513972067487e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0576900149363318,0.00376247702931627,0.0503155599588719,0.0650644699137917,1.27998608691434e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0393182993174851,0.00256293890605962,0.0342949390616082,0.0443416595733619,1.41442629020819e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINK1,Misshapen-like kinase 1,39929,0.143242582518774,0.00935038305513732,0.124915831730705,0.161569333306843,1.90000701277715e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS2,Protein MTSS 2,39919,0.153984036946325,0.010068663222473,0.134249457030278,0.173718616862372,2.81529116869507e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,41997,0.035235595263569,0.0023061986808205,0.0307154458491609,0.0397557446779772,2.92489215145203e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR3,Anterior gradient protein 3,41827,0.0901821725630297,0.0059116083188299,0.078595420258123,0.101768924867936,4.22454281766727e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42185,0.190632305095358,0.0125282559807665,0.166076923373056,0.21518768681766,7.38671582028423e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXIN1,Axin-1,42119,0.146674340302539,0.00964250787125428,0.12777502487488,0.165573655730197,7.99662070361671e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.12222164018272,0.00803922793807875,-0.137978526941354,-0.106464753424085,9.05838183733324e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCS1,Neuronal calcium sensor 1,42262,0.0428836306013076,0.00282671376708824,0.0373432716178146,0.0484239895848005,1.45068453918997e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR5,Complement factor H-related protein 5,39864,0.0632995759262619,0.00418175283203921,0.0551033403754651,0.0714958114770588,2.94037677798756e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYNU,Kynureninase,42296,0.0686795873845463,0.00454358700987984,0.0597741568451818,0.0775850179239108,3.3009557310002e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.16527952402382,0.0109313920185468,0.143853995667469,0.186705052380172,3.78397168117684e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP4,Dipeptidyl peptidase 4,41948,0.0420199395020754,0.00279085449277939,0.0365498646962278,0.047490014307923,8.19851004089496e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F9,Coagulation factor IX,42199,0.027483804506931,0.00183449643220485,0.0238881914998094,0.0310794175140525,2.43847539484584e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR4,Complement factor H-related protein 4,39945,0.109816140611854,0.00734850036301819,0.0954130799003379,0.124219201323369,5.09051837208916e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.0910241169470741,0.00612043530404168,0.0790280637511524,0.103020170142996,1.2563339720692e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42217,0.0686565343343035,0.00462068282005904,0.0595999960069877,0.0777130726616192,1.49671539525244e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR37,Prosaposin receptor GPR37,41900,0.0969229819706088,0.00652559937485594,0.0841328071958911,0.109713156745326,1.66424251726368e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42119,0.0635359827986269,0.00428101400589035,0.0551451953470818,0.071926770250172,1.93851747456231e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL17,C-C motif chemokine 17,42107,0.135639388554947,0.00914109808926948,0.117722836299979,0.153555940809916,2.02513678541121e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR2,Cadherin-related family member 2,42070,0.097742001186886,0.00658893671634178,0.0848276852228562,0.110656317150916,2.15753579438739e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0606023138957015,0.00408693713244512,0.0525919171161091,0.068612710675294,2.369357163181e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42070,0.0997022446424098,0.00675237100526667,0.0864675974720871,0.112936891812732,5.89801739695539e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAB2,Stabilin-2,39966,0.0415372149955114,0.00281765870015828,0.0360146039432012,0.0470598260478216,9.78901750340561e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGL1,Fibrinogen-like protein 1,39990,-0.0956603809593484,0.00650108308407562,-0.108402503804137,-0.0829182581145602,1.45020158590682e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL22,C-C motif chemokine 22,41991,0.0759617165401121,0.00517800800098391,0.0658128208581836,0.0861106122220405,2.37728381022292e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.132092605268611,0.00900703396690624,0.114438818693475,0.149746391843747,2.54006069126115e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0606062452203649,0.00414378990302342,0.052484417010439,0.0687280734302908,4.49118377425018e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0592164370571982,0.00405018776877805,0.0512780690303932,0.0671548050840031,4.88551745205844e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK10,Kallikrein-10,42138,0.0597105264158104,0.00408923169614154,0.051695632291373,0.0677254205402478,6.31825491178266e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,41839,0.115341556265855,0.00789886836538568,0.0998597742696994,0.130823338262011,6.4011582379533e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNA4,Plexin-A4,42119,0.117302998347799,0.00804319687094531,0.101538332480746,0.133067664214851,8.17480264452692e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP20,Centrosomal protein 20,41843,0.109526822110522,0.0075119868795177,0.0948033278266676,0.124250316394377,8.79200892469695e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.114626329611889,0.00787883410498373,0.0991838147661211,0.130068844457657,1.59921627421135e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42199,-0.0403111131851638,0.00277674682995164,-0.0457535369718691,-0.0348686893984586,2.12606547998412e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.121101698328037,0.008338331903,0.104758567798157,0.137444828857917,2.32821933833381e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0661256412467977,0.00455696197471389,0.0571939957763585,0.075057286717237,2.75039586814228e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.118108359372836,0.00814983644551222,0.102134679939632,0.13408203880604,3.04489750777802e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL13,C-X-C motif chemokine 13,42249,0.0831922921338121,0.00574553955204369,0.0719310346118065,0.0944535496558177,3.65274172664635e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD63,CD63 antigen,41992,0.0730864859454188,0.00504946723080715,0.0631895301730368,0.0829834417178009,4.0048139714206e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK1,Dickkopf-related protein 1,42249,0.0851283128252453,0.0058941227258873,0.0735758322825062,0.0966807933679844,6.16204844146107e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.152787571382729,0.0105924537705264,0.132026361992497,0.173548780772961,9.58988927651868e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0588549874537966,0.00408276590957404,0.0508527662710314,0.0668572086365617,1.06994770479799e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.140912168582594,0.00978341568871782,0.121736673832707,0.160087663332481,1.09807439109417e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0529605429874521,0.00368481300294627,0.0457383095016774,0.0601827764732268,1.69553041520844e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOE,Apolipoprotein E,39979,0.100855036928982,0.00702116188508866,0.0870935596342087,0.114616514223756,2.19953833715598e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.161906005667476,0.0113030848233413,0.139751959413727,0.184060051921225,3.37137786733196e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF1,Pigment epithelium-derived factor,39815,0.037815765448096,0.00264019521601836,0.0326409828247001,0.042990548071492,4.00224679370357e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0619728275954279,0.00433055991943315,0.0534849301533389,0.0704607250375169,4.7359302505305e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,39929,0.126824716900616,0.00887855875684781,0.109422741737194,0.144226692064038,6.8490151000885e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.074771681438987,0.00526132630831408,0.0644594818746914,0.0850838810032825,1.66085498440775e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCK2,Cytoplasmic protein NCK2,42185,0.151912179405475,0.0106903005763049,0.130959190275917,0.172865168535032,1.67536940031594e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES3,Carboxylesterase 3,42070,0.101109488984911,0.00711506102937058,0.0871639693673445,0.115055008602477,1.67781741896046e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.094230599563011,0.00663950657894562,0.0812171666682776,0.107244032457744,2.19555942924944e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL10,C-X-C motif chemokine 10,42185,0.0934637671361415,0.00659400623008682,0.0805395149251714,0.106388019347112,2.78773305150149e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELN,Elastin,39958,0.049371628183502,0.00348343947178011,0.042544086818813,0.056199169548191,3.25599307286964e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILPL2,RILP-like protein 2,39958,0.140190396481271,0.00991255877759701,0.120761781277181,0.159619011685361,4.98995855624446e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.14588223683301,0.0103173987101218,0.125660135361172,0.166104338304849,5.35585761248373e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,39934,0.161553553992356,0.0114801097867197,0.139052538810386,0.184054569174327,1.33004349642597e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.118722204144124,0.00847524318840369,0.102110727494852,0.135333680793395,3.24727096032378e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBIN,Erbin,42070,0.143623737500693,0.0102633017552634,0.123507666060377,0.163739808941009,3.46126391034307e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.101192297911458,0.00724029477444195,0.0870013201535518,0.115383275669364,4.43669181614808e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCTN3,Tectonic-3,39958,0.0426562778814951,0.00305020160367239,0.0366778827382972,0.048634673024693,4.478633202821e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.132647557336216,0.00950165680750755,0.114024309993501,0.151270804678931,5.46874481235283e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMIP,C-Maf-inducing protein,39919,0.117629693155242,0.00842011878788347,0.10112626033099,0.134133125979493,5.4997752775277e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,39930,0.135286279143495,0.00968781256582048,0.116298166514487,0.154274391772503,5.92792075521333e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD1,Sushi domain-containing protein 1,41900,0.0679307323308922,0.00487624695401307,0.0583732883010265,0.0774881763607578,8.34365825911618e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42119,0.0465534550935298,0.00334620457995265,0.0399948941168226,0.053112016070237,1.06667848310757e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.118437020446118,0.00851412478308157,0.101749335871278,0.135124705020958,1.27312037928793e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXLNA,Alpha-taxilin,42016,0.122503562596583,0.00881559607680816,0.105224994286039,0.139782130907127,1.33832301932755e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42249,0.132681708835825,0.00955476632240863,0.113954366843904,0.151409050827746,1.51351551467073e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP85,Centrosomal protein of 85 kDa,41843,0.0903198632899549,0.00650975709724713,0.0775607393793505,0.103078987200559,1.8200349488651e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.10158518563593,0.00732243059913204,0.0872332216616309,0.115937149610228,1.85503071646395e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42310,0.0561352807715507,0.00404852494893474,0.0482001718716386,0.0640703896714628,2.00955743098864e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG16L1,Autophagy-related protein 16-1,39930,0.12004077794008,0.00866136059454799,0.103064511174766,0.137017044705394,2.51924979014003e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFX1,Transcriptional repressor NF-X1,39575,0.0941011782420103,0.00679184086410444,0.0807891701483656,0.107413186335655,2.74282618584514e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,39736,0.1156216674186,0.00836399578728514,0.0992282356755208,0.132015099161679,4.15791721450347e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLA2,Src-like-adapter 2,39934,0.148246004592048,0.0107272045426338,0.127220683688485,0.16927132549561,4.33599921616313e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL5,C-C motif chemokine 5,42217,0.139453507570121,0.0101027048276247,0.119652206107976,0.159254809032265,4.72631611084522e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADIPOQ,Adiponectin,39979,-0.0955533985201045,0.00693239553977672,-0.109140893778067,-0.0819659032621422,7.06660842766392e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD6,T-cell differentiation antigen CD6,42284,0.0716264819965736,0.00521512659302984,0.0614048338742352,0.0818481301189121,1.21187202554112e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GASK1A,Golgi-associated kinase 1A,39575,0.0590051604055509,0.00429740920137174,0.0505822383708622,0.0674280824402395,1.49913351258989e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.116787418270825,0.00852034817326252,0.100087535851231,0.13348730069042,1.79940209317906e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0381548903752213,0.00278434931005174,0.0326975657275199,0.0436122150229227,1.86280259664963e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM1,Isthmin-1,42119,0.0541310434045666,0.00395176808171755,0.0463855779644003,0.061876508844733,2.00490136788152e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,39736,0.105183955193962,0.00767813746563399,0.0901348057613194,0.120233104626605,2.26381415482229e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTBDN,Retbindin,42070,0.0410944836148493,0.00300307525777632,0.0352084561096077,0.0469805111200909,2.42352485356036e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.148962943966011,0.0108787079767573,0.127640676331567,0.170285211600455,2.42533641900543e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARF6,ADP-ribosylation factor 6,39930,0.149323020031295,0.010921303314709,0.127917265534465,0.170728774528124,3.19791148543816e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEC31A,Protein transport protein Sec31A,39638,0.106178627843215,0.00777747267794129,0.0909347813944499,0.12142247429198,4.30772423808338e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCR,Breakpoint cluster region protein,42119,0.125996222426044,0.00924012511379091,0.107885577203014,0.144106867649074,4.65521520637883e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN1,Perilipin-1,41839,0.0462022649921703,0.00339191435284346,0.0395541128605971,0.0528504171237434,5.73731940308272e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.141793742721911,0.0104123047537388,0.121385625404583,0.162201860039239,5.92665122801927e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.051743165004799,0.00380332387165235,0.0442886502163603,0.0591976797932376,7.17406359415183e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFP,Alpha-fetoprotein,41976,0.0887095021185528,0.00653107515319863,0.0759085948182835,0.101510409418822,9.59488254257141e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0403423932796659,0.0029724991961559,0.0345162948552003,0.0461684917041315,1.09282104799102e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R9B,Neurabin-2,42296,0.128606017530261,0.00948976950894762,0.110006069292723,0.147205965767798,1.42743927300092e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.138972978529748,0.0102578926313585,0.118867508972285,0.15907844808721,1.51528630847959e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL16,Pro-interleukin-16,42296,0.0573642571971241,0.00423557235787971,0.0490625353756798,0.0656659790185683,1.60280115775317e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.154779151719707,0.0114615812476889,0.132314452474237,0.177243850965177,3.08073434474672e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.105784758887947,0.00786932554410627,0.0903608808214986,0.121208636954395,6.98799058383999e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO1,Forkhead box protein O1,42119,0.1161272604669,0.00867326820143399,0.0991276547920897,0.133126866141711,1.27038750613702e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK2,Docking protein 2,42145,0.164670382414363,0.0123065822181581,0.140549481266773,0.188791283561953,1.4192104125747e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH2,Neutral ceramidase,42016,0.0712667841126964,0.0053302996283659,0.0608193968410992,0.0817141713842935,1.64173367369914e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42070,0.183620529808962,0.0137393387749579,0.156691425810045,0.21054963380788,1.76284774832915e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99L2,CD99 antigen-like protein 2,42137,0.0329299051914787,0.00246432935141663,0.0280998196627021,0.0377599907202553,1.80399543552355e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL17,C-X-C motif chemokine 17,42296,0.0569809319894489,0.00426544334271945,0.0486206630377188,0.065341200941179,1.88657680470932e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,39934,0.159376231808711,0.0119355547530308,0.135982544492771,0.182769919124652,2.29319611840907e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.14780356372047,0.0110758021221483,0.12609499156106,0.169512135879881,2.56468004841858e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FETUB,Fetuin-B,42199,0.0429017044449176,0.00322389933333171,0.0365828617515875,0.0492205471382477,3.7371917783966e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKBKG,NF-kappa-B essential modulator,42119,0.121726532691158,0.00914754443242697,0.103797345603601,0.139655719778715,3.76867627863826e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1B,Meprin A subunit beta,42145,0.152830052608183,0.0114863535395524,0.13031679967066,0.175343305545706,3.84789661443764e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.0991875246249471,0.00745630402819527,0.0845731687296844,0.11380188052021,4.55135988105619e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.119996425639142,0.00902856522341906,0.102300437801241,0.137692413477043,5.21801874265204e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGCC,Regulator of cell cycle RGCC,39934,0.102347014187542,0.00770197797320831,0.0872511373600539,0.11744289101503,5.37999478855841e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HJV,Hemojuvelin,39934,0.0561490717286604,0.00423493847455857,0.0478485923185256,0.0644495511387952,7.96720345386307e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCG,Pro-glucagon,41843,0.164670746337016,0.0124310709157196,0.140305847342206,0.189035645331827,8.44342400976613e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREG1,Protein CREG1,41960,0.0534909023783227,0.00404658271552545,0.0455596002558928,0.0614222045007526,1.21229325963763e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0434281324059361,0.00328727235917248,0.0369850785819581,0.0498711862299142,1.33654456243194e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.092504912924319,0.00701093048849141,0.0787634891668759,0.106246336681762,1.6726124830059e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.113026273272875,0.00856714177858589,0.0962346753868469,0.129817871158904,1.91336333331437e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D23,TBC1 domain family member 23,42070,0.118940054578373,0.00902979026031193,0.101241665668161,0.136638443488584,2.22840475751033e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42185,0.112975290008275,0.00858189615767276,0.0961547735392368,0.129795806477314,2.44931248612422e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7,Interleukin-7,42119,0.0850985520356125,0.00646530958891184,0.0724265452413453,0.0977705588298797,2.522320392851e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FST,Follistatin,42166,0.0641388826877867,0.00488006826869289,0.0545739488811487,0.0737038164944248,3.23937323571122e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APPL2,DCC-interacting protein 13-beta,39736,0.149494976789862,0.0113718208515971,0.127206207920732,0.171783745658993,3.50671489858285e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,39929,0.0636316828502099,0.00485217574157967,0.0541214183967137,0.073141947303706,5.25978940308543e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPHN1,Oligophrenin-1,39929,0.143090499315059,0.0109151875230916,0.1216967317698,0.164484266860319,5.59445535600531e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD27,CD27 antigen,42181,-0.0560479723681225,0.00427940939460693,-0.0644356147815521,-0.047660329954693,5.88784078360027e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,39990,0.0351790659601343,0.00268638754187873,0.029913746378052,0.0404443855422167,6.68608308618909e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,39657,0.127809079259834,0.00976248004380334,0.10867461837398,0.146943540145689,7.1271266623221e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.135099623923815,0.0103225272242487,0.114867470564287,0.155331777283342,7.39056852440016e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPING1,Plasma protease C1 inhibitor,39959,0.0243513457905885,0.0018645582838831,0.0206968115541776,0.0280058800269993,1.05674765549435e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.118682742338077,0.00909616569834304,0.100854257569324,0.136511227106829,1.24515229746845e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELP,P-selectin,42217,0.0728427616383047,0.00559239432086549,0.0618816687694083,0.0838038545072011,1.49250833599332e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.152570934171198,0.0117152247293795,0.129609093701614,0.175532774640782,1.54089130062585e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USO1,General vesicular transport factor p115,42070,0.116146687195804,0.00892588907635575,0.0986519446061467,0.133641429785461,1.77564186171039e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.145789294647495,0.0112074569377781,0.12382267904945,0.16775591024554,1.87761422209167e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.0978277770258967,0.0075234796649361,0.083081756882622,0.112573797169172,2.25845637836857e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42145,0.112994909532488,0.00870459680070048,0.0959338998031146,0.13005591926186,2.65132977291229e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD7B,OTU domain-containing protein 7B,39934,0.0825846554516777,0.00635978713989066,0.070119472657492,0.0950498382458634,2.77396623526647e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0468288429698962,0.00360686425778376,-0.0538982969151524,-0.03975938902464,2.85377597912566e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1R,Complement C1r subcomponent,39979,0.0245862604115545,0.00189398311002842,0.0208740535158988,0.0282984673072102,2.92073033875006e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AAMDC,Mth938 domain-containing protein,39638,0.0690545196228209,0.00532435428795392,0.0586187852184312,0.0794902540272105,3.45979866455438e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0728975554866985,0.00562923851373408,0.0618642479997798,0.0839308629736173,3.98541100588558e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A4,Protein S100-A4,42181,0.0724948562054036,0.00561357302498758,0.0614922530764279,0.0834974593343792,6.25730145021298e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.0945227262516887,0.00732864478382229,0.080158582475397,0.10888687002798,8.68859802011288e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN2,CCN family member 2,42146,0.0728773014831808,0.00565717496889103,0.0617892385441544,0.0839653644222072,9.43418759925747e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBP2,Poly(rC)-binding protein 2,39934,0.0946521671670147,0.00734685947448564,0.0802523225970228,0.109052011737007,1.0270368205976e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEP,Leptin,42145,0.0896478611426692,0.00697140572922011,0.0759839059133978,0.103311816371941,1.26473056637922e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0678452050162603,0.00527792013058197,0.0575004815603197,0.078189928472201,1.36097684700786e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSC2,Desmocollin-2,41984,-0.0453065490255191,0.003525244999289,-0.0522160292241255,-0.0383970688269126,1.39744639333159e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.13776954785914,0.0107155930370902,0.116766985506444,0.158772110211837,1.43895114804973e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPC,C-type natriuretic peptide,42119,0.0676780020203487,0.00526967096549895,0.0573494469279708,0.0780065571127267,1.56171541412116e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPB,Natriuretic peptides B,41900,-0.180663077217043,0.0140701058012529,-0.208240484587499,-0.153085669846587,1.63026447252038e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2B3,SH2B adapter protein 3,41843,0.126279783019098,0.00986411803135322,0.106946111677646,0.145613454360551,2.66057379413445e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.107766179344299,0.0084234295595231,0.0912562574076341,0.124276101280965,3.22109480990687e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,39958,0.11743911189966,0.00917993368938133,0.0994464418684725,0.135431781930847,3.23911292508527e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK13,Kallikrein-13,41839,0.0573073044727928,0.0044958737750569,0.0484953918736812,0.0661192170719043,5.36876069825532e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLG,Plasminogen,39742,0.02801560310808,0.00220166388348523,0.0237003418964489,0.032330864319711,7.77198448043788e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.129469389334682,0.0101936308835535,0.109489872802917,0.149448905866447,9.4650832427431e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBNL,Drebrin-like protein,42185,0.117871777676503,0.00928746677961495,0.0996683427884573,0.136075212564548,1.06489246944987e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0800423401852771,0.00632572803663082,0.0676439132334807,0.0924407671370735,1.74062225746856e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,41900,0.0445498247040928,0.00352773172963233,0.0376354705140134,0.0514641788941721,2.37820342573513e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAP,Prolyl endopeptidase FAP,42310,0.0348340268948458,0.00276006431849252,0.0294243008306005,0.0402437529590912,2.58358308464008e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42100,0.0252882446422702,0.00200462595010605,0.0213591777800623,0.029217311504478,2.79813644658828e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA1,Glutathione S-transferase A1,42119,0.106965008174772,0.00848777343671908,0.0903289722388021,0.123601044110741,3.27896273879161e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42185,0.161271916073706,0.012799645050647,0.136184611774438,0.186359220372974,3.37687943595381e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPM,Carboxypeptidase M,42195,0.0428874618370364,0.00340808742409326,0.0362076104858136,0.0495673131882591,4.10882151672219e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA11,Annexin A11,42087,0.0832189748687146,0.00663305440351269,0.0702181882378297,0.0962197614995995,6.62450971966083e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BECN1,Beclin-1,39638,0.0750648241972756,0.00597976074264332,0.0633444931416947,0.0867851552528565,6.71587250404724e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.0987375716541672,0.00787207017613775,-0.114166829199397,-0.0833083141089372,6.88726250078754e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTPBP2,GTP-binding protein 2,39649,0.103593062765413,0.00825527988820604,0.0874127141845292,0.119773411346297,7.0940843509637e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.0832196681456368,0.00663262260256775,0.070219727844604,0.0962196084466696,7.13507102231491e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0251470087617055,0.00200724737915218,0.0212128038985672,0.0290812136248437,8.29197454232423e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0923581555888803,0.00737032868047485,0.0779123113751496,0.106803999802611,8.68817485295136e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0326031446242052,0.00260392951650478,0.0274994427718559,0.0377068464765546,9.08656067904543e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.13700346138995,0.0109517174443935,0.115538095198938,0.158468827580961,1.03840555446201e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.0985227222497289,0.00787463727900469,0.0830884331828797,0.113957011316578,1.11249830588132e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.111719388266441,0.00893000810794968,0.0942165723748592,0.129222204158022,1.12437324924382e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AREG,Amphiregulin,42070,-0.0491075234294248,0.0039290887553523,-0.0568085373899154,-0.0414065094689343,1.19998805591266e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEG1,Protein HEG homolog 1,39736,0.0347377858254411,0.00277907597961443,0.0292907969053968,0.0401847747454854,1.29768470550448e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN1,Dynactin subunit 1,42262,0.0799726692506461,0.00640439411580594,0.0674200567836665,0.0925252817176258,1.37211995130008e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLB,Beta-klotho,41839,-0.0933594583768694,0.00748102232158132,-0.108022262127169,-0.07869665462657,1.5303998534164e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL13,C-C motif chemokine 13,42275,0.0847806028354062,0.00682533967986417,0.0714029370628724,0.09815826860794,3.0964458875937e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,39627,0.071105961837979,0.00572210584624645,0.059890634379336,0.0823212892966221,3.227182504657e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.118471345402883,0.0095425755136127,0.0997678973962021,0.137174793409564,3.39332849763085e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.129189310278295,0.0104214779456111,0.108763213504898,0.149615407051693,4.22849578045193e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",41900,0.115261710047541,0.00931464799036587,0.0970049999864237,0.133518420108658,5.61128491939544e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.113414473876439,0.00917556290855408,0.0954303705756729,0.131398577177205,6.59881111024129e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCXR,L-xylulose reductase,42181,0.0671836817613854,0.00543772105363378,0.0565257484962632,0.0778416150265076,7.03593196621415e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0940838765142913,0.00762183320206585,0.0791450834382422,0.10902266959034,8.154888077107e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY4,Protein canopy homolog 4,42070,0.0928568794533508,0.00753987203902882,0.0780787302568543,0.107635028649847,1.14914190900503e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,39575,0.075370804610203,0.00611926731936928,0.0633770406642392,0.0873645685561668,1.24252196498849e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.156473837986203,0.0127261605787182,-0.181417112720491,-0.131530563251916,1.45824173513799e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.0848505305453734,0.00689749631208023,0.0713314377736962,0.0983696233170507,1.49841529853639e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.084902158541752,0.006903186325214,0.0713719133443326,0.0984324037391715,1.54333149314229e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSTN,Growth/differentiation factor 8,41900,0.0666056299590556,0.0054188245224388,0.0559847338950756,0.0772265260230357,1.54854859054961e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK1,Docking protein 1,39929,0.169933788222102,0.0138224232486759,0.142841838654697,0.197025737789506,1.61724473782983e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZI2,5-azacytidine-induced protein 2,39934,0.0687042131875649,0.00560038685553408,0.0577274549507181,0.0796809714244117,2.22863087195316e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42181,0.0304000087597389,0.00248057135598636,0.0255380889020056,0.0352619286174721,2.39113759596097e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MITD1,MIT domain-containing protein 1,42016,0.118719929878005,0.00969150500010562,0.0997245800777983,0.137715279678212,2.56536706516209e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINH1,Serpin H1,39757,0.158687041563575,0.0129717337535076,0.1332624434067,0.18411163972045,3.41663530688349e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.11632692558283,0.00951748990843206,0.097672645362303,0.134981205803357,3.58433252748312e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IST1,IST1 homolog,39850,0.121056160090964,0.00991277264457988,0.101627125707588,0.140485194474341,4.39909794665481e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42107,0.134012411675476,0.0109802620945403,0.112491097970177,0.155533725380775,4.42683782570856e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRAP,BRCA1-associated protein,39813,0.13508403109866,0.011075991868048,0.113375087037286,0.156792975160034,5.35132434488522e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0812384585169404,0.00666326630938863,0.0681784565505387,0.0942984604833422,5.59608356612293e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM17,Splicing factor 45,39934,0.0942271477905626,0.00774212176828485,0.0790525891247243,0.109401706456401,7.23955992740227e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.151125940116121,0.0124251564411032,0.126772633491559,0.175479246740683,7.4501439916484e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.0988494824138617,0.00816474835611576,0.0828465756358748,0.114852389191849,1.56397878274009e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB3,Plexin-B3,42099,0.0581142070714624,0.00482130264285179,0.0486644538914729,0.0675639602514519,2.75069801619442e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN2,Prorelaxin H2,39709,0.0625335125236078,0.00518939094450191,0.052362306272384,0.0727047187748315,3.11479360623394e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,39736,0.153109236208168,0.0127334793602868,0.128151616662006,0.178066855754331,4.25211620059345e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",41839,0.064179775085139,0.00534131036120696,0.0537108067771733,0.0746487433931046,4.36548302264732e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42123,-0.0417756331644587,0.00347863304082198,-0.0485937539244698,-0.0349575124044476,4.68126212575237e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0372874674196028,0.00310551857402154,-0.043374283824685,-0.0312006510145205,5.22841121366555e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.0844494946152527,0.00703548772964079,0.0706599386651567,0.0982390505653486,5.4071706187289e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPK2,SRSF protein kinase 2,42119,0.102251022232448,0.00853153785844384,0.0855292080298984,0.118972836434998,6.24810901346442e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0931037484528083,0.00778348517994212,0.0778481175001217,0.108359379405495,8.26733543210619e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11R,Junctional adhesion molecule A,42137,0.066806736121156,0.00559031431804788,0.0558497200577821,0.0777637521845298,9.43643537527547e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0860905620839011,0.00720690207501935,0.0719650340168631,0.100216090150939,9.98781636868267e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCC,Tubulin-specific chaperone C,42016,0.09636008690602,0.00806727537692847,0.0805482271672402,0.1121719466448,1.01549651537317e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA2,Apolipoprotein A-II,39990,-0.0593864749541865,0.00497021671030505,-0.0691280997063844,-0.0496448502019886,1.03704153140916e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR,GMP reductase 1,42296,0.0568586945804741,0.00477501619514002,0.0474996628379997,0.0662177263229486,1.56466188262132e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS1BP3,HCLS1-binding protein 3,39638,0.109442824807975,0.00918623843909444,0.0914377974673503,0.1274478521486,1.58728082413403e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42310,0.0273159647843753,0.00229853700455512,0.0228108322554473,0.0318210973133034,2.06598995691593e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMVK,Phosphomevalonate kinase,41832,0.129283869608348,0.0108816486707776,0.107955838213624,0.150611901003072,2.17305048589085e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.116428670445126,0.00980429343946104,0.0972122553037828,0.13564508558647,2.29350627646102e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRKL,Crk-like protein,42143,0.125269432306729,0.0105746723787287,0.104543074444421,0.145995790169038,3.24836200439776e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9,Complement component C9,39990,-0.0684697981157147,0.00579753138363599,-0.0798329596276412,-0.0571066366037881,5.31513312106324e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGLL,Monoglyceride lipase,42166,0.103117122956479,0.00874851384436043,0.085970035821533,0.120264210091426,6.53204926221539e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE4,Ribonuclease 4,39645,0.0329372955912266,0.00279320046470852,0.0274626226803979,0.0384119685020553,6.66970693405906e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC1,Stanniocalcin-1,42249,0.054126902310542,0.00459304373062064,0.0451245365985256,0.0631292680225585,6.69467230118468e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM13A,Protein FAM13A,39930,0.0806454556046561,0.00684173472575932,0.0672356555421679,0.0940552556671444,6.96857137208117e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.075944501111859,0.00644390052780478,0.0633144560773617,0.0885745461463564,7.16971906974147e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,39922,0.023847647844965,0.00202404973339478,0.0198805103675112,0.0278147853224188,7.40337284985779e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.0612565969272722,0.00520359460030003,0.0510575515106841,0.0714556423438603,7.78626919461438e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TWF2,Twinfilin-2,39966,0.100916508254141,0.00856984108819355,0.0841196197212821,0.117713396787001,7.96426302461073e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,41900,0.0906818722039243,0.00771986666384875,0.0755509335427807,0.105812810865068,1.05484985426024e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3B1,AP-3 complex subunit beta-1,39930,0.0911504783110914,0.00776192609522752,0.0759371031644454,0.106363853457737,1.16637800828833e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42098,-0.0762041501853022,0.00649369799293346,-0.0889317982514518,-0.0634765021191527,1.20004781214833e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1A,Lithostathine-1-alpha,42105,-0.0586548432721171,0.00500314338623472,-0.0684610043091371,-0.048848682235097,1.37245602422879e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0579279749211677,0.00494400063777906,0.0482377336711207,0.0676182161712146,1.49585121569521e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0281762120143451,0.00240911486161593,0.0234543468855779,0.0328980771431124,1.90000171219057e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL16,C-C motif chemokine 16,42310,0.06019304080331,0.00514717042116718,0.0501045867778223,0.0702814948287976,1.92007623023512e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANG,Angiogenin,42152,0.0384443790445699,0.00328895066121645,0.0319980357485856,0.0448907223405541,2.05406599058387e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0635658071366928,0.00543568368839233,0.0529118671074438,0.0742197471659418,2.08131993209528e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0908132035448563,0.00777000191106238,0.075583999799174,0.106042407290539,2.24660434766712e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYTL4,Synaptotagmin-like protein 4,39958,0.0854926912042632,0.00731632036373653,0.0711527032913396,0.0998326791171868,2.29311748738225e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0647003917755303,0.00554457230651128,0.0538330300547682,0.0755677534962924,2.57777446394169e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORD,Sorbitol dehydrogenase,42204,0.0802658603565349,0.00689389983754234,0.0667538166749519,0.0937779040381179,3.50004420344023e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0431409457426961,0.00370635883779428,-0.0504054090647729,-0.0358764824206193,3.6435000251611e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLSCR3,Phospholipid scramblase 3,39911,0.0676269030481486,0.00581484468263417,0.0562298074701856,0.0790239986261115,4.35623848886773e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0299177809682395,0.0025758986511701,0.0248690196119461,0.0349665423245329,4.87973974666193e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BACH1,Transcription regulator protein BACH1,42119,0.087318666841015,0.00751866229184831,0.0725820887489923,0.102055244933038,4.93460910945554e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0286560279284071,0.00247108004006368,0.0238127110498822,0.0334993448069319,6.4001119642619e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX15,Sorting nexin-15,39736,0.0630760141118611,0.00544275627838956,0.0524082118062175,0.0737438164175046,7.04554125101772e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0313974369585398,0.00271094910379128,0.0260839767151089,0.0367108972019707,7.13042060149327e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAX,Protein max,41839,0.123029681695022,0.0106332626826029,0.10218848683712,0.143870876552923,8.20062962312138e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0328413472537516,0.00284493191378842,0.0272652807027262,0.0384174138047769,1.17716916296559e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7,Complement component C7,39722,-0.0388007105303785,0.00336288234317072,-0.0453919599229932,-0.0322094611377639,1.26862080460234e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.128838337379082,0.0111726006371347,0.106940040130298,0.150736634627866,1.27977081490325e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EREG,Proepiregulin,41997,0.0927167105408866,0.00805437242384137,0.0769301405901575,0.108503280491616,1.60937159340057e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBPL,FK506-binding protein-like,39930,0.0688163138591929,0.00597809733351629,0.057099243085501,0.0805333846328848,1.70748115300499e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,41843,0.104524538256851,0.00908510140182325,0.0867177395092777,0.122331337004425,1.73672895743364e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTBS,Di-N-acetylchitobiase,39860,0.0318647699402277,0.00277377991488396,0.0264281613070552,0.0373013785734003,2.24155200940054e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0498027846673451,0.00434080263911625,-0.058310757840013,-0.0412948114946773,2.48621664665411e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPP,Lipoma-preferred partner,39575,0.0763637033820279,0.00665613031591226,0.0633176879628399,0.0894097188012159,2.69258539875851e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BID,BH3-interacting domain death agonist,42119,0.0759798592237081,0.00664080875225892,0.0629638740692806,0.0889958443781356,3.57644334833115e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD1,COMM domain-containing protein 1,39638,0.0703150137499322,0.00614235090748444,0.0582760059712627,0.0823540215286017,3.57802223946685e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPY30,Protein dpy-30 homolog,42216,0.068885038596099,0.00602974449222879,0.0570667393913305,0.0807033378008674,4.33963401874555e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK11,Serine/threonine-protein kinase STK11,41900,0.0837109544422807,0.00732795624942031,0.0693481601934169,0.0980737486911445,4.40704575483977e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIFBP,KIF-binding protein,42070,0.0946014096260633,0.00828977145890179,0.0783534575666158,0.110849361685511,5.0141526138e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP4,Secreted frizzled-related protein 4,39736,0.0460086762008587,0.00403691688726863,0.0380963191018122,0.0539210332999053,6.33988313779032e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNMBP,Dynamin-binding protein,42016,0.0693188872823537,0.00608713489906787,0.0573881028801807,0.0812496716845268,6.60071268824455e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.0657771748440072,0.00578845619173661,0.0544318007082035,0.077122548979811,9.29630896467715e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42119,0.0988274460835149,0.00870264794783395,0.0817702561057603,0.115884636061269,9.44166955015718e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN1,Pantetheinase,39990,0.0836613103329959,0.00736904397700906,0.0692179841380582,0.0981046365279337,1.03400451541468e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLA,Alpha-galactosidase A,39713,0.0448683154036052,0.00395186372394237,0.0371226625046781,0.0526139683025322,1.03598110111559e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPART,Spartin,39736,0.0889832598281706,0.00784893009198051,0.0735993568478888,0.104367162808452,1.25046402828333e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F12,Coagulation factor XII,39979,0.0470995684729318,0.00416295300226017,0.0389401805885019,0.0552589563573617,1.60847679873837e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.083675686163483,0.00740146802259161,0.0691688088392034,0.0981825634877625,1.79392416510412e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4D,Semaphorin-4D,42249,0.0340875082590826,0.00301731932333204,0.0281735623853518,0.0400014541328134,1.82901669654422e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0804205257115449,0.00711872420588961,0.0664678262680012,0.0943732251550885,1.84788529804688e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.123592149421304,0.0109375938675049,0.102154465440994,0.145029833401613,1.9230687862508e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHD3,EH domain-containing protein 3,39638,0.134323551712231,0.011889459198274,0.111020211683614,0.157626891740848,1.95377371017339e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.0979814421184975,0.00867807308983747,0.080972418862416,0.114990465374579,2.09486587085791e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0932852195507018,0.00827953211859211,0.0770573365982613,0.109513102503142,2.5793279380104e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,39657,0.099973550935297,0.00887600153692063,0.0825765879229326,0.117370513947661,2.87234560873388e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0755021448412431,0.00671245900396848,0.0623457251934649,0.0886585644890213,3.37972427496232e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.103036069002529,0.00916025696867103,0.0850819653439341,0.120990172661125,3.40583377091892e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMN,Protein amnionless,41913,0.0533227059272068,0.00474369806753364,0.0440250577148409,0.0626203541395728,3.48097074491495e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDHD2,Phospholipase DDHD2,39934,0.0751290137000863,0.0066871103442122,0.0620222774254304,0.0882357499747422,3.91670167003411e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0747544205138238,0.00666900079990326,0.0616831789460134,0.0878256620816342,4.91254583234432e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOT,Angiomotin,39736,0.043349915910916,0.00386717361200446,0.0357702556313873,0.0509295761904448,5.2234187456918e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,39638,0.068987860002249,0.00615502935381389,0.0569240024687738,0.0810517175357243,5.31910801215065e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0360840829937232,0.00322132955951397,-0.0423978889303706,-0.0297702770570758,5.36238206837846e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAP1,Proline-rich acidic protein 1,39966,0.0440963849888446,0.00393499573086378,0.0363837933563516,0.0518089766213376,5.39324034518381e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDC,Nuclear migration protein nudC,42296,0.0713510216143079,0.00637156322848192,0.0588627576864834,0.0838392855421325,5.55042096356695e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0821375204050995,0.00733701671519118,0.0677569676433248,0.0965180731668742,6.1768063158105e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB27B,Ras-related protein Rab-27B,39958,0.0929234897571793,0.00830386124905595,0.0766479217090296,0.109199057805329,6.43608317631408e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.0996573451026796,0.00892287314744093,0.0821685137336954,0.117146176471664,8.19193058206127e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,41992,0.0454204222454411,0.00407482833565435,0.0374337587075586,0.0534070857833236,9.95400921951018e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAN,Neurocan core protein,42249,0.0418809268756251,0.00375943800549294,0.0345124283848589,0.0492494253663913,1.06280473927159e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAMBP,STAM-binding protein,41997,0.0704301385992506,0.00632728703254358,0.0580286560154652,0.082831621183036,1.18141494465957e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF3,Trefoil factor 3,42143,-0.040319720174475,0.00362312181442084,-0.0474210389307399,-0.0332184014182101,1.21401646808262e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP43,Centrosomal protein 43,41797,0.07865057135309,0.00707262801971957,0.0647882204344397,0.0925129222717404,1.33722088831145e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0832289608286839,0.00748225287340043,0.068563745196819,0.0978941764605487,1.36251172702176e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA2,Adenosine deaminase 2,42096,-0.0489147842743221,0.00440340404081085,-0.0575454561943113,-0.0402841123543328,1.51820184841176e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEXN,Nexilin,39990,0.0780228335660483,0.00702548669498337,0.0642528796438809,0.0917927874882157,1.64861821938933e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2L,Ataxin-2-like protein,39934,0.053849280558867,0.00484957046217854,0.044344122452997,0.0633544386647369,1.68376623964807e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0582123696610382,0.00524648275483555,0.0479292634615605,0.0684954758605158,1.84912823248453e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLGA3,Golgin subfamily A member 3,39934,0.0868033269884225,0.00783010797915767,0.0714563153492734,0.102150338627572,2.05678287715933e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42070,0.0944265209089196,0.00852292040257458,0.0777215969198735,0.111131444897966,2.10113394551595e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA9,Carbonic anhydrase 9,42262,-0.0519057747399139,0.00468739551403837,-0.0610930699474291,-0.0427184795323987,2.22785090338911e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.105855930850849,0.00956230965347768,0.0871138039300332,0.124598057771666,2.32956823715295e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0752722564671972,0.00680184610998109,-0.0886038748427602,-0.0619406380916343,2.41635185962938e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP2,Methionine aminopeptidase 2,42247,0.0618897739380675,0.0055951388703013,0.050923301752277,0.0728562461238581,2.54843790229221e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.110181153875324,0.00996241480252697,0.0906548208623712,0.129707486888277,2.60250014920675e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.0705880381201175,0.00638867459919849,0.0580662359056884,0.0831098403345465,2.94751275063842e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0805131365624771,0.00728382371795973,0.066236842075276,0.0947894310496781,2.95032561221829e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0337326557517984,0.00305406468003531,-0.0397186225246676,-0.0277466889789292,3.05567119436251e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNST,Consortin,42145,0.120645128468278,0.0109316832892297,0.0992190292213882,0.142071227715169,3.36775341015064e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG2,Bone marrow proteoglycan,39966,-0.056881609755653,0.00516152287658198,-0.0669981945937537,-0.0467650249175524,4.23137181767247e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LG,CMRF35-like molecule 9,42137,-0.0412657816693218,0.00374660772768325,-0.048609132815581,-0.0339224305230627,4.29715077460132e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,A1BG,Alpha-1B-glycoprotein,39979,0.0183764744106402,0.00166850258276291,0.0151062093484249,0.0216467394728555,4.54612542679902e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPL,N-acetylneuraminate lyase,39958,0.0514648710130605,0.00467310285546865,0.042305589416342,0.0606241526097791,4.58672175853362e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEXIM1,Protein HEXIM1,42119,0.089068846507602,0.00809597629660129,0.0732007329662635,0.104936960048941,4.93514374815334e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2AP,CD2-associated protein,42145,0.0696670554015849,0.00633250135102453,0.0572553527535768,0.082078758049593,4.93866400161473e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.0853729620973538,0.00775778988990858,0.070167693913133,0.100578230281575,5.01851747328896e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC27,Cell division cycle protein 27 homolog,41843,0.0671337987830092,0.00610845865628016,0.0551612198167001,0.0791063777493183,5.62028924231085e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.079849567742825,0.00726829857693176,0.0656037025320388,0.0940954329536113,6.17453740516197e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT2,Angiopoietin-2,42262,-0.0411615256202746,0.00374850715547198,-0.0485085996449997,-0.0338144515955496,6.18693718081629e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0953949395313609,0.00868968331758711,0.0783631602288901,0.112426718833832,6.78423188470474e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0339595104361283,0.0031002899536853,0.0278829421269052,0.0400360787453515,8.90971255644143e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0797669108525189,0.00729087305080461,0.0654767996729418,0.0940570220320959,9.62887390627298e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN3,Centrin-3,39930,0.0867442693011979,0.00792781094060489,0.0712057598576123,0.102282778744784,1.0013855674056e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.114375914902661,0.0104601231456162,0.0938740735372527,0.134877756268068,1.03019860339164e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHBG,Sex hormone-binding globulin,39990,-0.0515368809907936,0.00471877888148922,-0.0607856875985125,-0.0422880743830747,1.24493071790215e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT,Linker for activation of T-cells family member 1,42296,0.0829364367160544,0.00760747727501195,0.068025781257031,0.0978470921750778,1.46387850827109e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0621664667702438,0.00570583812558699,0.0509830240440933,0.0733499094963943,1.5819976648756e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAN,Brevican core protein,42016,0.0377604934141718,0.00346695817338849,0.0309652553943303,0.0445557314340132,1.6488464141573e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.108670878615155,0.00997948613178944,0.0891110857968474,0.128230671433462,1.77088044494032e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0724706191828679,0.00666133167358566,0.05941440910264,0.0855268292630958,1.89022882967843e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXJ3,Forkhead box protein J3,39657,0.0496599285273853,0.00456800860703229,0.0407066316576021,0.0586132253971686,2.17386880075994e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYDGF,Myeloid-derived growth factor,39958,0.108860283685437,0.0100166770191809,0.0892275967278427,0.128492970643032,2.23519433635167e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD36,Platelet glycoprotein 4,39657,0.0510454795020825,0.0046967150636322,0.0418399179773634,0.0602510410268016,2.24346373861025e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL3,Insulin-like 3,39929,0.0986724876063788,0.00908018311514869,0.0808753287006874,0.11646964651207,2.26402418023307e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB2,BPI fold-containing family B member 2,39927,0.0669288137987924,0.00617051143343091,0.0548346113892678,0.079023016208317,2.81918891178666e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42181,0.0244615298139432,0.00225765044554239,0.0200365349406801,0.0288865246872063,3.03844196248523e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0496138035358108,0.00458342360659956,-0.0585973138047459,-0.0406302932668756,3.39088759450348e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0221314171096596,0.00204538097828793,-0.0261403638271039,-0.0181224703922153,3.56446427576831e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUCB2,Nucleobindin-2,42231,0.0406838511844504,0.00376170351953209,0.0333109122861674,0.0480567900827333,3.75605974471033e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT1,Deaminated glutathione amidase,39638,0.0483088655267002,0.00447310284419155,0.0395415839520848,0.0570761471013157,4.70598944333387e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.158875834398404,0.0147186188272657,0.130027341496963,0.187724327299844,4.96163952070768e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSB,Arylsulfatase B,42070,0.0600660031271939,0.00557877776392432,0.0491315987099022,0.0710004075444856,6.35060688517445e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0828229702573774,0.00770327792991883,0.0677245455147364,0.0979213950000183,7.84026551976933e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0365306407883857,0.00340459691965855,-0.0432036507509165,-0.0298576308258549,9.46902373681846e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.104977564900522,0.00980235387793428,0.085764951299771,0.124190178501273,1.18183830081797e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB9,Serpin B9,42016,0.0352289589044181,0.00329740050582536,0.0287660539130004,0.0416918638958358,1.54858017019436e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD226,CD226 antigen,39657,0.0459241253823672,0.00429724856902774,0.0375015181870728,0.0543467325776616,1.57978452633808e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD5,Programmed cell death protein 5,42249,0.0613561676180467,0.00574603459217209,0.0500939398173894,0.072618395418704,1.64170388995724e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED8,Protein TMED8,39930,0.111262562626268,0.0104167143164019,0.09084580256612,0.131679322686415,1.6670815622101e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.106620436259236,0.00998360966404661,0.0870525613177045,0.126188311200767,1.71131222902724e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICA1,Islet cell autoantigen 1,41913,0.0857519321967935,0.00803358706142738,0.0700061015563958,0.101497762837191,1.72050031534083e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42145,0.0332362320833815,0.00311458463441668,0.0271316461999248,0.0393408179668382,1.76936246201414e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0402255995574714,0.00376816285358524,0.0328400003644443,0.0476111987504985,1.78681443492218e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAX1BP1,Tax1-binding protein 1,39929,0.0668197357654004,0.00626182515188328,0.0545465584677091,0.0790929130630916,1.85841769556318e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTF1,Cardiotrophin-1,41900,0.0905621017623882,0.00849509056896519,0.0739117242472165,0.10721247927756,1.99078638992528e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRAP2,GRB2-related adapter protein 2,42145,0.137854880641418,0.0129632273856844,0.112446954965476,0.163262806317359,2.62050571548701e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.102171386536376,0.00962989380343549,0.0832967946816429,0.12104597839111,3.39874002602318e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0806275510414961,0.0076000891988792,0.0657313762116929,0.0955237258712993,3.44335061398006e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASC3,Protein CASC3,39649,0.0460658244210461,0.00434770372096901,0.0375443251279468,0.0545873237141453,4.17413845690452e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42016,0.0843314101420886,0.00796998079846614,0.068710247777095,0.0999525725070823,4.61759600261917e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0712061933818402,0.00672936722211076,0.0580166336265031,0.0843957531371773,4.82823044282184e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGF,Pro-epidermal growth factor,42081,0.110340803438664,0.0104410914936383,0.0898762641111334,0.130805342766195,5.30326038449588e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP1,Syntaxin-binding protein 1,39934,0.0829190286991591,0.00786561005177897,0.0675024329976723,0.0983356244006459,7.28775418657311e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB4,Ephrin type-B receptor 4,42310,-0.0268518420260331,0.00254840030294949,-0.0318467066198141,-0.0218569774322521,7.34357087646281e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.050337534516178,0.00477622648938412,0.0409761305969852,0.0596989384353709,7.50559368781505e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX6,Peroxiredoxin-6,42262,-0.0634946534105935,0.00603033647582725,-0.0753141129032149,-0.0516751939179721,7.95722702478196e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRY2,Protein sprouty homolog 2,41913,0.0981972684220281,0.00933058781687123,0.0799093163009605,0.116485220543096,8.4351348729908e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0815851145985413,0.00775548886720188,0.0663843564188256,0.096785872778257,8.8617846907165e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP7,Caspase-7,39929,0.0896590841529618,0.008528541876706,0.0729431420746181,0.106375026231306,9.90305975712773e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0902742630431721,0.00859218119897709,0.073433587893177,0.107114938193167,1.05754664699744e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLG4,Disks large homolog 4,39929,0.0763671936086942,0.00727758916813433,0.0621031188391509,0.0906312683782374,1.21331472227882e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.0587514209124797,0.00560133487411942,0.0477728045592056,0.0697300372657538,1.22418034475498e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0590678299444511,0.00563251961744505,0.0480280914942588,0.0701075683946434,1.24150010595576e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL1,Growth-regulated alpha protein,42117,0.097911633478252,0.0093365674683285,0.0796119612403281,0.116211305716176,1.244601533045e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0253485792289074,0.00241947187407764,0.0206064143557152,0.0300907441020996,1.38168988456547e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP25,Synaptosomal-associated protein 25,39586,0.0508228856641074,0.00485623004118488,0.0413046747833851,0.0603410965448298,1.63980642646183e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0539093198563161,0.00515511284364399,-0.0640133410298583,-0.0438052986827738,1.69339636546152e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0494171977329692,0.00472725632374921,0.0401517753384207,0.0586826201275176,1.84003719248035e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIN2,Bridging integrator 2,42137,0.0936464560581592,0.00896403103442415,0.0760769552306879,0.111215956885631,1.8914870956867e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRADD,Death domain-containing protein CRADD,41997,0.0782625444925335,0.00750158517424955,0.0635594375510043,0.0929656514340626,2.19710371547497e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.06074188963239,0.00583099329217497,0.0493131427797271,0.072170636485053,2.59788521714788e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX2,Heme oxygenase 2,41839,0.0498792384718356,0.00479194212599284,0.0404870319048896,0.0592714450387815,2.82418858533533e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY1,Aminoacylase-1,42145,0.0656824075929954,0.00631128396883457,0.0533122910140796,0.0780525241719111,2.86445787997859e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0328790516791691,0.00316047412943129,-0.0390735809728544,-0.0266845223854837,2.99634915510848e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA5,Integrin alpha-5,42137,0.0259675423790691,0.0024979995573752,0.0210714632466137,0.0308636215115245,3.23947988918492e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,39638,0.0599751702925578,0.00577189239280218,0.0486622612026655,0.0712880793824501,3.56297304939599e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD276,CD276 antigen,42123,-0.0374064116387756,0.00360516897464269,-0.0444725428290752,-0.0303402804484759,3.97107841011642e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,39736,0.125491859381583,0.0120950204046066,0.101785619388554,0.149198099374612,4.17083244617708e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.090721637713616,0.00874967848458206,0.0735722678838352,0.107871007543397,4.2831659503285e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGA,Protein O-GlcNAcase,39930,0.0746133613207163,0.0072001812423224,0.0605010060857644,0.0887257165556682,4.74091396248682e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0654073784006997,0.00632508045956544,0.0530102206999514,0.077804536101448,5.98661398326089e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1B,Lithostathine-1-beta,42310,-0.0592353278684695,0.00573284539252093,-0.0704717048378105,-0.0479989508991285,6.19327813805479e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPI,Mannose-6-phosphate isomerase,42070,0.0883580654233244,0.00855623641235466,0.0715878420551093,0.10512828879154,6.60611862742913e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT2,Omega-amidase NIT2,39903,0.0757959447306963,0.00734811024750187,0.0613936486455926,0.0901982408157999,7.76534688021449e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0248123616282224,0.00240856532083121,0.0200915735993932,0.0295331496570515,8.53586789398199e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0665090402703066,0.00645866369367168,0.0538500594307101,0.0791680211099031,9.28291818542078e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0648690426004043,0.00630446225593558,0.0525122965787706,0.077225788622038,1.010040181316e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0342010684728257,0.00332817987158575,0.0276778359245177,0.0407243010211338,1.11021925013799e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHK,Ketohexokinase,39638,0.0652919987958969,0.00635156384186381,0.0528429336658438,0.0777410639259499,1.12417152605689e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0529506876257984,0.00515462767383228,0.0428476173850871,0.0630537578665097,1.21171667853794e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,39657,0.0524791639442767,0.00510948423237636,0.0424645748488191,0.0624937530397344,1.22925059339754e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPN,Asporin,39958,0.0287758690902838,0.00280221019152011,0.0232835371149044,0.0342682010656632,1.24562153891608e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.132310923574934,0.0128917660913767,0.107043062035836,0.157578785114033,1.32244330690327e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MESD,LRP chaperone MESD,42137,0.125574898908898,0.0122420998824749,0.101580383139247,0.149569414678549,1.34546661762176e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAN,Aggrecan core protein,41994,0.0281503168472445,0.00274854504730528,0.0227631685545262,0.0335374651399629,1.58472201436813e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0459321253393731,0.00448796844497384,0.0371357071872244,0.0547285434915218,1.71358757918946e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0234928606287093,0.00229670561772353,0.0189913176179712,0.0279944036394474,1.80533421515214e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0716090044395984,0.00700114459795175,0.057886761027613,0.0853312478515838,1.90852249853234e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53,Cellular tumor antigen p53,41843,0.0455664487364348,0.00446177143571846,0.0368213767224266,0.054311520750443,2.1435751242356e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0601807326586065,0.00589100637474469,0.048634360164107,0.0717271051531061,2.16435567672017e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0534864598688756,0.00524068810979911,0.0432147111736694,0.0637582085640819,2.2828333595714e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS8,Galectin-8,42249,0.0623255305699593,0.00610889353009577,0.0503520992509716,0.074298961888947,2.36487669872188e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0491761531949434,0.00481904058343,0.0397308336514206,0.0586214727384662,2.41078823440808e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0386398814151666,0.00379243887037244,0.0312067012292366,0.0460730616010966,2.73552027223185e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST13,Hsc70-interacting protein,39736,0.0559516369247894,0.00549118398784652,0.0451889163086102,0.0667143575409686,2.82669812356447e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF2,TNF receptor-associated factor 2,42119,0.0709129189048607,0.00696315632887586,0.057265132500264,0.0845607053094574,2.85935415547482e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YJU2,Splicing factor YJU2,39919,0.0339494657251212,0.00333279211742875,0.0274171931749608,0.0404817382752815,2.89897039769402e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.12297906309389,0.0120904020920364,0.0992818749934985,0.146676251194281,3.24130885974116e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT2,Signal transducer and activator of transcription 2,39657,0.0807460410585229,0.00793804094086043,0.0651874808144364,0.0963046013026093,3.37774379272896e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGT1,Protein SGT1 homolog,41843,0.081432656638178,0.00801188754442961,0.065729357051096,0.09713595622526,3.5219176076751e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PENK,Proenkephalin-A,39736,0.0318380709627997,0.00313192763998733,0.0256994927884245,0.0379766491371748,3.5983096487515e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0381969584037795,0.00375927228005579,-0.0455651320726889,-0.0308287847348702,3.62521343429371e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0510650216403804,0.00502702653622314,0.041212049629383,0.0609179936513777,3.88356826549932e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAG1,Dystroglycan,42185,0.0483510620097407,0.00476581746942722,0.0390100597696634,0.0576920642498181,4.23357252043481e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.1238021657944,0.0122048327534736,0.0998806935975917,0.147723637991208,4.31090918633578e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.0955913820589806,0.00942677191762152,0.0771149091004424,0.114067855017519,4.46043987110218e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID1,Nidogen-1,42189,0.0366868659305826,0.00362065728984098,0.0295903776424943,0.0437833542186709,4.8179357616425e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.0890253530043744,0.00878527055937315,0.071806222708003,0.106244483300746,4.98805908275307e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D5,TBC1 domain family member 5,42119,0.0792003481266184,0.00782765387685418,0.0638581465279842,0.0945425497252526,5.59478127754658e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSPN,Persephin,42119,0.0877877586568654,0.00867715023340534,0.070780544199391,0.10479497311434,5.64606193578646e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLMH,Bleomycin hydrolase,42310,0.0314139425585189,0.00310574241149224,0.0253266874319941,0.0375011976850437,5.76500963204415e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0325143767215317,0.00321531757650553,0.0262123542715808,0.0388163991714825,6.19186242101979e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAXX,Protein PAXX,39736,0.047230560712024,0.00467518569588756,0.0380671967480844,0.0563939246759637,6.83255402325998e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0428301415708284,0.00424295019414916,-0.0511463239513608,-0.0345139591902961,7.10292899631352e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF7,SLAM family member 7,42119,-0.0604497223661561,0.00599177669620631,-0.0721936046907205,-0.0487058400415918,7.52205488051521e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB1,Heat shock protein beta-1,41949,0.0709142050884973,0.00703727637872332,0.0571211433861996,0.084707266790795,8.49895369752112e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0615664469872882,0.00611026056354646,0.0495903362827371,0.0735425576918392,8.55901849956065e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EZR,Ezrin,42249,0.0245529464507331,0.00244003850274474,0.0197704709853534,0.0293354219161128,9.78778832932231e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.0958400497979124,0.0095239548619122,0.0771730982685645,0.11450700132726,1.01199984151756e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA2,Integrin alpha-2,39736,0.0351741429725809,0.00349635924589727,0.0283212788506223,0.0420270070945396,1.04549388704901e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0849432438727408,0.00845417544854118,0.0683730599936,0.101513427751881,1.14549978099471e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM106A,Transmembrane protein 106A,39919,0.0725444231161636,0.00722353716990119,0.0583862902631573,0.08670255596917,1.24127278667759e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,39934,0.060702945193514,0.00605307456570277,0.0488389190447366,0.0725669713422915,1.43308090740243e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0663388383258464,0.00661926587514964,0.0533650772105531,0.0793125994411397,1.53883026192134e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNLR1,Interferon lambda receptor 1,42119,0.036599001455479,0.00365385454218742,0.0294374465527916,0.0437605563581663,1.5574006191686e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0636867618231729,0.00636033567359062,-0.0761530197434105,-0.0512205039029352,1.60778758670307e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP2B,DNA topoisomerase 2-beta,39657,0.0813323913883159,0.00812428595560533,0.0654087909153294,0.0972559918613023,1.71635413827028e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.0954752996277246,0.00954276933323311,0.0767714717345877,0.114179127520861,1.81361941260094e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0730325431940514,0.00730444644198758,0.0587158281677558,0.0873492582203471,1.86892468856699e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",41839,0.0507037929012903,0.00507441963793464,0.0407579304109384,0.0606496553916422,1.99915385261786e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL8,C-C motif chemokine 8,42239,0.0607823056457584,0.00608500232267713,0.0488557010933113,0.0727089101982056,2.0520949948176e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL32,Interleukin-32,42119,-0.0445101870258537,0.00446226362217662,-0.0532562237253199,-0.0357641503263875,2.36623681610707e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0491892766600979,0.00492959725496756,0.0395272660403615,0.0588512872798343,2.36716765039312e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLK1,Protein delta homolog 1,42310,0.0578430942752047,0.00581362265357474,0.0464483938741982,0.0692377946762112,3.03631850741528e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0320616727186341,0.00322851090471736,-0.0383895540918801,-0.0257337913453881,3.66992907647764e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH9,Protocadherin-9,39930,0.0339130624505163,0.00341485654846824,0.0272199436155185,0.040606181285514,3.79269102831587e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,39919,0.0554486039985184,0.00558337173526898,0.0445051953973913,0.0663920125996456,3.79389622831202e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0803173837190134,0.00809339496489736,0.0644543295878146,0.0961804378502122,3.9333176201726e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLU,Clusterin,39979,0.0301835312424799,0.00304088877825117,0.0242233892371076,0.0361436732478522,3.98798416296888e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RWDD1,RWD domain-containing protein 1,42249,0.0620367641579628,0.00625265417488709,0.0497815619751841,0.0742919663407415,4.01282220689599e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRAS,Ras-related protein R-Ras,39649,0.131404534581299,0.0132562540682356,0.105422276607557,0.157386792555041,4.57791862348713e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDS,Iduronate 2-sulfatase,42296,0.00914874589660112,0.000924148528605409,0.00733741478053451,0.0109600770126677,4.99142395924668e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASHC3,WASH complex subunit 3,39929,0.0758322956829111,0.00766762504615075,0.0608037505924556,0.0908608407733665,5.70290739217623e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKA,Diacylglycerol kinase alpha,39657,0.0551889957091753,0.00559292720411425,0.0442268583891114,0.0661511330292393,7.14704595558519e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHI3L1,Chitinase-3-like protein 1,41907,-0.0828844237131269,0.00840615192619123,-0.0993604814884617,-0.0664083659377921,7.43317040645066e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.107271644195868,0.0108765077664201,0.085953688973685,0.128589599418052,7.46769095651119e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TADA3,Transcriptional adapter 3,39919,0.0402086407625249,0.0040778626125762,0.0322160300418755,0.0482012514831742,7.65189495151897e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL24,C-C motif chemokine 24,42166,0.081517169721092,0.00827112787233339,0.0653057590913186,0.0977285803508655,7.73272676060527e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP5,Retinol-binding protein 5,42070,0.0557291185223852,0.00565814022158856,0.0446391636880716,0.0668190733566987,8.23634717106841e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES2,Cocaine esterase,42070,0.0550694809246865,0.00559686480587307,0.0440996259051752,0.0660393359441977,9.09332965389015e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGA,Chromogranin-A,39966,-0.0843250820791373,0.00856804449933389,-0.101118449297832,-0.0675317148604429,9.16824862198151e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.10100799860294,0.0102715151941352,0.0808758288224353,0.121140168383445,9.98301557977696e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0661498222077986,0.00674076321945795,0.0529379262976611,0.0793617181179362,1.1777550915911e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0749385933108151,0.00764518204107804,0.0599540365103021,0.089923150111328,1.31114925329052e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO9B,Unconventional myosin-IXb,41913,0.0649621068228085,0.00662872422411731,0.0519698073435386,0.0779544063020785,1.34124292367728e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK24,Serine/threonine-protein kinase 24,41839,0.0610488978315671,0.00623652637248175,0.0488253061415029,0.0732724895216313,1.49819144475564e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP2,Caspase-2,42119,0.0671516210347465,0.00686048916501757,0.0537050622713121,0.080598179798181,1.50391809235868e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCB,Tubulin-folding cofactor B,42016,0.0982691047656283,0.010053399502973,0.0785644417398011,0.117973767791455,1.71840831655194e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMFG,Glia maturation factor gamma,39958,0.070932318592703,0.00725560064857723,0.0567113413214917,0.0851532958639144,1.74688355980969e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C3,Complement C3,39445,0.0454355889564577,0.00464896843177397,0.0363236108301807,0.0545475670827346,1.81546612178768e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLM2,Protein GOLM2,42249,0.0223016616299445,0.00228384589128504,0.0178253236830259,0.0267779995768632,1.88527825897629e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACYBP,Calcyclin-binding protein,39713,0.102231430353671,0.0104820303731007,0.0816866508223939,0.122776209884949,2.20165239286131e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.082022065092381,0.00841531437076375,0.065528048925684,0.0985160812590779,2.2578489223316e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42185,0.0863572898041071,0.0088604860414919,0.068990737162783,0.103723842445431,2.26398209718004e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB6,Serpin B6,42216,0.0572907691103723,0.00588193013363093,0.0457621860484557,0.0688193521722889,2.40468656551904e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KITLG,Kit ligand,42145,-0.0373414973187731,0.00383600131764904,-0.0448600599013653,-0.029822934736181,2.54327612337252e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN2,Centrin-2,41839,0.066400447421588,0.0068282573453806,0.053017063024642,0.079783831818534,2.81828939427534e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0750657857490386,0.00772022028716998,0.0599341539861854,0.0901974175118917,2.837792009278e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GLB2,Endophilin-B2,39929,0.0645687900836422,0.00663953647285475,0.0515552985968469,0.0775822815704375,2.88555576264422e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.110968154140911,0.0114183349346153,0.0885882176690651,0.133348090612757,2.97293975860962e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD207,C-type lectin domain family 4 member K,41832,0.0380706811541365,0.00392069069096302,0.030386127399849,0.045755234908424,3.23589234538771e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,41843,0.0511941758636648,0.00527335125140695,0.0408584074109072,0.0615299443164224,3.30249802565625e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0841900222843174,0.00867404562578954,0.0671888928577699,0.101191151710865,3.36112990154372e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3F,Semaphorin-3F,42145,0.0259976103988769,0.0026786583441644,0.0207474400443147,0.0312477807534392,3.37545511793084e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0774955146832235,0.00798613163067376,0.0618426966871029,0.093148332679344,3.444989943609e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FIS1,Mitochondrial fission 1 protein,42125,0.0747562016896338,0.00770456052531965,0.0596552630600073,0.0898571403192603,3.46314641222748e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0463570063641043,0.00477890039452246,-0.0557236511373684,-0.0369903615908403,3.54831968600482e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC22D1,TSC22 domain family protein 1,39934,0.06455542713238,0.00666382745962104,0.0514943253115227,0.0776165289532372,4.15337539471529e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPSE,Heparanase,39866,0.0932174074543107,0.00962665662204964,0.0743491604750934,0.112085654433528,4.33050775642397e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR2,Folate receptor beta,42249,-0.0282022834463724,0.00291811327585214,-0.0339217854670426,-0.0224827814257022,5.0167239583342e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POMC,Pro-opiomelanocortin,39638,0.0715270495473425,0.00740225154626675,0.0570186365166597,0.0860354625780253,5.2978143206591e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0639801386277342,0.00662424439092632,-0.0769636576339498,-0.0509966196215186,5.32963410038765e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGLAP,Osteocalcin,39966,0.0819896557477197,0.00848802908607543,0.0653531187390118,0.0986261927564275,5.44538510836898e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTD,Deoxycytidylate deaminase,39736,0.0934841619609838,0.00968065697421592,0.0745100742915206,0.112458249630447,5.60901999647427e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF19,Fibroblast growth factor 19,42185,0.0752609665098466,0.00780360843096767,0.05996589398515,0.0905560390345432,6.10482144940451e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFB,Complement factor B,39794,0.0319490952248928,0.0033120497050154,0.0254574778030627,0.038440712646723,6.20096414879601e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN9,Septin-9,42070,0.0278478154600776,0.0028921330710352,0.0221792346408486,0.0335163962793066,7.10636084253153e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBN1,Drebrin,39657,0.0496364136808162,0.00515386631831419,0.0395348356969204,0.059737991664712,7.21382699703729e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAV,Integrin alpha-V,42262,0.0160666387131407,0.00167037321168601,0.0127927072182361,0.0193405702080453,7.82619794206465e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA13,Carbonic anhydrase 13,41967,0.101726484167713,0.0105866145243409,0.0809767197000052,0.122476248635422,8.6175343503501e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0342657576312662,0.00356656255030789,0.0272752950326628,0.0412562202298697,8.9992022581179e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0473981771376271,0.00493648398867588,0.0377226685198224,0.0570736857554318,9.57091251478843e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0585199158960749,0.00609875163567945,0.0465663626901432,0.0704734691020066,9.83726744052938e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42310,0.0692813045111821,0.00722246904565132,0.0551252651817055,0.0834373438406587,1.00625896584388e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0309311966038892,0.00322460653902601,-0.0372514254203802,-0.0246109677873982,1.00848220218943e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NSFL1C,NSFL1 cofactor p47,42249,0.0605412007716176,0.00631317320491545,0.0481673812899833,0.0729150202532519,1.03453427469982e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0693576807293853,0.00723216957509448,0.0551826283622001,0.0835327330965705,1.03458169832354e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGN,Secretagogin,41913,-0.0427794966202762,0.00446697988146588,-0.0515347771879493,-0.034024216052603,1.17511858069577e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0590918485991658,0.00616892668349574,0.0470007522995142,0.0711829448988175,1.18972256029225e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2,Microtubule-associated protein 2,39929,0.0451641572762554,0.00472909939343602,0.0358951224651208,0.05443319208739,1.55899392279634e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS15,Enteropeptidase,42070,0.0843322987818963,0.00883864298594613,0.0670085585294418,0.101656039034351,1.64917492108933e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.101128607450656,0.0106071625831004,0.0803385687877792,0.121918646113533,1.76929107202003e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42181,0.035413186363235,0.00371524457583105,0.0281313069946061,0.0426950657318639,1.80321414109418e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO3,Forkhead box protein O3,41843,0.0918782902096076,0.00964338452620698,0.0729772565382419,0.110779323880973,1.88562839519501e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42105,0.0610916821939284,0.00642422183225248,0.0485002074027135,0.0736831569851433,2.23303526295942e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0949458232469871,0.00998173372316631,0.0753816251495811,0.114510021344393,2.24824489650836e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0257019905799299,0.00270273123333884,0.0204046373625857,0.030999343797274,2.29753474967384e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CERT,Ceramide transfer protein,41839,0.0585472707160143,0.00615850030865734,0.0464766101110459,0.0706179313209827,2.30155304651461e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP5,Platelet glycoprotein V,39736,0.0351453507660784,0.00369715666266424,0.0278989237072565,0.0423917778249003,2.38611655715269e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.100538132199061,0.0105889913085281,0.0797837092343456,0.121292555163776,2.6613191588027e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD69,Early activation antigen CD69,42082,0.0835289142270201,0.00880106370075219,0.0662788293735458,0.100778999080494,2.67261605460417e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARC,SPARC,42181,0.0664723415212513,0.00702364246041229,0.0527060022988432,0.0802386807436594,3.44176609160396e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0836609631235195,0.0088391019741618,0.0663363232541624,0.100985602992877,3.53013514147355e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0550786692099638,0.0058222689646075,0.0436670220393331,0.0664903163805945,3.59160109748053e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPBP,Platelet basic protein,39908,0.0818520853314602,0.00866108215947948,0.0648763642988804,0.09882780636404,4.03220954582639e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42123,-0.0902140482098692,0.00955015160809392,-0.108932345361733,-0.0714957510580051,4.07574241374498e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL18,C-C motif chemokine 18,42020,0.0665969035329833,0.00705449230620992,0.0527700986128118,0.0804237084531547,4.31906492761261e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0251685188985281,0.00266700639668428,0.0199411863610269,0.0303958514360293,4.44709785842962e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PF4,Platelet factor 4,39914,0.0929057106806226,0.00986362125252898,0.0735730130256659,0.112238408335579,5.43393368149393e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN4,Cerebellin-4,42262,0.0300164900715901,0.00318997976950734,0.0237641297233557,0.0362688504198245,5.76248983544384e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2,Complement C2,42199,0.0213742973686415,0.00227218611508373,0.0169208125830774,0.0258277821542056,5.91467914259659e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB1,Beta-crystallin B1,39958,0.0626288698932973,0.00666674689281254,0.0495620459833847,0.0756956938032099,6.86274997235906e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA1,Ephrin type-A receptor 1,42162,0.0304093552180871,0.00324048534396053,0.0240580039439244,0.0367607064922497,7.33307758779547e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42016,0.0285750412313885,0.00305036609819736,0.0225963236789216,0.0345537587838553,8.57599190700457e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP6,Bone morphogenetic protein 6,41886,0.0377062871373767,0.0040292435239592,0.0298089698304166,0.0456036044443367,9.39851059734489e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L1,Bcl-2-like protein 1,39929,0.0941628255953576,0.0100655265551294,0.0744343935473039,0.113891257643411,9.93034196989076e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE2,Glia-derived nexin,39958,0.0611601655637461,0.00653802451676853,0.0483456375108798,0.0739746936166124,9.96799072007495e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOF,Apolipoprotein F,39990,0.0243890587597566,0.0026124475128123,0.0192686616346445,0.0295094558848687,1.18864121726485e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0297724331641122,0.0031919577824073,0.0235161959105939,0.0360286704176305,1.25055728706562e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRN,Agrin,42185,0.0335494439118895,0.00360163229114831,0.0264902446212389,0.0406086432025402,1.40350322034445e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF21,Fibroblast growth factor 21,42247,0.112222092563588,0.0120638535808481,0.0885769395451262,0.135867245582051,1.57989921327875e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD2,Polycystin-2,39575,0.0549543108938964,0.00590867652102297,0.0433733049126914,0.0665353168751014,1.66088018934168e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.0893406995086316,0.0096185658700796,0.0704883104032756,0.108193088613988,1.80270064916619e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.043112826893527,0.00464294990921768,0.0340126450714604,0.0522130087155937,1.85418084172576e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.0811756720291813,0.00874557028870576,0.064034354263318,0.0983169897950446,1.96710408661269e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRGN,Neurogranin,39990,0.0863096628171061,0.00932130142994208,0.0680399120144197,0.104579413619793,2.42285737819287e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COCH,Cochlin,39958,0.0428471736266371,0.00462859328918505,0.0337751307798344,0.0519192164734397,2.47723734445145e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0451125137934528,0.00487467022174854,0.0355581601588257,0.05466686742808,2.53749553302568e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL4,C-C motif chemokine 4,42148,0.0578029517603044,0.00625061763669226,0.0455517411923876,0.0700541623282212,2.63537852598161e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0767154331038706,0.00831221523180492,0.0604234912495329,0.0930073749582082,3.12493659598864e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C19orf12,Protein C19orf12,41839,0.0618375616255939,0.00670005506144712,0.0487054537051576,0.0749696695460303,3.12899563159027e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0359990320489787,0.00390230122775771,0.0283505216425736,0.0436475424553838,3.24262520582222e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0652307185266648,0.00706860735145992,0.0513762481178034,0.0790851889355263,3.25179290525316e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA4,Protein disulfide-isomerase A4,39966,0.0570202796964137,0.00618026417937319,0.0449069619048423,0.0691335974879852,3.29849021733947e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGFR,Opioid growth factor receptor,42070,0.0297590160150776,0.00322883287361636,0.0234305035827895,0.0360875284473657,3.51361890946472e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.103639954673805,0.0112611516588165,0.0815680974225243,0.125711811925085,3.98200259264014e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA6,Corticosteroid-binding globulin,39979,0.0143377979466231,0.00155827641731046,0.0112835761686946,0.0173920197245516,4.16082901439915e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0262693320650198,0.00285887836554064,-0.0318727336614795,-0.0206659304685601,4.55227248438217e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0314242421895705,0.00342005420929585,0.0247209359393506,0.0381275484397903,4.56508233394189e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICALL2,MICAL-like protein 2,39649,0.0634434355645816,0.00690885527231858,0.0499020792308372,0.076984791898326,4.94278974452022e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT1,Angiopoietin-1,42085,0.0770030149576922,0.0083937649267141,0.0605512357013326,0.0934547942140519,5.21865877442924e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP3,Syntaxin-binding protein 3,41843,0.0400125281171703,0.00436348360328849,0.0314601002547248,0.0485649559796157,5.4267347315568e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD4B,FERM domain-containing protein 4B,39575,0.0651269199599843,0.00710274421923976,0.0512055412902744,0.0790482986296942,5.61145240550001e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH17,Cadherin-17,42145,-0.0628582669286431,0.006859595729305,-0.0763030745580809,-0.0494134592992053,5.73411594184457e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA3,Annexin A3,42224,0.0639288294589492,0.00697699588055044,0.0502539175330703,0.077603741384828,5.76950711293509e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0607954892807493,0.00663714040541432,0.0477866940861372,0.0738042844753613,5.92214570512123e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBXN1,UBX domain-containing protein 1,39736,0.0637324580155146,0.00696086620462822,0.0500891602544433,0.0773757557765859,6.33496858273103e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42016,0.0424425925972717,0.00465896718231741,0.0333110169199296,0.0515741682746138,9.40128339272472e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42137,0.0457018631961362,0.00501902234024618,0.0358645794092537,0.0555391469830187,9.75335883769711e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C5,Complement C5,39979,0.0138248148949933,0.0015191335286246,0.0108473131788891,0.0168023166110975,1.04880208668725e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.0448147593782026,0.00493115200872118,0.0351497014411091,0.0544798173152961,1.14801197922105e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP170,Centrosomal protein of 170 kDa,39638,0.0706770547892475,0.00779352505468315,0.0554017456820685,0.0859523638964265,1.40811349514173e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,41843,0.0411780580596645,0.00454254012971999,0.0322746794054133,0.0500814367139157,1.41925953322424e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,39930,0.0530427672827045,0.00585272799096774,0.0415714204204077,0.0645141141450012,1.47823224403625e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0915059497775399,0.0101073395863046,0.0716955641883828,0.111316335366697,1.61159094389323e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.034558278184816,0.00381814841220565,0.027074707296893,0.0420418490727391,1.64665080373203e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.109074300923293,0.0120602916998891,0.0854361291915103,0.132712472655076,1.71229268092033e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS10,Regulator of G-protein signaling 10,39934,0.0543417151178425,0.00601114376527814,0.0425598733378974,0.0661235568977877,1.81790809219308e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GET3,ATPase GET3,39958,0.049230358699901,0.00544951628693961,0.0385493067774994,0.0599114106223026,1.92374747433231e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0736819450713535,0.00816724938890196,0.0576741362691057,0.0896897538736014,2.15870861652618e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM1,Dynamin-1,39930,0.105287495236554,0.0116788284735414,0.0823969914284129,0.128177999044695,2.2790499127559e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBI3_IL27,Interleukin-27,42247,-0.0277470592841092,0.0030793064082799,-0.0337824998443379,-0.0217116187238806,2.31357512684685e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0435376554314294,0.00483686891341141,0.034057392361143,0.0530179185017157,2.58772139569519e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCA2A,Guanylin,42083,-0.0318521834543504,0.00354043430451028,-0.0387914346911905,-0.0249129322175102,2.63330891373887e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0532933447509765,0.00592416901000312,0.0416819734913704,0.0649047160105826,2.65809630730303e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0584987030337925,0.00650138999177683,0.0457559786499099,0.071241427417675,2.66697511714031e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK7,Kallikrein-7,39475,0.0359934191228978,0.00400519644677994,0.0281432340872091,0.0438436041585865,2.96901103178915e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMT,Catechol O-methyltransferase,41740,0.0752564812251464,0.00838317355425159,0.0588254610588133,0.0916875013914795,3.1539486182418e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0620335301465232,0.00691139147635374,0.0484872028528699,0.0755798574401766,3.18314127280624e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0587745241853659,0.00654877009710467,0.0459389347950407,0.0716101135756911,3.21386621259212e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42093,0.0807761995862374,0.00900519070049758,0.0631260258132622,0.0984263733592127,3.35254223030287e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPB1,Beta-ureidopropionase,39958,0.0819653428975621,0.00913639953825068,0.0640579998025908,0.0998726859925335,3.38915634783569e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTDH,Protein LYRIC,39657,0.0863751052000203,0.00963428194576862,0.0674919125863138,0.105258297813727,3.58849321561623e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP2B1,AP-2 complex subunit beta,39649,0.0439539912509278,0.00490626979521961,0.0343377024522973,0.0535702800495582,3.81043695423837e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0479005597164934,0.0053513842399451,0.037411846606201,0.0583892728267858,3.97620004664148e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0752527964804593,0.00840956326181599,0.0587700524873,0.0917355404736187,4.06568172658695e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42125,-0.0841456081275711,0.0094048707050951,-0.102579154709558,-0.0657120615455847,4.12130769927594e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0987139846480571,0.0110361727306397,0.0770830860960033,0.120344883200111,4.2107209152873e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0709173367548955,0.00794087164596227,0.0553532283288095,0.0864814451809816,4.77890840669798e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATOX1,Copper transport protein ATOX1,42181,0.0637586600811703,0.0071430765230937,0.0497582300959066,0.0777590900664339,4.97934634769789e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.0489445598386129,0.00549399576854099,0.0381763281322726,0.0597127915449533,5.83126130853184e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP3,Caspase-3,42310,0.0788435636509091,0.00885322827922761,0.061491236223623,0.0961958910781952,5.9680680754658e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THOP1,Thimet oligopeptidase,42081,0.0280494278330362,0.00314966420290558,0.0218760859953412,0.0342227696707311,5.98521950368769e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL16,C-X-C motif chemokine 16,42295,0.0208710947245972,0.00234518976556117,0.0162745227840973,0.025467666665097,6.30388868474666e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0548079698947083,0.00616007369038641,0.0427342254615509,0.0668817143278656,6.44151124705063e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,39919,0.039368396302388,0.0044243616807823,0.0306966474080547,0.0480401451967213,6.54339895844895e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0405793338945717,0.00456182041958838,0.0316381658721784,0.0495205019169649,6.5528280721394e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42113,-0.0212811148710641,0.00240011991363566,-0.02598534990179,-0.0165768798403383,8.46887318697754e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0831878721926719,0.00941241125292393,0.064739546136941,0.101636198248403,1.09346626035688e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.032041303078713,0.00362803055703122,-0.0391522429704941,-0.0249303631869318,1.15742308514406e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RFC4,Replication factor C subunit 4,39919,0.019741104532372,0.00223603698734812,0.0153584720371697,0.0241237370275744,1.21541070909721e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP1,Secreted frizzled-related protein 1,41968,0.0380266635996559,0.00432667313842211,0.0295463842483486,0.0465069429509633,1.69284335995617e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF2,Scavenger receptor class F member 2,42249,-0.0251038857433586,0.00285854053156761,-0.0307066251852311,-0.0195011463014861,1.79405161703554e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,39930,0.0779593175923737,0.00887593376441245,0.0605624874141253,0.0953561477706221,1.8165025297936e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RP2,Protein XRP2,42070,0.0376128636809742,0.00428542658551089,0.0292134275733729,0.0460122997885756,1.88021714503647e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP2,Retinol-binding protein 2,42070,-0.0687621834993104,0.00784117255336599,-0.0841308817039078,-0.0533934852947131,2.00987688067758e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0329765318350579,0.00376709487557028,0.0255930258789402,0.0403600377911757,2.3538836863862e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUB1,NEDD8 ultimate buster 1,42119,0.073839267046127,0.00845309138283002,0.0572712079357802,0.0904073261564738,2.71573990393233e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0260772142472963,0.00298532397236731,0.0202259792614564,0.0319284492331363,2.71992905206293e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB2B,Ras-related protein Rab-2B,39919,0.0549416906076929,0.00628836428143103,0.042616496616088,0.0672668845992977,2.72919354761197e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0788755139729635,0.00903334408557706,0.0611701595652325,0.0965808683806946,2.86162763075961e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCLY,Selenocysteine lyase,42224,0.0426774762295654,0.00489110526086336,0.0330909099182732,0.0522640425408576,2.95376144500278e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0798906742288205,0.00916188826777667,0.0619333732239782,0.0978479752336628,3.18321770649105e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR2,GMP reductase 2,39736,0.058590360141068,0.00672018815172176,0.0454187913636933,0.0717619289184426,3.21686264937147e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA12,Serpin A12,41751,0.0948198915175115,0.0108893264281804,0.0734768117182779,0.116162971316745,3.47067468038224e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTF2,Transcription termination factor 2,39649,0.0437208523766539,0.00502202907058298,0.0338776753983113,0.0535640293549966,3.60075287553396e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,39958,0.0245518014429154,0.00282113876152359,0.0190223694703292,0.0300812334155016,3.68385834034526e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP6,Platelet glycoprotein VI,42115,0.0770727992647663,0.00886123918342612,0.0597047704652511,0.0944408280642815,3.77246844739143e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMTN,Smoothelin,39897,0.0813642125433444,0.00936143923929874,0.0630157916343189,0.0997126334523699,4.07230576725361e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18R1,Interleukin-18 receptor 1,42296,0.0288465175355866,0.00332020216630068,0.0223389212896373,0.0353541137815359,4.09617814315093e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0464248659647404,0.00534875674523231,0.0359413027440851,0.0569084291853957,4.51533772471339e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRZB,Secreted frizzled-related protein 3,41973,0.0215541834164612,0.00248465462170856,0.0166842603579125,0.02642410647501,4.61155005386913e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YWHAQ,14-3-3 protein theta,39736,0.065052007645983,0.00749960396392872,0.0503527838766827,0.0797512314152833,4.74808419187703e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.046513485180406,0.00536995603926438,0.0359883713434478,0.0570385990173642,5.27289962204382e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL26,C-C motif chemokine 26,42119,0.0780182923112086,0.00902237750159236,0.0603344324080876,0.0957021522143297,5.86664810053812e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0603205491898963,0.00698382983064427,0.0466322427218335,0.074008855657959,6.55918829759075e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTX3,Pentraxin-related protein PTX3,42119,-0.0431396958012768,0.00499642242970268,-0.052932683763494,-0.0333467078390595,6.57428633325522e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0516449049566553,0.00598622165245167,0.03991191051785,0.0633778993954605,6.98731823807002e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QDPR,Dihydropteridine reductase,42081,0.0365426630997537,0.00423582957979158,0.0282404371233622,0.0448448890761452,6.99374144084322e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIAE,Sialate O-acetylesterase,42147,0.0402718866183228,0.00467267647721118,0.0311134407229889,0.0494303325136567,7.52248602553769e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM20A,Pseudokinase FAM20A,39958,0.0244639506880435,0.00283999645620005,0.0188975576338914,0.0300303437421956,7.98069830758491e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS1,Galectin-1,42145,0.0303093509721565,0.00352046841017543,0.0234092328882127,0.0372094690561004,8.14266230519945e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.103268369179999,0.0120062905922258,0.079736039619236,0.126800698740761,8.74714811794766e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6AP2,Renin receptor,41843,0.0339672346485429,0.00395164646586628,0.026222007575445,0.0417124617216408,9.19479838585337e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0500265056118496,0.00582134845594183,0.0386166626382037,0.0614363485854956,9.55025853824114e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0286283403280239,0.00334348085486,0.0220751178524983,0.0351815628035495,1.22211352313279e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0250616748349349,0.00292642199474862,0.0193258877252276,0.0307974619446422,1.23421178169315e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,39952,0.0410433536062445,0.004793942093325,0.0316472271033275,0.0504394801091615,1.25735896707525e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDRKH,Tudor and KH domain-containing protein,41839,0.0730674393301068,0.00853786289710617,0.0563332280517787,0.0898016506084349,1.27333388578802e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.0781478487874128,0.00913945501492426,0.0602345169581612,0.0960611806166643,1.38557917305425e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VGF,Neurosecretory protein VGF,39934,0.0260585197426612,0.00304844709351223,0.0200835634393772,0.0320334760459451,1.41114473737033e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1,Allograft inflammatory factor 1,41843,0.0448519621462666,0.0052485481299281,0.0345648078116075,0.0551391164809257,1.41755759805346e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIAPIN1,Anamorsin,42181,0.0526234364816016,0.00616317836920976,0.0405436068779505,0.0647032660852528,1.5048047740239e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THTPA,Thiamine-triphosphatase,39897,0.0755934268338276,0.00885492431921565,0.0582377751681649,0.0929490784994903,1.5551128390402e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARFIP1,Arfaptin-1,39934,0.0596884761706329,0.0069948612960945,0.0459785480302877,0.0733984043109781,1.60460023138316e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTC,Probetacellulin,41843,0.0628027024156036,0.00736764670128723,0.0483621148810806,0.0772432899501266,1.70514741616945e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB6,Integrin beta-6,41913,0.0263476887637857,0.00309180741794858,0.0202877462246065,0.0324076313029649,1.73890299737844e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0649916436483195,0.00763730078551541,0.0500225341087093,0.0799607531879297,1.96801378270421e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM3,Dynamin-3,39934,0.0473791197062314,0.00556848604412883,0.0364648870597389,0.0582933523527239,1.98425453107618e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD22,B-cell receptor CD22,42296,0.0364498778318431,0.00428820472947325,0.0280449965620755,0.0448547591016106,2.08963042412207e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MME,Neprilysin,42070,0.0665265834353689,0.00783406065417474,0.0511718245531864,0.0818813423175514,2.24273256599752e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0251001039062636,0.00295666919690829,0.0193050322803233,0.0308951755322038,2.33880870732425e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.0722329285744789,0.0085184735751199,0.0555367203672439,0.0889291367817139,2.49208410292021e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,39657,0.073035979548928,0.00862625187083296,0.0561285258820954,0.0899434332157606,2.84289479933633e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.022780172824295,0.00269171226273696,-0.0280559288592595,-0.0175044167893306,2.9225007701689e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEPD,Xaa-Pro dipeptidase,39990,0.0225167519507336,0.00266162194341562,0.017299972941639,0.0277335309598282,3.00534647354562e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP5,Fatty acid-binding protein 5,42218,0.0564941014404685,0.00669143273701102,0.0433788932759269,0.0696093096050101,3.41029701714909e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0508496402727297,0.00602304775754788,0.0390444666679359,0.0626548138775236,3.49053865205052e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42181,0.0357470574196455,0.0042374046566803,0.0274417442925521,0.0440523705467388,3.61064336017247e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUOM,Fucose mutarotase,39736,0.0548967382842377,0.00652118888131898,0.0421152080768525,0.0676782684916229,4.2904898967232e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLC,Galectin-10,42119,-0.0568064625375589,0.00675403775443186,-0.0700443765362453,-0.0435685485388724,4.47947967348594e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,39735,0.05606695828289,0.00666994259828803,0.0429938707902455,0.0691400457755346,4.76174774640113e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0208430093412189,0.00248409590176236,0.0159741813737647,0.0257118373086732,5.41068260076434e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C8B,Complement component C8 beta chain,39979,0.025636124317573,0.00305812943894114,0.0196421906172484,0.0316300580178976,5.76869955124243e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1RL,Complement C1r subcomponent-like protein,39958,0.0166937247000422,0.00199488026800641,0.0127837593747497,0.0206036900253348,6.52973889814375e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACTB2,Endoribonuclease LACTB2,42145,0.0553726591728512,0.00662874351339128,0.0423803218866043,0.0683649964590981,7.27149294214229e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0829803598683115,0.00993803994107919,0.0635018015837963,0.102458918152827,7.63170915000998e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0320676351431461,0.00384496282256313,0.0245315080109224,0.0396037622753698,8.14683642986298e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0738761380075851,0.00885724163474341,0.0565159444034881,0.0912363316116822,8.23588733497163e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0590576108325362,0.00708870016657752,0.0451637585060443,0.0729514631590281,8.92262277145102e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0371049934974246,0.00445603508574448,0.0283711647293654,0.0458388222654838,9.27735157987783e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42119,0.0549781232611648,0.00660870963949277,0.0420250523677589,0.0679311941545706,9.71076550739956e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.0544484835462677,0.00655300549001493,0.0416045927858385,0.067292374306697,1.05898404606373e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0244491490421587,0.00294789000358823,0.0186712846351257,0.0302270134491916,1.20231545413825e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRD2,Protein ZNRD2,39930,0.0584052857594142,0.00704809629879875,0.0445910170137687,0.0722195545050598,1.29562169006972e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.034556699622823,0.00417472244725318,-0.0427391556194392,-0.0263742436262067,1.37254117346723e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0387138177718834,0.00467858609529489,0.0295437890251054,0.0478838465186614,1.41034298163361e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0372897866611317,0.00451362492589328,-0.0461364915158825,-0.0284430818063809,1.56872875981148e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0312764271533487,0.00378844218668332,0.0238510804674494,0.038701773839248,1.67983010306079e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0309234355066561,0.00374952100622322,0.0235743743344586,0.0382724966788536,1.79900847967977e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0515091158641718,0.00624575229567305,0.0392674413646526,0.063750790363691,1.8024106258989e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0582175181737697,0.00706488347313775,0.0443703465664197,0.0720646897811197,1.87262189638069e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0470576343290883,0.00572012448462224,-0.0582690783189479,-0.0358461903392287,2.09947943271529e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBP,Lipopolysaccharide-binding protein,42217,-0.0483987199084971,0.00589971816953857,-0.0599621675207927,-0.0368352722962015,2.54148179708877e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0530195072807903,0.00646570525569431,0.0403467249796295,0.0656922895819511,2.62152999149457e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSV,Cathepsin L2,42200,0.0330200570676953,0.00402936902741814,0.0251224937739557,0.0409176203614348,2.73196339706456e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0443756487204496,0.00541490997454807,0.0337624251703353,0.0549888722705638,2.77327222041501e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLNK,B-cell linker protein,39657,0.034602867432385,0.00423046454259446,0.0263111569288998,0.0428945779358701,3.16332484044648e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH2,Cadherin-2,42145,0.0290012885746686,0.00354851599018462,0.0220461972339068,0.0359563799154305,3.27904854504639e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB33A,Ras-related protein Rab-33A,39575,0.054919158205692,0.00671904096439723,0.0417498379154734,0.0680884784959106,3.32052270584649e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL5A1,Collagen alpha-1(V) chain,39736,-0.0338828706648272,0.00415086837427082,-0.042018572678398,-0.0257471686512564,3.6246730384716e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0534539686926865,0.00655235495172813,0.0406113529872993,0.0662965843980736,3.71042460273008e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0551365664768647,0.00676470852882684,0.0418777377603641,0.0683953951933653,4.01118606133819e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX1,Peroxiredoxin-1,41742,-0.0751889055292615,0.00922773797538271,-0.0932752719610116,-0.0571025390975114,4.02781362854812e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPA1,Inositol monophosphatase 1,42016,0.0501046397038267,0.00615168168764779,0.0380473435960371,0.0621619358116164,4.13043340658879e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42070,0.026857032915332,0.00329975967209693,0.020389503958022,0.0333245618726419,4.33001927437584e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0448598043202039,0.00551517735291643,0.0340500567084877,0.0556695519319201,4.52363163305799e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42016,0.0330218923750504,0.00406236643713862,0.0250596541582588,0.0409841305918421,4.71593710971421e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REEP4,Receptor expression-enhancing protein 4,39934,0.0512421738339316,0.00630487190550042,0.0388846248991508,0.0635997227687124,4.84147284161887e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC1,MANSC domain-containing protein 1,42181,-0.0227114763142917,0.00279530342781638,-0.0281902710328118,-0.0172326815957716,4.86292440665187e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0329811615415904,0.00405976257339245,0.0250240268977412,0.0409382961854396,4.99757962723808e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40LG,CD40 ligand,42296,0.064699954130174,0.00796991282695446,0.0490789249893432,0.0803209832710047,5.14016873203399e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TST,Thiosulfate sulfurtransferase,41809,0.0613954629186343,0.00758099222893087,0.0465367181499298,0.0762542076873388,6.04406972826187e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FADD,FAS-associated death domain protein,42145,0.0621462774197262,0.00767624167215098,0.0471008437423103,0.0771917110971421,6.16524077161758e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRK5,G protein-coupled receptor kinase 5,41900,0.0418458316107194,0.00517943848358079,0.031694132182901,0.0519975310385377,7.07698345005617e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0377749070898883,0.00468444746519329,-0.0469564241216672,-0.0285933900581095,8.00193706125542e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0415078929710207,0.00515079385331556,-0.0516034489235192,-0.0314123370185222,8.36215856672316e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0547826819798907,0.00680159781673375,0.0414515502590926,0.0681138137006889,8.80164597388208e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXN,Paxillin,41839,0.0414605055823926,0.0051496919091921,0.0313671094403761,0.0515539017244091,8.9046617735114e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBP,Protein AMBP,42239,0.016296697117016,0.00202633549865802,0.0123250795396463,0.0202683146943858,9.52808138066147e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP10,Caspase-10,41839,0.0575682017602218,0.00716032990252818,0.0435339551512665,0.071602448369177,9.75189380171296e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0275914543072951,0.00343269259189914,0.0208633768271728,0.0343195317874175,9.89812036095602e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0220947263815481,0.00275180590184594,0.0167011868139301,0.0274882659491662,1.06193399229646e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0306141501209505,0.00382140796973472,0.0231241905002705,0.0381041097416306,1.22821706004608e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42119,-0.0193263543481687,0.00241353848222136,-0.0240568897733226,-0.0145958189230148,1.26601292794442e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42296,0.0537104980501496,0.00671798728629321,0.0405432429690149,0.0668777531312843,1.39865782032977e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.033169643930687,0.00415306423020704,0.0250296380394812,0.0413096498218928,1.52125534277424e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.032762918211276,0.00410522721550744,-0.0408091635536706,-0.0247166728688814,1.57138322089192e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0382684848531236,0.00479940468782806,-0.0476753180412666,-0.0288616516649806,1.66299009940782e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0534987743267563,0.00671218397915702,0.0403428937276086,0.0666546549259041,1.73830317585667e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LARP1,La-related protein 1,39919,0.0500723230758541,0.0062857305378908,0.0377522912215881,0.0623923549301201,1.79531296517102e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0426356655736953,0.00535483667652029,0.0321401856877155,0.0531311454596751,1.82886697005156e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0583334097821227,0.00732875287409138,0.0439690541489036,0.0726977654153418,1.89108763240613e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0285302531679304,0.00358683778143178,-0.0355604552195367,-0.0215000511163241,1.94626105191908e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MILR1,Allergin-1,41913,-0.0408973548345296,0.00514893870358553,-0.0509892746935572,-0.0308054349755019,2.13336568799317e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0273430833035463,0.00344932667152762,0.0205824030273522,0.0341037635797405,2.41876770483761e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42249,0.0542215142256579,0.00684114545425795,0.0408128691353123,0.0676301593160034,2.44185745578196e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGA,Fibrinogen alpha chain,39735,0.024940752616644,0.00314825320713198,0.0187701763306654,0.0311113289026227,2.55768752409188e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROD,Uroporphyrinogen decarboxylase,39736,0.054304102771238,0.00686081970956666,0.0408568961404873,0.0677513094019886,2.70465243514992e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0450576890084718,0.00570303048161088,0.0338797492645145,0.0562356287524291,2.98763036023171e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYAL1,Hyaluronidase-1,42077,-0.0183466137988422,0.00232249227103678,-0.0228986986500742,-0.0137945289476101,3.01535140922695e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APP,Amyloid-beta precursor protein,42112,0.0525339820800601,0.00665459887921141,0.0394909682768057,0.0655769958833144,3.14128986542005e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKN3,Serine/threonine-protein kinase N3,39757,0.0586168980685105,0.00744085623755243,0.0440328198429077,0.0732009762941132,3.64377669356081e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0223026689458564,0.00283465057523884,0.0167467538183883,0.0278585840733246,3.88111150386044e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRG,Histidine-rich glycoprotein,39925,0.0247610125293014,0.00314870512648594,0.018589550481389,0.0309324745772139,4.06219023122833e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0563317701972859,0.00716719557266807,0.0422840668748564,0.0703794735197153,4.19907029673697e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BDNF,Brain-derived neurotrophic factor,39966,0.0666017952282034,0.00847587607847207,0.0499890781143981,0.0832145123420086,4.26128898945541e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0424028666376212,0.00540149799327115,0.0318159305708097,0.0529898027044326,4.46605972159721e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.053034506165402,0.0067567528340825,0.0397912706106003,0.0662777417202037,4.50318834371122e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNAS,Neuroendocrine secretory protein 55,39934,0.0685961295221465,0.00874075785911724,0.0514642441182767,0.0857280149260163,4.61275984740365e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAYN,Layilin,41997,-0.0282674763051545,0.00360350157403618,-0.0353303393902654,-0.0212046132200436,4.67668223361867e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0584147075748804,0.00745756786621377,0.0437978745571014,0.0730315405926594,5.12742122224633e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK6,Kallikrein-6,42158,0.0242951425752399,0.00310691810445107,0.0182055830905158,0.030384702059964,5.68474898250735e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO1A,Coronin-1A,41883,0.0698118242004173,0.00892911164773538,0.052310765370856,0.0873128830299786,5.74920636523308e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESYT2,Extended synaptotagmin-2,39929,0.0658540633898661,0.00843054362080123,0.0493301978930957,0.0823779288866365,6.1561399696216e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0363558946067797,0.0046576050554821,0.0272269886980347,0.0454848005155246,6.34967840804131e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42230,-0.0175492012617233,0.00225064660781434,-0.0219604686130394,-0.0131379339104072,6.77628000876313e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC79,Protein unc-79 homolog,39560,0.0440247245691176,0.00564543415064004,0.0329596736338631,0.0550897755043721,6.84422566547955e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0454659867535072,0.00583536553281355,0.0340286703091927,0.0569033031978218,7.10954386061456e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROK1,Prokineticin-1,42119,0.0389056765099515,0.00499833945347996,0.0291089311811308,0.0487024218387722,7.55208015785696e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0436277606414578,0.00560594907535538,0.0326401004537613,0.0546154208291544,7.7499226057567e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0314773582707092,0.00405505618956233,0.023529448139167,0.0394252684022513,9.04138298269015e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLUL1,Clusterin-like protein 1,42123,-0.034870716171835,0.0044942420177766,-0.0436794305266771,-0.0260620018169928,9.17347597133615e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSN,Gelsolin,39943,0.0148432681145402,0.00191323235887564,0.0110933326911439,0.0185932035379364,9.35115637565759e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPACT,Protein IMPACT,39929,0.0425288481081632,0.00548199916397741,0.0317841297467675,0.053273566469559,9.37460876790215e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0621379075582327,0.00801397609788057,0.0464305144063867,0.0778453007100786,9.70971504748604e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADD1,Alpha-adducin,39736,0.0546050700767377,0.00705742106781812,0.0407725247838142,0.0684376153696612,1.10358398896751e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIF,Macrophage migration inhibitory factor,42105,0.0521011938737503,0.00673893542258377,0.0388928804454861,0.0653095073020145,1.13898817671337e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABHD14B,Protein ABHD14B,41976,0.0434067006055407,0.00562834772964206,0.0323751390554422,0.0544382621556391,1.32430197976792e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUS,RNA-binding protein FUS,41831,0.0307178294432937,0.0039896911986635,0.0228980346939132,0.0385376241926741,1.46501848387316e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0225753789271086,0.00293310655472021,-0.0283242677743603,-0.016826490079857,1.49214305291756e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0382015442550438,0.00496514626102614,0.0284698575834326,0.047933230926655,1.54800488447799e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0619032633249019,0.00804833501168501,-0.0776779999478045,-0.0461285267019993,1.55506212867072e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0362407554027467,0.00471102738530923,0.0270071417275406,0.0454743690779527,1.56263534636559e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS27,Serine protease 27,42107,0.0309651260129698,0.00404214844216547,0.0230425150663255,0.0388877369596141,1.97694916474795e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.019423713726789,0.00253741506225368,0.0144503802047718,0.0243970472488062,2.06489912000108e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0313269256514778,0.00409245208343824,-0.0393481317350168,-0.0233057195679389,2.06750578115904e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0300232668238226,0.00392793117562052,0.0223245217196063,0.0377220119280388,2.25483281442398e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0355712383050549,0.00465805718951966,0.0264414462135963,0.0447010303965134,2.38018970942706e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0434179333844786,0.00568981616908636,0.0322658936930693,0.0545699730758878,2.4918980176655e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL,Podocalyxin,42070,0.0116261107205594,0.00152407939894146,0.00863891509863413,0.0146133063424847,2.53826288737002e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.047360962032217,0.00621146868462689,0.0351864834103483,0.0595354406540857,2.6397117860526e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1F,Protein phosphatase 1F,39958,0.0409674058074587,0.00538385263400852,0.030415054644802,0.0515197569701154,2.97341266722014e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2R,Proteinase-activated receptor 1,42166,0.0437657729692941,0.00576346612425299,0.0324693793657582,0.0550621665728299,3.3129846209933e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0860771408649141,0.0113451346933347,-0.10831360486385,-0.0638406768659782,3.48549556618788e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0474519406503668,0.00625933684200572,0.0351836404400356,0.059720240860698,3.65005053180627e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17C,Interleukin-17C,41913,-0.0540238989711835,0.007137629442943,-0.0680136526793518,-0.0400341452630152,4.01153176648249e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRG1,Scrapie-responsive protein 1,39958,0.0208659632951928,0.00275830441254348,0.0154596866466075,0.026272239943778,4.18505562229004e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO2,Roundabout homolog 2,42249,0.0171859139174516,0.00227637197802331,0.0127242248405259,0.0216476029943772,4.63909716813594e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0221103976113932,0.00292994799402716,0.0163676995431,0.0278530956796864,4.76050715270352e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0367736256528934,0.00488434804234103,0.027200303489905,0.0463469478158819,5.50684104606248e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TF,Serotransferrin,39979,0.0163236785108009,0.00216942794451,0.0120715997395613,0.0205757572820405,5.6947205298767e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0391420198860796,0.00521126763088428,0.0289279353295464,0.0493561044426128,6.241464464661e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPY,Pancreatic prohormone,42089,0.0776722510267825,0.0103504869464828,0.0573852966116763,0.0979592054418888,6.56649889975369e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0295608426549888,0.00394171982572987,-0.0372866135134193,-0.0218350717965582,6.81771130265549e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN3,Ataxin-3,39929,0.0462604283789626,0.00617430617806268,0.0341587882699598,0.0583620684879655,7.26517538646918e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLTA,Clathrin light chain A,41900,0.0352875577787153,0.00471276670191712,0.0260505350429577,0.0445245805144728,7.45272167779994e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO2,Gamma-enolase,42249,0.049010578770956,0.00654775731577772,0.0361769744320316,0.0618441831098803,7.58692218050293e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG6,Large proline-rich protein BAG6,41900,0.0278027905027954,0.00371846835192836,0.0205145925330158,0.0350909884725749,8.08265990120761e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL3,Follistatin-related protein 3,42084,-0.0245781946006584,0.00329162634469188,-0.0310297822362545,-0.0181266069650623,8.71517513570894e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0232835498528622,0.00312144908549631,-0.029401590060435,-0.0171655096452895,9.23363092124034e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42070,0.017568470547922,0.00235850607594774,0.0129457986390644,0.0221911424567796,9.97820539413158e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS2,Thrombospondin-2,42137,-0.0289165033606379,0.00388863036297079,-0.0365382188720606,-0.0212947878492151,1.09875649977409e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARA5,Scavenger receptor class A member 5,42249,0.0227636243995472,0.00306897600199043,0.016748431435646,0.0287788173634485,1.26545830338814e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGFAC,Hepatocyte growth factor activator,39897,0.0201707975170014,0.00273353724594944,0.0148130645149405,0.0255285305190623,1.70655859671879e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC4,Apical endosomal glycoprotein,39919,0.0421505916376122,0.00571442894351277,0.0309503109083272,0.0533508723668972,1.74294568184171e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0282767108133306,0.00384064550571956,-0.0358043760045409,-0.0207490456221203,1.93015486896449e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL2,Chordin-like protein 2,42145,0.033818977758872,0.00460070842443048,0.0248015892469882,0.0428363662707557,2.08283499207837e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0265756290830036,0.00361836691636684,0.0194836299269246,0.0336676282390826,2.20711435254752e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0478179481431302,0.0065142738530392,0.0350499713911733,0.060585924895087,2.24847964315321e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0645814594877073,0.00880522471440532,0.0473232190474729,0.0818396999279417,2.38070529333214e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0394979807563747,0.00538573194405088,0.0289419461460349,0.0500540153667144,2.39358177541532e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN6,Dynactin subunit 6,41839,0.0531375141175688,0.00725627380555114,0.0389152174586885,0.067359810776449,2.56543505410378e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAD,Chondroadherin,39736,0.0347601241940432,0.00474748173337962,0.0254550599966192,0.0440651883914673,2.61535676437214e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42185,0.0183108364591645,0.00250244610060816,0.0134060421019725,0.0232156308163565,2.67447839226008e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN2,Matrilin-2,42144,0.0217051226692499,0.00298139699506198,0.0158615845589284,0.0275486607795714,3.51736469910112e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0208846811391554,0.00286875158727433,-0.026507434250213,-0.0152619280280977,3.52063036862018e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF1,Trefoil factor 1,42084,-0.0589639719961728,0.00810618333337689,-0.0748520913295915,-0.0430758526627541,3.68389883941076e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0253209600246067,0.00348467289579745,-0.0321509189003697,-0.0184910011488436,3.89824080602242e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0786856795523458,0.0108325103371823,0.0574539592914685,0.0999173998132232,4.0092380615194e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,39966,0.019804600251036,0.00272705704499647,0.014459568442843,0.0251496320592291,4.05543424206607e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOB,Apolipoprotein B-100,39990,0.0166818156979661,0.0023032767162228,0.0121673933341694,0.0211962380617628,4.68391058707808e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR2,Anterior gradient protein 2 homolog,41740,-0.0729651847695505,0.0100826657535068,-0.0927272096464238,-0.0532031598926772,4.8526366274798e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARD3,Partitioning defective 3 homolog,39757,0.0542773865434262,0.00750229762469594,0.0395728831990221,0.0689818898878302,4.96905055892504e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0648113793123968,0.00896008613643095,0.0472496104849921,0.0823731481398015,4.9702959937739e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA12,Carbonic anhydrase 12,42070,-0.0238307432424193,0.00329692906001854,-0.0302927242000556,-0.0173687622847829,5.159318430623e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPI,Glucose-6-phosphate isomerase,39990,0.0349240576144569,0.00483194608912842,0.0254534432797652,0.0443946719491486,5.22496411300318e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSP1,Lymphocyte-specific protein 1,42119,0.029407445511308,0.00407122011694914,0.0214278540820877,0.0373870369405283,5.34749796346504e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0319514534389996,0.00442341153090117,0.0232815668384333,0.0406213400395659,5.40109014943736e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA6,Integrin alpha-6,42119,0.0369004686543462,0.00512114454580745,0.0268630253445636,0.0469379119641288,6.08896346354909e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0287269015177458,0.00398935850999317,-0.0365460441973324,-0.0209077588381592,6.29843294025399e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0205125024962498,0.00284968220149653,0.0149271253813165,0.026097879611183,6.4214243365677e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXT,Oxytocin-neurophysin 1,42249,0.104838916498792,0.0145710441601281,0.0762796699449412,0.133398163052643,6.57100034534212e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPP1,Osteopontin,42286,-0.0318171895338098,0.00442875900400272,-0.0404975571816552,-0.0231368218859645,7.10850429478007e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0363270027971482,0.00505716520320378,0.0264149589988687,0.0462390465954276,7.24062684709755e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0416526677332025,0.00580152681552189,0.0302816751747796,0.0530236602916254,7.35373608633374e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0460314456690517,0.00641646228494272,-0.0586077117475394,-0.033455179590564,7.66608801490662e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECE1,Endothelin-converting enzyme 1,41839,0.025467692762079,0.00355109366822775,0.0185075491723526,0.0324278363518054,7.79558648806177e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0372779222788593,0.00520035340327722,0.0270852296084359,0.0474706149492827,8.06309784253093e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0271347611390986,0.00379097721765683,0.0197044457924912,0.034565076485706,8.6330873259914e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREH,Trehalase,39966,0.0543896230309181,0.00760321246284722,0.0394873266037375,0.0692919194580986,8.97888594256164e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM3,Myomesin-3,39736,-0.0702230843454466,0.00981887153958581,-0.0894680725630348,-0.0509780961278584,9.09862326325637e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL5,Fc receptor-like protein 5,42137,-0.0425719071282895,0.00595389578735702,-0.0542415428715093,-0.0309022713850697,9.10558876300043e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC3,Membrane primary amine oxidase,42217,-0.0213489075613456,0.00298686960789099,-0.0272031719928119,-0.0154946431298793,9.28132196607134e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DXO,Decapping and exoribonuclease protein,39929,0.0327051410299707,0.00458415040743899,0.0237202062313902,0.0416900758285511,1.03144755361289e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX8,Syntaxin-8,42119,0.0342454420710766,0.00481120182862235,0.0248154864869768,0.0436753976551763,1.15147242611102e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN5,Contactin-5,42170,0.0265108508521212,0.00372579383809582,0.0192082949294534,0.033813406774789,1.1711054314101e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0313357751283378,0.00440621514955821,0.0226995934352037,0.0399719568214719,1.21686959471718e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0462815311931848,0.00651614343671066,0.0335098900572319,0.0590531723291377,1.28502168464936e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDHB,Succinate dehydrogenase,39930,0.0470854584923488,0.0066346060565908,0.0340816306214309,0.0600892863632668,1.35158739311445e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB10,Ras-related protein Rab-10,39958,0.0382843287853644,0.0053966160449041,0.0277069613373523,0.0488616962333764,1.37903751196036e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0139665347505275,0.0019695609822335,-0.0178268742757051,-0.0101061952253498,1.3959187242361e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,41913,0.0467503003906911,0.00660888170521029,0.0337968922484789,0.0597037085329032,1.58212728706878e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML1,Trem-like transcript 1 protein,39990,0.037878887936837,0.00535425367265031,0.0273845507384423,0.0483732251352316,1.58738110721371e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN2,Transcobalamin-2,42286,-0.0215325343192672,0.00304593521611716,-0.0275025673428569,-0.0155625012956776,1.63299172685643e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARK7,Parkinson disease protein 7,42137,0.036016284282421,0.0050965492429617,0.0260270477662161,0.0460055207986259,1.66307248160513e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TALDO1,Transaldolase,39948,0.031448362929442,0.00446491489603931,0.022697129733205,0.0401995961256791,1.98396969326216e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS1,Nephrin,39657,0.0237235871144419,0.00336878781380143,0.0171207629993911,0.0303264112294927,2.00498032992344e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSHB,Thyrotropin subunit beta,42145,0.0482079530277969,0.00685465362461917,0.0347728319235433,0.0616430741320504,2.12018178892487e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0344588096178116,0.00490341922238415,0.0248481079419387,0.0440695112936846,2.20545742079527e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE,Angiotensin-converting enzyme,39990,-0.0190692821223462,0.00272953147129657,-0.0244191638060875,-0.0137194004386049,2.98000506872576e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSO,Cathepsin O,42296,0.0215030699096256,0.00307901415751792,0.0154682021608905,0.0275379376583608,3.00652608184764e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM3,Junctional adhesion molecule C,39736,0.0359507087105891,0.00514977639445133,0.0258571469774645,0.0460442704437137,3.0970814033216e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GC,Vitamin D-binding protein,39979,0.0182502609900775,0.0026148754094013,0.0131251051876509,0.023375416792504,3.12923419041863e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0218043228926937,0.00312522613763517,0.0156788796629288,0.0279297661224587,3.18596032919744e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0557556020567341,0.00799209078668284,0.0400911041148358,0.0714200999986325,3.20315110677134e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WDR46,WD repeat-containing protein 46,39919,0.0257994674899524,0.00369868388733625,0.0185500470707733,0.0330488879091314,3.2221488889568e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0302469879656538,0.00434327190727716,0.0217341750273906,0.038759800903917,3.49124421114386e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,39945,0.034770146324727,0.00500767226583906,0.0249551086836824,0.0445851839657715,4.03749661034856e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0619565760552006,0.00893441854103954,0.0444451157147631,0.0794680363956381,4.29551753369161e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA4,Annexin A4,42088,0.0505085497676315,0.00729325016415845,0.036213779445881,0.0648033200893821,4.54489432149118e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF2,Trefoil factor 2,42166,-0.0407012952831392,0.00587904147608222,-0.0522242165762604,-0.0291783739900181,4.61676542454353e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.050149432136682,0.0072659104098952,0.0359082477332874,0.0643906165400766,5.35761494556233e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,39990,0.0184254636392033,0.00267043736162633,0.0131914064104157,0.0236595208679909,5.48404529774109e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0645038699490905,0.0093682113029423,0.0461421757953236,0.0828655641028574,6.06717906476942e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK3,NT-3 growth factor receptor,42249,0.0146742042677029,0.0021344189098447,0.0104907432044073,0.0188576653309985,6.46679459424276e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0349139054186082,0.00508266146352186,0.0249518889501053,0.044875921887111,6.73763111802302e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0291478822018934,0.00425014813712308,0.0208175918531322,0.0374781725506546,7.27926211558264e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0210516878374485,0.00306967302630967,-0.0270682469690155,-0.0150351287058816,7.34866066355275e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX16,Syntaxin-16,41843,0.0392648302713153,0.00573709225846798,0.0280201294447181,0.0505095310979126,8.0384650674883e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,39657,-0.0867435491985004,0.0126834625839817,-0.111603135863105,-0.0618839625338962,8.38932908567803e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0362684643542803,0.00530628232421568,0.0258681509988176,0.0466687777097431,8.62872797385737e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0162709092710285,0.00238197428876592,0.0116022396650473,0.0209395788770097,8.80026008617889e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS8,Prostasin,42080,-0.0286870632719312,0.00420047182427469,-0.0369199880475096,-0.0204541384963528,8.88717415712058e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PER3,Period circadian protein homolog 3,39657,0.0849280178715546,0.0124368145419384,0.0605518613693554,0.109304174373754,9.01437184080304e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEMIP2,Cell surface hyaluronidase,39657,0.0223679389077115,0.00327943939065611,0.0159402377020255,0.0287956401133975,9.53535598105012e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17D,Interleukin-17D,41913,0.0233459901485263,0.00343377599007983,0.0166157892079698,0.0300761910890827,1.09895378729794e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0248799214016963,0.0036629077071467,0.0177006222956887,0.0320592205077038,1.15955422712217e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0613584440182839,0.00903605428736577,0.043647777615047,0.0790691104215208,1.17512823413906e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0212676178813677,0.00313775988159879,-0.0274176272493013,-0.0151176085134341,1.26887124962306e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42119,0.0407720723146496,0.00601941353385373,0.0289740217882963,0.0525701228410029,1.30965066183659e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKZ,Diacylglycerol kinase zeta,41913,0.0246261930387367,0.00363765839782503,0.0174963825789996,0.0317560034984737,1.34371990752301e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0225585274836028,0.00334196324938757,-0.0291087754524025,-0.0160082795148032,1.55104572224023e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD84,SLAM family member 5,42119,0.0215913253931715,0.00320528044817902,0.0153089757147406,0.0278736750716023,1.6918921838808e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL1,Follistatin-related protein 1,39638,-0.0158112860389179,0.00234808234745836,-0.0204135274399363,-0.0112090446378995,1.73614362123196e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0330426579907068,0.00491642133339595,0.0234064721772507,0.0426788438041628,1.89464360629299e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPMT,Thiopurine S-methyltransferase,41843,0.0482920685731312,0.00719194331262961,0.0341958596803772,0.0623882774658852,1.96078179769192e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAC1,Cartilage acidic protein 1,42310,0.0209300951259297,0.00311841510873179,0.0148180015128154,0.027042188739044,1.99829797814256e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39281,-0.0748929616346699,0.0112088133455513,-0.0968622357919505,-0.0529236874773893,2.48090876545269e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGED1,Melanoma-associated antigen D1,41843,0.0323972290007658,0.00485125617851397,0.0228887668908785,0.0419056911106532,2.51699226347717e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH7,Protocadherin-7,39930,0.0235312253094815,0.00352767902569885,0.0166169744191118,0.0304454761998513,2.66885230628404e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42070,0.0401136348755339,0.0060220743827725,0.0283103690852998,0.051916900665768,2.82338450705187e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0266525711465669,0.00400201157591357,0.0188086284577763,0.0344965138353575,2.8480716616744e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.024483407019857,0.00368677526846065,0.0172573274936741,0.0317094865460399,3.23839281788266e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOTL2,Angiomotin-like protein 2,39882,0.0327301840124907,0.00493630293222533,0.023055030265329,0.0424053377596523,3.49812712977684e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEPR,Leptin receptor,42145,-0.0209621697969164,0.00316502264181351,-0.0271656141748709,-0.0147587254189619,3.65086728036818e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0374375152363938,0.00566673124397341,0.0263307219982059,0.0485443084745817,4.0836473275409e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0326942134795155,0.0049504212122856,0.0229913879034357,0.0423970390555953,4.1718153973922e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0419283025242166,0.00636487796571884,0.0294531417114077,0.0544034633370255,4.67204508085832e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNMT,Histamine N-methyltransferase,41961,0.031752666968556,0.00482414175538642,0.0222973491279986,0.0412079848091134,4.81375395133113e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZD2,PDZ domain-containing protein 2,39575,0.0392240312043879,0.0059601518977203,0.0275421334848561,0.0509059289239197,4.88441434204892e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFAP,Glial fibrillary acidic protein,41820,0.0301332342277708,0.00457996167072809,0.0211565093531437,0.0391099591023979,4.90262887134665e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC1,Sialoadhesin,42185,-0.0275254422361229,0.00418498333070044,-0.0357280095642957,-0.01932287490795,4.96956232134924e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL1,Delta-like protein 1,42181,-0.0203044770652569,0.0030900526623772,-0.0263609802835162,-0.0142479738469976,5.18301104251295e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0371812119966294,0.00565925422748958,-0.048273350282509,-0.0260890737107499,5.25984896867403e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0196873610834795,0.00300035890340335,0.0138066576328089,0.0255680645341501,5.55231499693673e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF2,Fibroblast growth factor 2,42119,0.0455811834723219,0.00695085852583711,0.0319575007616812,0.0592048661829627,5.66550514246647e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0275861532467113,0.00421159379179022,0.0193314294148024,0.0358408770786201,6.00848558139208e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRBP,Acrosin-binding protein,39919,0.0263945395088988,0.00403265300441684,0.0184905396202418,0.0342985393975558,6.1981228076086e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA2,Ephrin type-A receptor 2,41614,-0.021299164818614,0.00325788495709572,-0.0276846193345216,-0.0149137103027064,6.47915539485267e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0269434013423326,0.00412482118312,-0.0350280508612478,-0.0188587518234174,6.76595846693921e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT2A1,Bile salt sulfotransferase,42119,0.0385525970895356,0.00591522870095792,0.0269587488356581,0.0501464453434131,7.40163466304411e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17A,Interleukin-17A,41877,-0.0281788404016378,0.00432722960464348,-0.036660210426739,-0.0196974703765366,7.68356747735436e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0385593400464052,0.00592235058824423,0.0269515328934465,0.0501671471993639,7.73831971665178e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164,Sialomucin core protein 24,42137,0.0176823009495387,0.00272019159144394,0.0123507254303086,0.0230138764687689,8.29209475423411e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFA,Vascular endothelial growth factor A,42253,0.0370010548384959,0.00569732447204209,0.0258342988732935,0.0481678108036984,8.6215877467336e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM1,Probable carboxypeptidase X1,42181,0.0449579162343575,0.00692392127535635,0.0313870305346591,0.058528801934056,8.69953608704861e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS53,Serine protease 53,39929,0.0250816961359322,0.00386320696030176,0.0175098104937407,0.0326535817781236,8.79789114408945e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK4,Serine/threonine-protein kinase 4,42145,0.0570263317280659,0.00880025613810475,0.0397778296973806,0.0742748337587512,9.48477339650475e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,39757,0.0231477845506492,0.00357363240455541,0.0161434650377206,0.0301521040635778,9.72531055572037e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELENOP,Selenoprotein P,39979,0.0148177197398513,0.00229018192500012,0.0103289631668511,0.0193064763128515,1.01953953766048e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRN1,Secernin-1,42119,0.0360183190557028,0.00556869337284998,0.0251036800449169,0.0469329580664888,1.02724091572962e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0320584573110969,0.00495671302100611,0.0223432997899249,0.0417736148322689,1.03612348092693e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXN,"Frataxin, mitochondrial",42262,0.0472967752123543,0.00731745336118438,0.0329545666244329,0.0616389838002757,1.05742026387853e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0276509560685188,0.00428344055911749,0.0192554125726486,0.0360464995643891,1.12524959138714e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA4,Laminin subunit alpha-4,42185,0.0222186086775682,0.00344283318943358,0.0154706556262783,0.028966561728858,1.1294325115242e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL3,Myosin light chain 3,39638,-0.0512014615696165,0.00793770204701815,-0.0667593575817721,-0.0356435655574609,1.16210692185377e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX4,Syntaxin-4,42070,0.0383070150079037,0.00594335237974136,0.0266580443436107,0.0499559856721968,1.1925791760141e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLB1,Beta-galactosidase,42016,0.0279611211535733,0.00434134837106828,0.0194520783462795,0.0364701639608672,1.23016115248471e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.017797683872984,0.00276873270270584,0.0123709677756806,0.0232243999702875,1.34529707562648e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIT,Vitrin,39958,0.024932306536322,0.0038817897486491,0.0173239986289697,0.0325406144436742,1.39052043613392e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0209969166451049,0.00327031189106932,0.014587105338609,0.0274067279516007,1.41278586684208e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0371707834606625,0.00579408556791949,0.0258143757475403,0.0485271911737847,1.45328162801356e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0255788851665349,0.00398726188478582,0.0177638518723547,0.0333939184607152,1.46290385041315e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRDT,Bromodomain testis-specific protein,39575,0.0237336499552608,0.00370059549961104,0.0164804827760232,0.0309868171344985,1.48095052379308e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42310,-0.0211342201686366,0.00329770050849018,-0.0275977131652773,-0.0146707271719958,1.51491028158258e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0292302420861371,0.00457230426385416,0.0202685257289829,0.0381919584432912,1.68148255968644e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0284955167827351,0.00446169089330551,0.0197506026318563,0.0372404309336139,1.7506144844325e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0573026234261253,0.00897190438269562,0.0397176908360419,0.0748875560162087,1.76081177826286e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.030868046974157,0.00483561108617982,0.0213902492452445,0.0403458447030694,1.79867532034759e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI1,Neuroserpin,39713,0.0186778502981475,0.00293144360609912,0.0129322208301933,0.0244234797661018,1.9452391184575e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP3,Stromelysin-1,42137,-0.0318424623722782,0.00500496205029341,-0.0416521879908533,-0.0220327367537031,2.05313419022177e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAP3,Cytosol aminopeptidase,41913,0.0307314406717163,0.00483654547717014,0.0212518115364629,0.0402110698069698,2.16609598476909e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POF1B,Protein POF1B,39657,-0.0292140438349314,0.00459919316506744,-0.0382284624384636,-0.0201996252313992,2.20889804210645e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0528013281348306,0.0083192711891164,0.0364955566041625,0.0691070996654987,2.26754424434778e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR2,Complement factor H-related protein 2,39904,0.0366163128938838,0.00577955431042892,0.0252883864454431,0.0479442393423245,2.45578540881756e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM2,Myomesin-2,39575,-0.0357110613579794,0.00563807105625325,-0.0467616806282358,-0.0246604420877231,2.48369193779036e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSR,"Glutathione reductase, mitochondrial",39949,0.0146799109625027,0.00231876760630217,0.0101351264541504,0.0192246954708549,2.52916914536863e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0481757026168968,0.00763738588984623,0.0332064262727982,0.0631449789609954,2.93427535781522e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0194720545782141,0.00308780220331622,-0.0255241468967139,-0.0134199622597144,2.96766204496097e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0359255906058394,0.00570143745396222,0.0247507731960735,0.0471004080156054,3.04650692719964e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILP,Rab-interacting lysosomal protein,42224,0.0371700189827773,0.00589933146445036,0.0256073293124546,0.0487327086531,3.05387031476204e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0297730887146967,0.00472896984354886,0.0205043078213409,0.0390418696080525,3.15283332387567e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD244,Natural killer cell receptor 2B4,42296,0.0174396592188702,0.00277079580625536,0.0120088994386097,0.0228704189991307,3.18616265839772e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0154321315014663,0.00245513335854816,0.010620070118712,0.0202441928842207,3.36530415133258e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRIB,Protein scribble homolog,39638,0.0556460898003204,0.00885203449994783,0.0382961021804226,0.0729960774202181,3.37505428717758e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0148503348327236,0.00236641927818489,0.0102121530474812,0.0194885166179659,3.59271942562166e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGH,Gamma-glutamyl hydrolase,41933,0.0214656578208773,0.00342238085499477,0.0147577913450875,0.028173524296667,3.67114315082682e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOA,Elongin-A,42070,0.0339609073782236,0.00541897979021885,0.0233397069893946,0.0445821077670525,3.79212794961794e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPT,Dermatopontin,42310,0.0160249898750597,0.00255766791477262,0.0110119607621054,0.0210380189880141,3.82818091400517e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0178479004455904,0.00284972516830669,0.0122624391157093,0.0234333617754715,3.91706147047665e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0174849895309009,0.00279750570780734,0.0120018783435985,0.0229681007182033,4.22197537011238e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE6,Ribonuclease K6,39937,-0.0203797986181119,0.00326201501189816,-0.0267733480414323,-0.0139862491947915,4.31720516431952e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY96,Lymphocyte antigen 96,42016,-0.0229775182660169,0.00368182016819968,-0.0301938857956882,-0.0157611507363455,4.4842636011538e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0247093179366927,0.00396660053349848,0.0169347808910357,0.0324838549823497,4.84970814855675e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH1,Protocadherin-1,42264,0.0128915519785218,0.00207361559101197,0.00882726542013831,0.0169558385369052,5.2167866003524e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBI,Acyl-CoA-binding protein,42085,0.0487174917110874,0.00784338513880819,0.0333444568390234,0.0640905265831515,5.40973383863046e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42310,-0.016918540071072,0.00272765547226482,-0.022264744796711,-0.0115723353454329,5.71355842443054e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0351323004377589,0.00567235944772098,0.0240144759202258,0.0462501249552921,6.08684402569273e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFAP1,Actin filament-associated protein 1,39736,0.0524411822703586,0.00846729160833819,0.0358452907180157,0.0690370738227014,6.09628472340773e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0401807906066036,0.00649180769659656,0.0274568475212743,0.0529047336919328,6.24569201833938e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.024703129246902,0.00399923874860664,-0.032541637194171,-0.0168646212996329,6.71973935978043e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0437864071558658,0.00709477926703391,0.0298806397924794,0.0576921745192523,6.9936562899891e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0145053431347645,0.00235170945391851,0.00989599260508418,0.0191146936644447,7.11027925511048e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,39513,0.0332052618131884,0.00538301609780923,0.0226545502614823,0.0437559733648945,7.13724787946131e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0202609135244517,0.00328945099126828,0.0138135895815659,0.0267082374673375,7.55776908917303e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPLAH,5-oxoprolinase,39638,0.0431592281207731,0.00701731809217607,0.029405284660108,0.0569131715814382,7.99689836572011e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1A,Protein phosphatase 1A,41843,0.0193680383857266,0.00315345863620893,0.0131872594587571,0.0255488173126961,8.39055836119728e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0292724417381869,0.00477093023963433,0.0199214184685037,0.0386234650078702,8.72656679194473e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCG,Gamma-synuclein,42016,0.0411886977811515,0.0067288415816423,0.0280001682811326,0.0543772272811704,9.54519365153001e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42310,-0.0144787267648302,0.00236538372069656,-0.0191148788573955,-0.00984257467226497,9.54714650344913e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCA,Tubulin-specific chaperone A,39736,0.0520545559646608,0.008512977595843,0.0353691198768085,0.0687399920525131,9.99630949522325e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0423946887921911,0.00693718003797201,0.028797815917766,0.0559915616666163,1.01594384325499e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGLN1,Egl nine homolog 1,42119,0.0343411601194317,0.00562364724760864,0.0233188115141188,0.0453635087247447,1.04588140283838e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0290861086541737,0.00476846573654416,0.0197399158105472,0.0384323014978003,1.09235056009923e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN2,Alpha-actinin-2,39575,-0.0398646902187081,0.00653596075305622,-0.0526751732946983,-0.0270542071427179,1.10132242093351e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0354448048191192,0.0058139964889094,0.0240493717008568,0.0468402379373817,1.11416855112072e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD1,Bromodomain-containing protein 1,39757,-0.0187661699617175,0.00307786166115123,-0.0247987788175739,-0.0127335611058611,1.11551114980562e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0150390927142428,0.00246914819280759,-0.0198786231721457,-0.0101995622563399,1.1535035576829e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.033211953281882,0.00545208444165879,0.0225258677762307,0.0438980387875332,1.15504010954788e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSNL1,Visinin-like protein 1,39929,0.0238797638018282,0.00392359759285258,0.0161895125198371,0.0315700150838193,1.19367828547781e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX9,Sorting nexin-9,42145,0.0415659248956648,0.00684407658744168,0.0281515347842791,0.0549803150070505,1.28685490735185e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0175377516245819,0.00288986382802358,-0.0232018847275081,-0.0118736185216557,1.3237016571479e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.046517532975645,0.00766491842026916,0.0314942928719175,0.0615407730793726,1.32916870683979e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD93,Complement component C1q receptor,41654,-0.0192418813403976,0.00317420439659948,-0.0254633219577326,-0.0130204407230626,1.38185936173456e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0510764628500969,0.0084423604168495,0.0345294364330719,0.0676234892671219,1.49400299970078e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0516861948047124,0.00855253722073163,0.0349232218520784,0.0684491677573464,1.54976329945687e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA14,Carbonic anhydrase 14,42262,0.0222678292560003,0.00369631380363785,0.0150230542008701,0.0295126043111305,1.7417065304932e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0159969144045218,0.00265666623493558,-0.0212039802249956,-0.0107898485840481,1.78342386977236e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42070,0.0439124388253046,0.00729813928937982,0.0296080858181202,0.0582167918324891,1.82359908415692e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PQBP1,Polyglutamine-binding protein 1,41843,0.0340637140885353,0.00568696857304001,0.0229172556853769,0.0452101724916938,2.15566769911659e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD48,CD48 antigen,42166,-0.0185195676216195,0.00309473467442127,-0.0245852475834852,-0.0124538876597538,2.22912445589103e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0442714880503452,0.00740077265493632,0.02976597364667,0.0587770024540204,2.26088324390964e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH1,Neurexophilin-1,41839,0.0233323261185462,0.00390505399147439,0.0156784202952564,0.030986231941836,2.3613625756761e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSNAX,Translin-associated protein X,39575,0.0237189628154054,0.00397833676667875,0.0159214227527151,0.0315165028780958,2.56792017672506e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SWAP70,Switch-associated protein 70,39930,0.0220688318889233,0.0037077169964179,0.0148017065759442,0.0293359572019024,2.72503890458063e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL4,Myosin light chain 4,39638,-0.030957596353162,0.00520934932500622,-0.0411679210301742,-0.0207472716761498,2.88837498518972e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0157106670946251,0.00264578122620854,0.0105249358912563,0.0208963982979938,2.96971012459233e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACYP1,Acylphosphatase-1,39701,0.0389846939206233,0.00659146093363084,0.0260654304907069,0.0519039573505398,3.4285719278411e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0197969690958524,0.00334880135524717,0.013233318439568,0.0263606197521369,3.46753547002978e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.032097003531658,0.00543570607639569,0.0214430196219225,0.0427509874413936,3.61446551358594e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BP1,SH3 domain-binding protein 1,39930,0.0294854908645896,0.00499873091232583,0.0196879782764309,0.0392830034527482,3.77084275718544e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN2,Dynactin subunit 2,42070,0.05634875890102,0.00956204831314799,0.0376071442072499,0.07509037359479,3.88405742187354e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASET2,Ribonuclease T2,42258,-0.0158925265310188,0.00270023904712732,-0.0211849950633884,-0.0106000579986493,4.05913243291425e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0495710117636582,0.00845593957373718,0.0329973701991333,0.0661446533281831,4.67515040694921e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS1,"Nitric oxide synthase, brain",41839,-0.0345685829782967,0.0059116432410639,-0.0461554037307819,-0.0229817622258114,5.10657971372803e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDK2,Protein sidekick-2,39736,0.0232570778726246,0.0039862419536876,0.0154440436433969,0.0310701121018523,5.55088807483887e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL3A1,Collagen alpha-1(III) chain,39966,-0.0138782765829077,0.00238292003887235,-0.0185487998590975,-0.00920775330671791,5.89897204882446e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMM2,Phosphomannomutase 2,39575,0.0353487650694601,0.00607257762710758,0.0234465129203293,0.047251017218591,6.01177426156677e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG4A,Cysteine protease ATG4A,41843,0.0340437722142393,0.00585231390049107,0.0225732369692768,0.0455143074592018,6.1243377900929e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCT,Secretin,39649,0.0282986220063218,0.00486496105173306,0.018763298344925,0.0378339456677186,6.16399382116698e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0232865133721973,0.00400618236752547,0.0154343959318474,0.0311386308125472,6.28613259245612e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0282424501698886,0.00486770150107432,0.0187017552277829,0.0377831451119942,6.70259382875168e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGF,Hepatocyte growth factor,42296,0.0201581737990817,0.00347515594709366,0.0133468681427781,0.0269694794553852,6.75160108287303e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MET,Hepatocyte growth factor receptor,42158,0.0112187075262273,0.00193472482154228,0.00742664687600446,0.0150107681764502,6.83581768633666e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPAG1,Sperm-associated antigen 1,39934,0.0342556661286399,0.00591264025113436,0.0226668912364166,0.0458444410208632,7.07130142540367e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0343358879330011,0.00593233870148148,0.0227085040780974,0.0459632717879048,7.32013085707854e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPM3,Tropomyosin alpha-3 chain,39575,-0.0270811695274969,0.0046845853169249,-0.0362629567486697,-0.0178993823063241,7.63223071998003e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4R,Reticulon-4 receptor,42262,0.0196100729307967,0.00339507439610915,0.0129557271144227,0.0262644187471706,7.81461162141466e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.0532493254363219,0.00924291447331125,0.0351332130686319,0.071365437804012,8.54197014765179e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA10,N-alpha-acetyltransferase 10,39575,0.0295625903103447,0.00513092476976844,0.0195059777615986,0.0396192028590909,8.55364381811718e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL7,C-C motif chemokine 7,42119,0.0325449157122329,0.00565420589231863,0.0214626721632884,0.0436271592611774,8.8063806063125e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18,Interleukin-18,42069,0.0255823891087689,0.00445870366668458,0.0168433299220672,0.0343214482954707,9.80767905600138e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0381326122145806,0.00665856757211589,0.0250818197732335,0.0511834046559277,1.04914357631966e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.032148515007088,0.00561842915810027,0.0211363938572114,0.0431606361569645,1.0752241710921e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42181,0.0170939919164185,0.00298973209190994,0.011234117016275,0.022953866816562,1.10334708616643e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF22,Kinesin-like protein KIF22,39575,0.0718620063361722,0.0125738312466611,0.0472172970927164,0.0965067155796281,1.12427777606396e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENAH,Protein enabled homolog,41913,0.0277012827350041,0.00485602817244265,0.0181834675170165,0.0372190979529917,1.19158322045301e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00927155824370604,0.00162568154435941,0.00608522241676159,0.0124578940706505,1.20018361985447e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML2,Trem-like transcript 2 protein,42137,0.0198000205170094,0.00347255909058149,0.0129938046994696,0.0266062363345491,1.20987760894463e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0229352992758992,0.00402397124108343,-0.0308222829084227,-0.0150483156433757,1.23036603824098e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP9,Caspase-9,39657,0.0368071486337525,0.00646562695266481,0.0241345198065295,0.0494797774609755,1.28198271216981e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",39638,0.0504675705803876,0.00887365832909939,0.0330752002553528,0.0678599409054224,1.32307411863776e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0376127840636272,0.00662046001319373,0.0246366824377674,0.0505888856894869,1.37081572605374e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7orf50,Uncharacterized protein C7orf50,39929,0.0131054299270073,0.00230760451924623,0.00858252506928468,0.0176283347847299,1.3862831359901e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0209937699314082,0.00370762655607167,0.0137268218815077,0.0282607179813087,1.52339528339248e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0375071011967181,0.00665443386889014,0.0244644108136934,0.0505497915797428,1.77781154217348e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0230927716560597,0.00410327422184899,0.0150503541812357,0.0311351891308838,1.86869273305249e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPK2,Death-associated protein kinase 2,39657,0.0315253545271902,0.00560795699700567,0.0205337588130591,0.0425169502413213,1.93849467832391e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0243292035445875,0.00433365066102038,0.0158352482489876,0.0328231588401875,2.01599544435308e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0274709668874502,0.00491984804591889,-0.0371138690574512,-0.0178280647174492,2.3996850904551e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCA,Calcitonin,41997,0.0390693160915225,0.00700059278740202,0.0253481542282146,0.0527904779548305,2.43979289956381e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.047372548174801,0.00849249247038955,-0.0640178334167645,-0.0307272629328375,2.48816723255393e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0297415504139292,0.00533464637384631,0.0192856435211904,0.040197457306668,2.531024197901e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME1,Proteasome activator complex subunit 1,42002,0.0203878176709607,0.00365767828763839,0.0132187682271895,0.027556867114732,2.53794337308678e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDM1,Nuclear protein MDM1,39649,0.0176961297399991,0.00317889538999226,0.0114654947756142,0.0239267647043839,2.65584801880708e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0378565157289946,0.00680561435885816,0.0245175115856326,0.0511955198723566,2.72101767171593e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL2,C-C motif chemokine 2,41992,0.0290643968208493,0.00522631399054383,0.0188208213993834,0.0393079722423152,2.73109978348147e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0194433213170595,0.00349779095392643,-0.0262989915867553,-0.0125876510473637,2.76859397414369e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18BP,Interleukin-18-binding protein,42217,-0.0175699234746787,0.00316294894405128,-0.0237693034050192,-0.0113705435443382,2.82947783965451e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ING1,Inhibitor of growth protein 1,41820,0.0266272372181902,0.00479392969014638,0.0172311350255033,0.0360233394108771,2.84001024297808e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42070,0.0474473219574693,0.00855744425595059,0.0306747312158061,0.0642199126991324,3.00226804049365e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,39990,0.0151955075792344,0.00274073343633102,0.00982367004402561,0.0205673451144432,3.01670050911135e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL3,C-C motif chemokine 3,42119,0.0330400084854297,0.00597200617498966,0.0213348763824499,0.0447451405884094,3.21601448156529e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2orf69,UPF0565 protein C2orf69,39649,0.032873240625027,0.00595952439318027,0.0211925728143937,0.0445539084356603,3.54440474751715e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1A,Meprin A subunit alpha,39930,0.0423695152359866,0.00769322271325103,0.0272907987180146,0.0574482317539586,3.72155817853293e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0256540282766011,0.00466399876961651,0.0165125906881527,0.0347954658650495,3.87219733664269e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42296,0.0407583726682759,0.00741360669685165,0.0262277035424467,0.0552890417941052,3.91487631863329e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN5,CCN family member 5,42137,0.0209513204655643,0.00382495638878403,0.0134544059435476,0.028448234987581,4.38998150256343e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID2,Nidogen-2,42137,0.0401958126273792,0.00734578583496409,0.0257980723908496,0.0545935528639088,4.53010294713181e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDHB15,Protocadherin beta-15,39919,-0.0220266111822813,0.00402559341980238,-0.029916774285094,-0.0141364480794686,4.55374081709389e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0236306276421301,0.00432364717167069,-0.0321049760986047,-0.0151562791856555,4.70009821491751e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASSF2,Ras association domain-containing protein 2,41843,0.031369421686111,0.00574177178532679,0.0201155489868705,0.0426232943853515,4.75620295903627e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVALB,Parvalbumin alpha,42208,0.0613338695488647,0.0112556794032091,0.0392727379185749,0.0833950011791545,5.14921304606052e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0133811561306597,0.00245748031483439,0.0085644947135843,0.0181978175477351,5.26901997985599e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC16,Mucin-16,42070,0.103995985586517,0.0192452006463742,0.0662753923196232,0.14171657885341,6.63773769023741e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA7,Carbonic anhydrase 7,39757,-0.01830843301458,0.00339568392101119,-0.0249639734997619,-0.0116528925293981,7.12263246928504e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0419332613666354,0.00778734945655917,-0.0571964663014913,-0.0266700564317794,7.39736069590576e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0201808034138515,0.00375085302260286,0.0128291314895499,0.0275324753381531,7.55855266138563e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0323560024278219,0.00601399378672117,-0.0441434302497954,-0.0205685746058484,7.569635776034e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,39757,0.040410121083106,0.00751066445470128,0.0256892187518915,0.0551310234143205,7.58381228182762e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,39963,-0.013938378906011,0.00259258706951438,-0.0190198495622592,-0.00885690824976282,7.75616048174744e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBN,Nibrin,41913,0.0294123812994745,0.00547778692448435,0.0186759189274852,0.0401488436714638,8.03295058985984e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA4,Carbonic anhydrase 4,42310,-0.0131255947959905,0.0024447029100392,-0.0179172124996674,-0.00833397709231367,8.04675866194127e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP10,Bone morphogenetic protein 10,39736,0.0153428040331133,0.00286524472392989,0.00972692437421072,0.0209586836920159,8.73561046501839e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0334484979853999,0.00626852619085046,-0.0457348093194669,-0.021162186651333,9.68835523459728e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL19,C-C motif chemokine 19,42249,0.0606186258693805,0.0113678390749404,0.0383376612824972,0.0828995904562638,9.84319427813019e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP6,Gastrotropin,41881,0.0305541509470999,0.00573059234273622,0.0193221899553369,0.0417861119388629,9.88576595221637e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF1,Scavenger receptor class F member 1,42310,0.0228037495859463,0.00428071834423488,0.0144135416312459,0.0311939575406467,1.01379209935323e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XRCC4,DNA repair protein XRCC4,41839,0.0197658237527974,0.00371243758187877,0.012489446092315,0.0270422014132798,1.03045381811578e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL19,Interleukin-19,41756,-0.0393569894620644,0.00739726507162112,-0.0538556290024418,-0.024858349921687,1.05191837330653e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0144480127401652,0.00271715257544432,0.00912239369229429,0.019773631788036,1.07353174694837e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0181605586483564,0.0034160316482714,-0.0248559806789684,-0.0114651366177445,1.07595303068002e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0308687775140929,0.00580810100481749,0.0194848995446507,0.0422526554835352,1.08518696014529e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMSB10,Thymosin beta-10,42137,0.0406827895395925,0.00765704411541846,0.0256749830733723,0.0556905960058127,1.09472230184506e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAL,Integrin alpha-L,39657,0.0233928269290626,0.00442768243232449,0.0147145693617066,0.0320710844964186,1.29280804211287e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM,Paralemmin-1,39859,0.0163259261561121,0.00309606779508306,0.0102576332777493,0.0223942190344749,1.3661105549783e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM25,Transmembrane protein 25,39934,-0.0250048114594465,0.00474240544026559,-0.0342999261223671,-0.015709696796526,1.36977930936279e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.026557104173709,0.00503940239136736,0.016679875486629,0.0364343328607891,1.38646721659941e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.0436942277676671,0.00829662694734234,0.0274328389508761,0.0599556165844581,1.41222189417386e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD209,CD209 antigen,42171,0.0206585288660905,0.00393123182868153,0.0129533144818747,0.0283637432503063,1.5028583993663e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0222268570997059,0.00423700378894461,-0.0305313845260374,-0.0139223296733745,1.58005029057499e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0321788684280109,0.0061393218464617,0.020145797608946,0.0442119392470758,1.61729032254952e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH5,Cadherin-5,42310,-0.0160393482166509,0.00306135059981563,-0.0220395953922895,-0.0100391010410123,1.63571030980096e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICOSLG,ICOS ligand,42070,0.010099013110903,0.00192772294702335,0.00632067613473724,0.0138773500870688,1.64034086035488e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42217,0.0172047985801081,0.00329865848582922,0.0107394279478828,0.0236701692123334,1.85813094670554e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH6,Cadherin-6,42145,-0.0204443493781497,0.00392201386479427,-0.0281314965531464,-0.0127572022031529,1.88830794038964e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.035926006448931,0.00692846616383084,0.0223462127678226,0.0495058001300395,2.19472620842577e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD160,CD160 antigen,42296,-0.025295121078518,0.00487975105184226,-0.0348594331401288,-0.0157308090169071,2.20632624018079e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0195753705236283,0.00378085620040461,0.0121648923708352,0.0269858486764213,2.28741353874443e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42137,0.0277590839048129,0.00536446081778213,0.01724474070196,0.0382734271076659,2.31632145974414e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF4,Neurotrophin-4,41843,0.0197107067498152,0.00381022725906098,0.0122426613220557,0.0271787521775748,2.33597029711173e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0255700110090353,0.00497126220401922,0.0158263370891577,0.035313684928913,2.73336340963781e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0596698264656168,0.0116002957227449,0.0369332468490367,0.0824064060821969,2.73706994996212e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0178151524692813,0.00346382263138079,0.0110260601117749,0.0246042448267876,2.74589665501106e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMNL1,Formin-like protein 1,41839,0.0326579603462279,0.00635712896634295,0.0201979875721957,0.0451179331202601,2.82798673947891e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,41843,0.0200388050146884,0.00390155542353155,0.0123917563845666,0.0276858536448102,2.84471308245022e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0207457378757883,0.00404016122028702,0.0128270218840257,0.0286644538675508,2.86331279933868e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0349763426203703,0.00681327088737767,0.02162233168111,0.0483303535596305,2.88220060821344e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0220339234285478,0.00429747003539143,-0.030456964697915,-0.0136108821591806,2.98164198703926e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0110514446938738,0.00216111854677015,0.00681565234220431,0.0152872370455433,3.20140477620632e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1,Integrin beta-1,42167,0.0108620306467582,0.00212577529853622,0.00669551106162722,0.0150285502318892,3.27089182455706e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK1D,Casein kinase I isoform delta,39657,0.0332971191802199,0.00651728662699364,0.0205232373913123,0.0460710009691274,3.29189833046488e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0163043363437398,0.00319652349236423,-0.0225695223887737,-0.0100391502987059,3.43094880192565e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,41820,0.0341602937604803,0.00671539472715618,0.0209981200952542,0.0473224674257064,3.69022387745249e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0369862428970293,0.00727311481820973,0.0227309378533382,0.0512415479407203,3.71960229984587e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD101,Immunoglobulin superfamily member 2,39930,0.022235129043497,0.00437410484363317,0.013661883549976,0.030808374537018,3.7674333231949e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF6,SLAM family member 6,41843,0.0197555519353346,0.003889533490306,0.0121320662943349,0.0273790375763344,3.84268082297115e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERI1,3'-5' exoribonuclease 1,39757,0.0176634005628412,0.00347744294532806,0.0108476123899982,0.0244791887356842,3.84702645110318e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP8,Caspase-8,42224,0.0312322039859446,0.00615400222113139,0.0191703596325271,0.0432940483393621,3.92385540248729e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAP18,Chromatin complexes subunit BAP18,39929,0.0348651420301741,0.00690127786367003,0.0213386374173808,0.0483916466429673,4.44058431864342e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0213126238278272,0.0042260435432277,-0.0295956691725535,-0.0130295784831009,4.63776574441845e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGT,Angiotensinogen,39990,0.0110995610070991,0.00220201082487435,0.00678361979034532,0.0154155022238528,4.71086459497403e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0146221937154867,0.00290898585870923,-0.0203238059985568,-0.0089205814324166,5.05791461830242e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN3,Perilipin-3,42145,-0.0216040496697177,0.00431651141407627,-0.0300644120413072,-0.0131436872981282,5.65695238081167e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDUA,Alpha-L-iduronidase,42262,0.0237322943583223,0.00474782190209223,0.0144265634302215,0.033038025286423,5.8474043739194e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTB,Lymphotoxin-beta,39919,0.0173705853391321,0.0034770146763518,0.0105556365734826,0.0241855341047816,5.94570964803666e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0221358785234595,0.0044338005389117,0.0134456294671926,0.0308261275797264,6.03477244222663e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDF1,Endothelial differentiation-related factor 1,39934,0.0334233903214946,0.00672097715689391,0.0202502750939825,0.0465965055490067,6.6891979360837e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0169758543692732,0.00342005270029027,-0.0236791576618422,-0.0102725510767043,7.02233850467272e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENR,Density-regulated protein,39657,0.028909467304807,0.0058248954556529,0.0174926722117273,0.0403262623978867,7.04152650339441e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMB1,Laminin subunit beta-1,39638,0.0157012882883691,0.00317420159845452,0.0094798531553982,0.0219227234213399,7.66608736596745e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.033940163599215,0.00686814233229964,0.0204786046279077,0.0474017225705223,7.83992931113376e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOD,Apolipoprotein D,39468,0.0212135704420361,0.00430154754453885,0.01278253725474,0.0296446036293322,8.27596928461464e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0200856191951589,0.00407443839905851,0.0120997199330042,0.0280715184573136,8.35393324555823e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3BP,Galectin-3-binding protein,39979,0.0155978416666019,0.00316516547688874,0.00939411733189999,0.0218015660013039,8.42586384838456e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QL2,Complement C1q-like protein 2,39657,0.0214841491700021,0.00436117297644437,0.0129362501361711,0.030032048203833,8.50443313241805e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP7,Matrilysin,41881,0.0257096705580181,0.0052297703604903,0.0154593206514571,0.0359600204645791,8.9375225306604e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0240964126281418,0.00490398248447952,-0.0337082182977217,-0.014484606958562,9.04472592406398e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR15L,Protein GPR15L,39930,0.0309542347876813,0.00630986865758058,0.0185868922188234,0.0433215773565393,9.43955754564462e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0153615086327785,0.00313315463215884,-0.0215024917118098,-0.00922052555374715,9.55189574685479e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LXN,Latexin,41960,-0.0338465060458647,0.00690839937523417,-0.0473869688213236,-0.0203060432704057,9.72926806373085e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO4,Roundabout homolog 4,39638,-0.00903497037294075,0.00184427109532755,-0.0126497417197828,-0.00542019902609874,9.77236836548495e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS7_LGALS7B,Galectin-7,42076,0.0217045637622318,0.00443420685277857,0.0130135183307858,0.0303956091936778,9.95441250903291e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN4,Nectin-4,42181,-0.0165633534449842,0.00338673994928035,-0.0232013637455737,-0.00992534314439475,1.01655248141048e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG4,Regenerating islet-derived protein 4,42144,-0.0251126504014222,0.00513572785432431,-0.0351786769958978,-0.0150466238069465,1.02099800814605e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAM,Signal transducing adapter molecule 1,39919,0.0178505112302266,0.00365550376440484,0.0106857238519932,0.0250152986084601,1.05811267813587e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTPN,Myotrophin,41900,0.0159699021181359,0.0032769026043394,0.00954717301363063,0.0223926312226411,1.10917109106282e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERMAP,Erythroid membrane-associated protein,39657,0.0220191931874064,0.00451870800625918,0.0131625254951384,0.0308758608796744,1.11500827271058e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0268434366078514,0.00552271206130774,0.0160189209676883,0.0376679522480146,1.18668301829979e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0211491109354953,0.00437517710104696,0.0125737638174433,0.0297244580535473,1.35395678209191e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA10,Annexin A10,41839,-0.0397586377136671,0.00822792171265332,-0.0558853642704676,-0.0236319111568666,1.36573763578363e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0276117632051103,0.0057250583931185,0.0163906487545981,0.0388328776556226,1.43012775014717e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0290109621724616,0.00601479778598274,0.0172219585119355,0.0407999658329878,1.43065279239059e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,41814,0.0261020916149031,0.00541767969697979,0.0154834394088227,0.0367207438209835,1.46654161863931e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,39736,0.0255838527656209,0.00531556712691328,0.0151653411968709,0.036002364334371,1.50630697402008e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMS,Spermine synthase,39586,0.031250912591685,0.00650735975712008,0.0184964874677297,0.0440053377156403,1.58849278948199e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFASC,Neurofascin,42296,-0.0140514597936187,0.00293582929192096,-0.0198056852057838,-0.00829723438145367,1.71745759184035e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0290305669334687,0.0060656573589404,0.0171418785099456,0.0409192553569919,1.71868543596824e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN3,Neuronal-specific septin-3,39934,-0.0379104301376356,0.00792668242967375,-0.0534467276997962,-0.0223741325754751,1.75191142071279e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0150844361485879,0.00315554886207819,-0.0212693119182611,-0.00889956037891462,1.77135450560042e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0233815919309229,0.00490356067722035,-0.0329925708582748,-0.013770613003571,1.87767440832906e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6,Interleukin-6,42070,-0.0358381905650398,0.00753041168744513,-0.0505977974724322,-0.0210785836576473,1.96451640740865e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENSA,Alpha-endosulfine,39919,0.0254616131807499,0.00535760451133368,0.0149607083385359,0.0359625180229639,2.03465062111429e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH3,Neurexophilin-3,39657,0.0144384080083932,0.00303923867932501,0.00848150019691619,0.0203953158198702,2.0529875604682e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.0088039898268057,0.00186022348241231,0.00515795180127757,0.0124500278523338,2.24156566325618e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RETN,Resistin,42105,-0.0204605951508661,0.00432626533602824,-0.0289400752094814,-0.0119811150922508,2.2747364624302e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTL1,Cytokine-like protein 1,39966,0.0122013145395653,0.00258060956912246,0.00714331978408529,0.0172593092950454,2.29382310554953e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR3,Toll-like receptor 3,42296,0.0291052569873907,0.00615831238332245,0.0170349647160786,0.0411755492587027,2.31065389453785e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.02427943707572,0.00514620260671469,0.0141928799665592,0.0343659941848809,2.41194089922511e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.023605401770861,0.00500496925395296,0.0137956620331132,0.0334151415086088,2.42513784150228e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0150023034209843,0.00318122200505105,0.00876710829108426,0.0212374985508844,2.43108070343421e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELL,L-selectin,39979,0.0111062416245105,0.00236087217153906,0.00647893216829394,0.0157335510807271,2.57741779562012e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0173540315485673,0.0036935804691674,0.0101146138289992,0.0245934492681354,2.65329054169292e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACRT,Extracellular glycoprotein lacritin,39895,0.0216036954422158,0.00460073741586237,0.0125862501071256,0.0306211407773061,2.68820131727002e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0227476668278907,0.00484822121125411,0.0132451532538326,0.0322501804019487,2.73867703407762e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL12,Stromal cell-derived factor 1,41913,0.0186527459706506,0.00398130196821626,0.0108493941129467,0.0264560978283545,2.82610490429011e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPS,Colipase,42115,0.0347872306316857,0.00743408028227395,0.0202164332784288,0.0493580279849427,2.90469998178507e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0173661645775864,0.00371664343924317,0.0100815434366698,0.024650785718503,3.00411647881455e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRB1,Chymotrypsinogen B,42137,0.0274318480754788,0.00588684152665117,0.0158936386832425,0.0389700574677151,3.19443009337098e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0193908732667121,0.00418080824216727,0.0111964891120643,0.02758525742136,3.55047449418721e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPO,Lactoperoxidase,41647,-0.0287354955770799,0.00620394063733635,-0.0408952192262592,-0.0165757719279007,3.6597957242149e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3D,Protein FAM3D,39930,-0.0410108328339995,0.00885496530745077,-0.058366564836603,-0.023655100831396,3.6725475587575e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK4,Kallikrein-4,42262,-0.0291885259355064,0.00630729932959529,-0.0415508326215132,-0.0168262192494997,3.730816328459e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOB,Elongin-B,39575,0.0183434920293439,0.00397158061946736,0.0105591940151879,0.0261277900434999,3.9056511973322e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0188797632815361,0.00409830515691417,-0.0269124413890879,-0.0108470851739844,4.12825522746761e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMD,Dystrophin,39638,0.0239574173630697,0.00520336497308074,0.0137588220158314,0.0341560127103079,4.18646848548056e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIT2,Slit homolog 2 protein,41839,0.0239058433828628,0.00519727354642294,0.0137191872318738,0.0340924995338517,4.27044473864863e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANPEP,Aminopeptidase N,42187,0.0126366377882364,0.00274950235529255,0.00724761317186303,0.0180256624046098,4.3461382149271e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAM,Basal cell adhesion molecule,42137,-0.011369459578531,0.00247440553313426,-0.0162192944234741,-0.00651962473358784,4.37024144608002e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECM1,Extracellular matrix protein 1,39720,0.0169638258578419,0.00369666653890644,0.0097183594415853,0.0242092922740985,4.50352958772182e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL11,Eotaxin,42296,0.0172682743425443,0.00376458450348974,0.00988968871570439,0.0246468599693842,4.53575296516401e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0160728713277955,0.00350766853634652,-0.0229479016590347,-0.00919784099655632,4.64988221931151e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA7,Thyroxine-binding globulin,39979,0.00852022923742087,0.00186087780830081,0.00487290873315127,0.0121675497416905,4.73044884915178e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0266180193238247,0.00581790924580309,-0.0380211214455988,-0.0152149172020507,4.80019713788133e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPPK1,Epiplakin,39638,0.0342646427423105,0.00749074986396348,0.019582773008942,0.0489465124756789,4.83110253428071e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYM,Ketimine reductase mu-crystallin,39586,0.034994102826713,0.0076619476803012,0.0199766853733227,0.0500115202801034,4.9951873773663e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL21,C-C motif chemokine 21,42185,-0.0176058755578119,0.00385558036183292,-0.0251628130670045,-0.0100489380486194,5.00683088802035e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD2,Sushi domain-containing protein 2,42137,-0.0130381069768169,0.0028581533030759,-0.0186400874508457,-0.00743612650278816,5.11808310334544e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH17,Protocadherin-17,42145,-0.0171984310233054,0.00377563763038464,-0.0245986807788592,-0.00979818126775147,5.28160656875969e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1B,Interleukin-1 beta,41825,0.0259023351826293,0.00569021841340597,0.0147495070923536,0.037055163272905,5.3591530614811e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF5,Fibroblast growth factor 5,41913,-0.0156474157694294,0.00343745516084214,-0.02238482788468,-0.00891000365417881,5.36001265726201e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCND2,G1/S-specific cyclin-D2,39757,0.017097550587671,0.00375873697134647,0.00973042612383191,0.0244646750515101,5.45349644927424e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,39638,0.0184916287450963,0.00406671331747397,0.0105208706428473,0.0264623868473453,5.49771136959322e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGRN,Neugrin,39929,0.0103202575431164,0.00227060524258727,0.0058698712676453,0.0147706438185874,5.5462703952455e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP1,Guanylate-binding protein 1,39911,0.0297529503942554,0.00654655014129042,0.0169217121173262,0.0425841886711846,5.55499377875591e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRELP,Prolargin,42123,0.0107044305783368,0.0023573043281106,0.00608411409523999,0.0153247470614336,5.64817211086711e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0192056246233508,0.00423966287864756,-0.0275153638655,-0.0108958853812016,5.96003387599122e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0151839565909714,0.00335234269432489,0.00861336491009458,0.0217545482718482,5.96687331985743e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0233274754101688,0.00516313869483508,0.013207723568292,0.0334472272520455,6.29427223833251e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP9,Fatty acid-binding protein 9,42119,0.0256364296774858,0.00567533279111083,0.0145127774069085,0.036760081948063,6.32030120806115e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGA,Glycoprotein hormones alpha chain,42137,-0.0281271122100973,0.00623588079480895,-0.0403494385679229,-0.0159047858522718,6.52104012522152e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC2,Mucin-2,39966,0.0422838360700139,0.00937901243474634,0.0239009716979111,0.0606667004421167,6.59884250784445e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0214943367937194,0.00476968627097138,-0.0308429218848233,-0.0121457517026155,6.6486988968037e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0195320787869716,0.00433978352446028,0.0110261030790294,0.0280380544949137,6.83032764732685e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHISA5,Protein shisa-5,39966,-0.0118095725373311,0.00262435062064864,-0.0169532997538024,-0.00666584532085976,6.86290327250654e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0286801661331675,0.00637380800888702,0.0161875024357489,0.041172829830586,6.86321496791169e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD109,CD109 antigen,42137,-0.0154453046829068,0.00343935196473709,-0.0221864345337915,-0.00870417483202209,7.1556267110553e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0156141542451684,0.00347975121770604,-0.0224344666318722,-0.00879384185846453,7.27791868394737e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP9,Matrix metalloproteinase-9,42125,-0.0270556908145262,0.00603143027505134,-0.0388772941536268,-0.0152340874754256,7.32451320808194e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEK,Angiopoietin-1 receptor,42181,0.00999324472185758,0.00223039425097209,0.00562167198995228,0.0143648174537629,7.50825562068194e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMP,Cartilage oligomeric matrix protein,42042,0.015026840822166,0.00335811943351203,0.00844492673248243,0.0216087549118496,7.71188551000034e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP13,Collagenase 3,41839,-0.0144690325922106,0.00324790369613888,-0.0208349238366428,-0.00810314134777843,8.46269889034744e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPA,Apolipoprotein(a),39775,-0.082314911295774,0.0185005107538323,-0.118575912373285,-0.0460539102182626,8.69710330693117e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0157851514250392,0.0035519612065936,-0.0227469953899627,-0.00882330746011579,8.89710792213528e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN2,Calsyntenin-2,42296,-0.0178598796994541,0.0040338096253959,-0.02576614656523,-0.00995361283367809,9.60487280960491e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG4,Desmoglein-4,42018,0.0213979910494285,0.00483429567595501,0.0119227715245567,0.0308732105743003,9.66245540999481e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0181437390922023,0.00410819404584541,0.0100916787623453,0.0261957994220593,1.01120035455696e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0166953663522902,0.0037859497062227,0.0092749049280937,0.0241158277764867,1.04432752705372e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0156306948175321,0.00354490560479068,0.00868267983214239,0.0225787098029219,1.04484811303328e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,39951,0.00663675298844055,0.00150784872253958,0.00368136949226298,0.00959213648461812,1.0850147381702e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLF4,Krueppel-like factor 4,39586,0.0180884536178927,0.00411010350541733,0.0100326507472747,0.0261442564885106,1.08783509896427e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0169922341855385,0.0038621807529613,-0.0245621084613427,-0.00942235990973436,1.0925818907298e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASN,Vasorin,41975,0.01213989454892,0.00276035588613468,0.00672959701209603,0.017550192085744,1.10124646422518e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,39934,0.0161727201789066,0.00367778095256812,0.00896426951187312,0.0233811708459402,1.10547720388466e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0179580637339944,0.0040865646454421,0.00994839702892791,0.0259677304390609,1.11908484855979e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0155473027541944,0.0035434191212989,0.00860220127644859,0.0224924042319403,1.15435626070797e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0112754892225725,0.00257347315446529,0.00623148183982054,0.0163194966053245,1.18961361800588e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARCO,Macrophage receptor MARCO,42145,0.0114056383865929,0.00260419750784728,0.00630141127121225,0.0165098655019736,1.19727719353618e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL9,C-X-C motif chemokine 9,42185,-0.0286300268187266,0.00654562527332744,-0.0414594523544484,-0.0158006012830049,1.22945209725355e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSH,Pro-cathepsin H,41865,0.0328948676113273,0.00752719075638909,0.0181415737288046,0.0476481614938499,1.25111615344141e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0449801284583878,0.01029458643235,0.0248027390509818,0.0651575178657937,1.25582875400147e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0137784731407758,0.00316174876288755,-0.0199755007160354,-0.00758144556551622,1.32533803421326e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGF,Hepatoma-derived growth factor,42243,0.0398875436250525,0.00920638461716189,0.0218430297754152,0.0579320574746898,1.48415288333188e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTN,Titin,39575,-0.0303821656542981,0.00701197350897227,-0.0441256337318838,-0.0166386975767125,1.4846871433402e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0103307888190921,0.00238761909064661,-0.0150105222367594,-0.0056510554014247,1.52611298711313e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0168270705457384,0.00390719729858501,0.00916896384051179,0.024485177250965,1.66912496013078e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MB,Myoglobin,42310,-0.0242970939545807,0.00565516396018489,-0.0353812153165431,-0.0132129725926183,1.74756100772306e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0234108033924252,0.00545162984947566,0.0127256088874529,0.0340959978973975,1.76725304857949e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,39934,0.0126484994267836,0.00294792229939784,0.00687057171996382,0.0184264271336033,1.79630137016213e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",39929,0.0257697329625576,0.00600680344098569,0.0139963982182257,0.0375430677068896,1.8008192538436e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGMN,Legumain,42185,0.0156817203781965,0.00365807885219506,0.00851188582789418,0.0228515549284988,1.82455265626872e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCP1,Plastin-2,39966,0.0207539065571628,0.00484315010274391,0.0112613323557848,0.0302464807585409,1.84071497312432e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH1,Cadherin-1,41697,-0.0173418939212141,0.00404842241819053,-0.0252768018608675,-0.00940698598156066,1.8519040261409e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0387534072672948,0.00905068251041181,0.0210140695468876,0.0564927449877019,1.86644035840587e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0298859898688699,0.00698057993817036,0.016204053190056,0.0435679265476838,1.87086629886328e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTXR,Neuronal pentraxin receptor,42145,0.0147258168949384,0.00344117837522239,0.00798110727950251,0.0214705265103743,1.88774414036798e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWF,von Willebrand factor,42310,-0.0319380622650674,0.00746461679637872,-0.0465687111859697,-0.0173074133441651,1.89353560091463e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0165265639832648,0.00386309234364504,-0.0240982249768091,-0.00895490298972055,1.89804725105668e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0115734302159263,0.00271984366033781,-0.0169043237901884,-0.00624253664166415,2.10279134835165e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0306955056923058,0.00721823766465853,0.0165477598695751,0.0448432515150365,2.13144718863629e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42093,0.0175652457231797,0.0041339002227124,0.00946280128666342,0.025667690159696,2.1609740828473e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.020317943521513,0.00478847758202171,-0.0297033595822756,-0.0109325274607504,2.22262799642222e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,39736,0.0128677690234532,0.00303291060082334,0.00692326424583943,0.0188122738010669,2.22620632166719e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0174132036827,0.00410463223767413,-0.0254582828685413,-0.00936812449685873,2.23026837522449e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0191356409542818,0.00451390308915521,0.0102883908995376,0.027982891009026,2.26072465454519e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0230941029521342,0.00544919937169643,0.0124136721836092,0.0337745337206592,2.2697357104931e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XG,Glycoprotein Xg,42261,0.0147943923023909,0.00349204407928324,0.00794998590699577,0.0216387986977861,2.28418060641623e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPE,Carboxypeptidase E,42134,0.0166773117034396,0.00394268460804509,0.00894964987167119,0.024404973535208,2.35293266436454e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A13,Protein S100-A13,39657,0.0152575424840687,0.00360777580456215,0.00818630190712686,0.0223287830610105,2.36546448085219e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,41839,0.0365341933394259,0.00864489171217936,0.0195902055835544,0.0534781810952975,2.39367796265602e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHPS,Deoxyhypusine synthase,39919,0.0172176239033286,0.00407475268440637,0.00923110864189211,0.0252041391647651,2.40343012334049e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAM,Integrin alpha-M,42137,-0.0133967269116473,0.00318359698851193,-0.0196365770091307,-0.00715687681416388,2.59247673178499e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPL,Periplakin,39657,0.0137644638760878,0.00327138182157143,0.00735255550580784,0.0201763722463678,2.60205824014524e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA3,Carbonic anhydrase 3,42287,-0.0249070662806585,0.00592814041911838,-0.0365262215021306,-0.0132879110591865,2.66836140612179e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR4,Proline-rich protein 4,39652,-0.0301781691711351,0.0071963163975506,-0.0442829493103343,-0.0160733890319359,2.76754447522104e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD14,Monocyte differentiation antigen CD14,41932,0.0173978735488096,0.00415641031693336,0.00925130932762019,0.0255444377699989,2.85995336378094e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL2A1,Collagen alpha-1(II) chain,39638,0.0333489574298249,0.00796988338919451,0.0177279859870037,0.0489699288726462,2.88169573862356e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0388298779132897,0.00931089926109719,0.0205805153615392,0.0570792404650402,3.0643272426287e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0142121900806048,0.00342166066226263,0.00750573518257007,0.0209186449786396,3.29693736098981e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0119706846091486,0.00288444617665304,-0.0176241991153886,-0.00631717010290867,3.34781486294559e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAL,Galanin peptides,42185,0.0278341793607567,0.00670869082518379,0.0146851453433964,0.0409832133781169,3.36002800943023e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0116047400417733,0.00280070608724051,0.00611535611078189,0.0170941239727647,3.44588550736756e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.01295665564399,0.00312768808372994,0.00682638699987936,0.0190869242881007,3.45934329610494e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME2,Proteasome activator complex subunit 2,41955,-0.014706495508921,0.00355497902258875,-0.021674254393195,-0.00773873662464704,3.54227544986055e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTN,Pleiotrophin,41900,0.0207617485710196,0.0050224714604745,0.0109177045084896,0.0306057926335496,3.59046828885296e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0265761037595006,0.00645977032861446,0.0139149539154163,0.0392372536035849,3.91524263715756e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX6,Syntaxin-6,41843,0.0271510636858752,0.0066020539974197,0.0142110378509325,0.0400910895208178,3.93730952701456e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX,Glutaredoxin-1,42057,0.023003067827423,0.00559883511959733,0.0120293509930123,0.0339767846618338,4.00516529284216e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITM2A,Integral membrane protein 2A,42119,-0.0256707559500565,0.00624949694988933,-0.0379197699718396,-0.0134217419282734,4.02056238190933e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0185732931371451,0.00452578982371327,-0.0274438411916231,-0.00970274508266711,4.09170458157009e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX5,Sorting nexin-5,39638,0.0123654581243099,0.00301315789070304,0.00645966865853193,0.0182712475900879,4.09305398329497e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0163660923387026,0.00398866009165884,-0.0241838661183539,-0.00854831855905127,4.10498705717109e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00911278764822347,0.00222439326853605,0.0047529768418928,0.0134725984545541,4.21893629622161e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0112455392791442,0.00274719602139053,-0.0166300434810696,-0.00586103507721878,4.27434005682635e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.02334744184737,0.00570583554904259,0.0121640041712465,0.0345308795234935,4.30903781037301e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0178642739687211,0.00436887945043132,0.00930127024587567,0.0264272776915665,4.36341205403316e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEG1,Protein LEG1 homolog,39398,-0.0292581215843592,0.0071583554896918,-0.0432884983441551,-0.0152277448245633,4.39641081883765e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0124314002655274,0.00304708035633064,0.00645912276711931,0.0184036777639354,4.53377718046306e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBKS,Ribokinase,41830,0.0203583868939782,0.00499308910122755,0.0105719322555722,0.0301448415323842,4.58256932605216e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0257012884055286,0.00631125305141757,0.0133312324247502,0.038071344386307,4.68767555898919e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0230064058009654,0.00565865430715483,0.0119154433589419,0.0340973682429889,4.82218578777716e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH1,Acid ceramidase,39876,0.0194235819321466,0.00478315435685054,0.0100485993927195,0.0287985644715736,4.92289797254484e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.078547269197609,0.0193579834763131,0.0406056215840354,0.116488916811183,4.98554891129236e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPB2,Coatomer subunit beta',39575,0.0176708299479765,0.00435759841567619,0.00912993705325115,0.0262117228427018,5.04427144668229e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDT,D-dopachrome decarboxylase,39966,0.0166473456809906,0.00411476978175822,0.00858239690874452,0.0247122944532368,5.24999653476982e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0138992735595962,0.00343787071750022,-0.0206375001658967,-0.00716104695329578,5.30715073621373e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN1,Tetraspanin-1,41900,0.0296505037831619,0.00734744142822714,0.0152495185838367,0.044051488982487,5.47940967499181e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD86,T-lymphocyte activation antigen CD86,39930,0.0124044822679654,0.00307462492518912,0.00637821741459474,0.0184307471213361,5.50849363160413e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0354877585939933,0.00879979777194188,0.0182401549609873,0.0527353622269994,5.54792513803392e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42144,0.00969945119633559,0.00240750744804978,0.00498073659815802,0.0144181657945132,5.63599423706041e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.011053512541635,0.00274694494056155,0.00566950045813432,0.0164375246251356,5.76069800434611e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFHD1,EF-hand domain-containing protein D1,39934,0.01466455646933,0.00364465959846547,0.0075210236563377,0.0218080892823223,5.76939765767283e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFIC,Nuclear factor 1 C-type,39934,0.0185839881478232,0.00463127697870201,0.00950668526956723,0.0276612910260791,6.04106376794237e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE2,Angiotensin-converting enzyme 2,41900,0.0220800534053316,0.00550436253554169,0.0112915028356699,0.0328686039749933,6.06967610669526e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIC5,Chloride intracellular channel protein 5,39649,-0.0127615518016183,0.00318558344533816,-0.0190052953544811,-0.00651780824875547,6.21517620064607e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0121475445786109,0.00304012823762101,0.00618889323287367,0.018106195924348,6.48432504875558e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0119427620178216,0.00300270327692028,0.00605746359505783,0.0178280604405853,7.0139524207786e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0126555493998834,0.00318266305322497,0.00641752981556243,0.0188935689842043,7.041191770339e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0179583537803044,0.004528350458178,0.00908278688227551,0.0268339206783333,7.36234052514233e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0204853026707613,0.00517117429723295,-0.0306208042933379,-0.0103498010481848,7.48839922455251e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRH,Corticoliberin,41830,0.0341695011882884,0.0086296165167573,0.017255452815444,0.0510835495611327,7.54804195970337e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF8,SLAM family member 8,41843,-0.0214264050491934,0.00542215853246622,-0.0320538357728272,-0.0107989743255596,7.80210836605836e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA1,Carboxypeptidase A1,42310,0.0257276312835993,0.00652215451500415,0.0129442084341911,0.0385110541330074,8.03138058386028e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGF,Beta-nerve growth factor,42016,0.00484036749468869,0.00122802963688513,0.00243342940639383,0.00724730558298356,8.13599624766084e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0414950149354454,0.0105298431446501,0.0208565223719311,0.0621335074989596,8.17300215134518e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGN,Biglycan,41820,-0.0466652929677583,0.0118780347505845,-0.0699462410789039,-0.0233843448566128,8.58389114846619e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA2,Annexin A2,39492,0.0279888257483218,0.0071335773856728,0.0140070140724031,0.0419706374242405,8.77959775715999e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0117621758052038,0.00300198847097414,-0.0176460732083131,-0.00587827840209444,8.97635504830179e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0243949773742712,0.00623241085130664,-0.0366105026428322,-0.0121794521057102,9.11447011284046e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0137015612963175,0.00350152281163282,0.00683857658551713,0.0205645460071178,9.16788841089927e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0155420123401374,0.00397245005874253,0.00775601022500206,0.0233280144552728,9.19119236018e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,39958,-0.015232156405971,0.00389628022361939,-0.022868865644265,-0.00759544716767697,9.30595750981987e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0156541521841651,0.00400420170287751,0.00780591684652522,0.0235023875218051,9.3060973774072e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.019539124203295,0.00501001219055437,0.00971950030980845,0.0293587480967816,9.66503784620656e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,39575,0.0172677679239349,0.00442757563287119,0.00858971968350739,0.0259458161643625,9.67459344362876e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MVK,Mevalonate kinase,41913,0.032481508605323,0.00834012037472111,0.0161348726708696,0.0488281445397764,9.88378125849388e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0239581151119095,0.00616122597964513,0.011882112191805,0.036034118032014,0.000101447458022994
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDA,Cytidine deaminase,39946,0.0187292053623508,0.00481780787694496,0.00928630192353867,0.0281721088011629,0.000101860815463137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA3,Protein disulfide-isomerase A3,39736,0.00968561753416378,0.00249233626406414,0.00480063845659807,0.0145705966117295,0.000102432620339499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42262,0.0207901251710969,0.00535171096287355,0.0103007716838647,0.031279478658329,0.000102913079503518
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.019209762745764,0.00494820404629847,0.009511282815019,0.028908242676509,0.000104132017479942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA2,Carboxypeptidase A2,42205,-0.025904334460407,0.00670149004779485,-0.0390392549540849,-0.012769413966729,0.000111395803889763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE1,Ribonuclease pancreatic,39990,-0.00966228600904406,0.00250091120993698,-0.0145640719805206,-0.00476050003756758,0.000112390498777364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS4,Thrombospondin-4,42189,0.0176482094889365,0.00458197036961832,0.00866754756448465,0.0266288714133885,0.000117856535128433
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMCN2,Hemicentin-2,39721,-0.0226449422790945,0.00588192047435911,-0.0341735064088383,-0.0111163781493506,0.000118816685861797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0117883778550573,0.00306610512718642,0.00577881180577191,0.0177979439043427,0.000121356638116289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN1,Ficolin-1,39978,0.0216544816246622,0.00564216479074936,0.0105958386347935,0.032713124614531,0.000124724847394003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0273736161110972,0.00713532824580454,0.0133883727493203,0.0413588594728741,0.000125564418484462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0184446892360877,0.00481110908107252,-0.0278744630349898,-0.00901491543718558,0.000126766693181568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0246259359485157,0.00643108658884879,0.0120210062343721,0.0372308656626593,0.000129251234947912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JCHAIN,Immunoglobulin J chain,41913,-0.0236191533811148,0.0061809850413778,-0.0357338840622153,-0.0115044227000143,0.000133375146977908
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0464134039564731,0.0121481722501904,0.0226029863461,0.0702238215668463,0.000133834169279198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIGR,Polymeric immunoglobulin receptor,41987,-0.0142918757790845,0.00374492515455814,-0.0216319290820184,-0.00695182247615049,0.000136060082962651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.00920549390237962,0.00241407192522842,-0.0139370748758273,-0.00447391292893192,0.00013775739613268
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL6,Fc receptor-like protein 6,42119,-0.0263181531107121,0.00691168328984614,-0.0398650523588106,-0.0127712538626137,0.000140840874883664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0167404382761755,0.0044018828844611,0.0081127478226318,0.0253681287297193,0.000143569777842879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CABP2,Calcium-binding protein 2,39649,0.0251639615725857,0.0066171996015918,0.0121942503534658,0.0381336727917057,0.000143833258696962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASS1,Argininosuccinate synthase,39575,0.0297054114219591,0.00783440001938155,0.0143499873839713,0.0450608354599469,0.000150443222622002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN15,Lipocalin-15,39934,-0.0232584199998782,0.00614070739170396,-0.035294206487618,-0.0112226335121384,0.000152907845076777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0249523508709729,0.0065942438392086,0.012027632946124,0.0378770687958218,0.000155148818075982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0220500238755221,0.00582987849599766,0.0106234620233667,0.0334765857276775,0.000156241285568127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.037086045992463,0.00980573219896316,0.0178668108824952,0.0563052811024308,0.000156345228585798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ULBP2,UL16-binding protein 2,42016,-0.0149719153605649,0.00396889617020686,-0.0227509518541704,-0.00719287886695946,0.000162436941742271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0113806684636938,0.00301988912734314,0.00546168577410125,0.0172996511532864,0.000164878511035068
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42119,-0.0199063122718271,0.00528970126519366,-0.0302741267516066,-0.00953849779204749,0.00016844820839227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42217,-0.0121466629283028,0.00322879893724202,-0.0184751088452971,-0.0058182170113084,0.00016928302955534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN1,Nectin-1,39657,0.0125705328131107,0.00334381189755969,0.00601666149389371,0.0191244041323277,0.000171238085988002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGBL1,Integrin beta-like protein 1,39966,-0.0149716607490073,0.00398285186806717,-0.0227780504104189,-0.00716527108759561,0.000171427427863458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0170169938469098,0.0045276300501536,0.0081428389486087,0.0258911487452108,0.000171809886420202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0275831484151642,0.0073409483908722,0.0131948895690547,0.0419714072612737,0.000172521734981084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS2,Trypsin-2,42217,0.0216336163631412,0.00576242832774582,0.0103392568407594,0.032927975885523,0.000174581963678275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS2,Growth arrest-specific protein 2,39757,0.0197779684617029,0.00528044305611661,0.00942830007171438,0.0301276368516915,0.000180931579010013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG3,Desmoglein-3,42196,0.0132591064375643,0.00354268001215472,0.00631545361374109,0.0202027592613876,0.000182819946505308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK14,Kallikrein-14,42262,0.0174211243480501,0.00466856232791273,0.00827074218534113,0.026571506510759,0.000191051839458337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0211941196837734,0.00568292249846935,0.0100555915867735,0.0323326477807733,0.000192871802723442
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0368887389185765,0.0098918420952543,0.0175007284118781,0.056276749425275,0.00019304921071418
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGF,Placenta growth factor,42296,0.00983610729316501,0.00263846693062069,0.00466471210914845,0.0150075024771816,0.000193811000330392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMOD4,Tropomodulin-4,39560,-0.0151179290950764,0.00406041797637822,-0.0230763483287777,-0.00715950986137504,0.000197664220896053
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0129150600671837,0.00347258170427682,0.00610879992680117,0.0197213202075663,0.000200703780392906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR1,Complement receptor type 1,39970,0.0133161663955461,0.00359012750337258,0.0062795164889358,0.0203528163021563,0.000208981810499952
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_DRA,,42060,-0.0135358671332012,0.00366244877324019,-0.020714266728752,-0.00635746753765047,0.000220020235861611
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAST,Gastrin,39929,-0.0489800633327784,0.0132555125998538,-0.0749608680284917,-0.022999258637065,0.000220860539560075
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0187416797604186,0.00507274127438523,0.00879910686262356,0.0286842526582137,0.00022110175029231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN8,Septin-8,39906,-0.0121950756569137,0.00330221547087304,-0.0186674179798249,-0.00572273333400257,0.000222669423054294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0152406518731986,0.00412772524459776,0.00715031039378699,0.0233309933526102,0.000223311274543111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST3,Cystatin-C,42184,0.0106678766981551,0.00289043367353284,0.00500262669803075,0.0163331266982795,0.000224465418395726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD1,Leiomodin-1,39934,-0.0129511447406876,0.00351292026063254,-0.0198364684515274,-0.00606582102984786,0.000228225689151301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0141082752548012,0.00384555439722161,0.00657098863624687,0.0216455618733556,0.000244699471000698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0158961419997639,0.00433644463376481,-0.0243955734819429,-0.00739671051758488,0.00024759251337579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMB,RGM domain family member B,42249,0.0103182104090971,0.00282425849726319,0.00478266375446123,0.0158537570637329,0.000259736821870143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0127960265376397,0.00350364734204763,0.00592887774722639,0.0196631753280531,0.000260969889818835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0126970600642841,0.00349041425550468,-0.0195382720050733,-0.00585584812349495,0.000276116938251309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP152,Centrosomal protein of 152 kDa,39560,0.0154891366438622,0.00426396004007977,0.00713177496530589,0.0238464983224186,0.000281893035244659
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,39638,0.00907017395912775,0.00250035142230181,0.0041694851714162,0.0139708627468393,0.000287403312025874
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0380227537050766,0.0104904206287953,0.0174615292726378,0.0585839781375154,0.000290797595073034
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0144090212383995,0.00397793439227082,0.00661226982954864,0.0222057726472503,0.000293130624179248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCOR1,REST corepressor 1,41900,0.0163087082898163,0.00450322871042456,0.00748238001738421,0.0251350365622485,0.000293922276378542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.00848978411128206,0.00234696852800894,0.00388972579638453,0.0130898424261796,0.000298935865500636
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0188859687734213,0.00522810991121917,0.00863887334743177,0.0291330641994109,0.000304733435283043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.020277837897197,0.005614437937639,0.00927353953942456,0.0312821362549694,0.000305495635873658
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0130875205713707,0.00362463256051121,-0.0201918003899726,-0.00598324075276869,0.00030670453759867
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0161336119150213,0.00447213116924731,0.00736823482329659,0.0248989890067461,0.000310428765425135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2,T-cell surface antigen CD2,39575,-0.0142114148110271,0.00394134134219951,-0.0219364438417382,-0.0064863857803161,0.000312656626163951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPA2,Replication protein A 32 kDa subunit,39657,0.0113092153116485,0.00313724046563066,0.00516022399901237,0.0174582066242846,0.000313732397882855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0352668958439263,0.00980772423696977,0.0160437563394655,0.054490035348387,0.000324523170444846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK3,Prostate-specific antigen,39966,0.0416354541698599,0.0115808166274053,0.0189370535801455,0.0643338547595744,0.00032550445368427
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELE,E-selectin,42310,0.0182898215255005,0.00508902443385684,0.00831533363514108,0.0282643094158599,0.000326814257622173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0247870805630052,0.00690167844505975,-0.0383143703153223,-0.0112597908106881,0.000329991830824561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,39757,0.0162021863436223,0.00451780033761765,0.00734729768189168,0.0250570750053529,0.000336837355661509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0224362247132971,0.00626088114428062,0.0101648976705071,0.0347075517560871,0.000340407289138621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHPK,Sedoheptulokinase,39757,-0.0144489762911319,0.00404775313781763,-0.0223825724412544,-0.00651538014100933,0.000358989345479635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00961481086563552,0.00269368907710876,-0.0148944414567687,-0.00433518027450234,0.000359065115798353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF20B,Kinesin-like protein KIF20B,39586,0.0270335686203185,0.00757344645261673,0.0121896135731897,0.0418775236674473,0.000359161741580302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA4,Carboxypeptidase A4,39518,0.0159315288460068,0.00446350201660489,0.00718306489346121,0.0246799927985524,0.000359487654718422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0145175334121383,0.00406791068762438,0.00654442846439449,0.0224906383598821,0.000360111304343232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.022411677636056,0.00628305116190532,-0.0347264579133905,-0.0100968973587216,0.000362600575306767
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0202802051217659,0.00570344331363115,0.00910145622704885,0.0314589540164829,0.000378169849194857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42070,0.0131737652706738,0.00370613877447552,0.00590973327270181,0.0204377972686458,0.000379880400746091
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0110216697426652,0.00310058717958161,0.00494451887068526,0.0170988206146452,0.000379946104049203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYT1,Synaptotagmin-1,39929,0.0144198633637352,0.00405680582145282,0.0064685239536877,0.0223712027737827,0.000380259535894607
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0136904067331167,0.00385675984303346,0.00613115744077108,0.0212496560254623,0.000387246261784141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP4,Bone morphogenetic protein 4,41992,-0.0168733313278907,0.0047737903738259,-0.0262299604605894,-0.00751670219519191,0.000409805357632424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD7,FERM domain-containing protein 7,39649,0.0121496401637971,0.00343727547263669,0.00541258023742919,0.018886700090165,0.000409951698511485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42249,0.0168271631261546,0.00476377683072174,0.00749016053793999,0.0261641657143692,0.000413297311000531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0861534509406683,0.0244357131794293,0.0382594531089869,0.13404744877235,0.000424003674325695
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.027876271589991,0.00790702016183663,0.0123785120727912,0.0433740311071908,0.000424097438925833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0371168316564562,0.0105293771924326,0.0164792523592884,0.0577544109536241,0.000425035977116649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0124819947356329,0.00354873232503154,0.00552647937857112,0.0194375100926947,0.000437354457584379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNR,Tenascin-R,42016,0.0148206689169537,0.00422224822171658,0.00654506240238924,0.0230962754315183,0.000449345414075943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APRT,Adenine phosphoribosyltransferase,42002,0.0165792979868005,0.00474414724403762,0.00728076938848672,0.0258778265851142,0.000476155515913057
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42070,0.013043946861322,0.00373343461769927,0.00572641501063145,0.0203614787120126,0.000477691665654612
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA1,Alpha-1-antitrypsin,39795,-0.0028944207839122,0.000829374901894297,-0.00451999559162502,-0.00126884597619937,0.000485092818698382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSA,Arylsulfatase A,42137,0.0158610325488355,0.00454855349165748,0.00694586770518682,0.0247761973924841,0.000489929530369938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD80,T-lymphocyte activation antigen CD80,39958,-0.0120680345691244,0.00346297302018989,-0.0188554616886966,-0.00528060744955224,0.00049422097124605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1,Methionine aminopeptidase 1,41839,0.0101854362040056,0.00292344264206628,0.00445548862555569,0.0159153837824555,0.000495473929233179
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA1,BolA-like protein 1,39586,0.0192455913465453,0.00552368348887324,0.00841917170835373,0.0300720109847368,0.00049554326344385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR1,Folate receptor alpha,42110,-0.0103539119631315,0.00297359295831592,-0.0161821541614307,-0.00452566976483226,0.00049934385795981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A12,Protein S100-A12,41910,0.0257447705967178,0.00740453210564257,0.0112318876696584,0.0402576535237773,0.0005088777601736
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSR,Insulin receptor,39657,0.00603413300300443,0.00173660499545156,0.00263038721191938,0.00943787879408948,0.000513438600726403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LF,CMRF35-like molecule 1,42262,0.0210242635227397,0.00605258828735368,0.00916119047952649,0.0328873365659529,0.000515119094508753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0207968771949505,0.00599552398223968,-0.0325481042001403,-0.00904565018976075,0.000524524647240599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0196647887292261,0.00567605493080918,0.00853972106484007,0.0307898563936121,0.000533171563292854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAA4,Serum amyloid A-4 protein,39979,0.0115706675232788,0.00334146556579678,0.00502139501431708,0.0181199400322405,0.000536646443099708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.01965903253829,0.00568159787247531,-0.0307949643683416,-0.00852310070823842,0.000541965829951141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY2,Protein canopy homolog 2,41900,0.0211690567434995,0.00614378629952655,0.00912723559642745,0.0332108778905715,0.00057154330032297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL1,Chordin-like protein 1,42166,0.0113473022113887,0.00329576509527686,0.00488760262464602,0.0178070017981313,0.000577046936297417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0128406279647862,0.00373169249850837,0.00552651066770979,0.0201547452618626,0.000581389401686479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3B,Protein FAM3B,42070,-0.0122035305306776,0.00354862861494363,-0.0191588426159671,-0.00524821844538812,0.000585758440317798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RB,Interleukin-17 receptor B,41934,-0.0186460590489121,0.00544193883854012,-0.0293122591724508,-0.0079798589253735,0.000613566915902427
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MBL2,Mannose-binding protein C,39826,0.0382054925970709,0.0111851012692573,0.0162826941093267,0.0601282910848152,0.000638322758291663
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,39638,0.0178155030960368,0.00521681817087137,0.00759053948112893,0.0280404667109447,0.000640084958561724
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD72,B-cell differentiation antigen CD72,39736,0.0149972733701957,0.00440415152713788,0.00636513637700549,0.023629410363386,0.000663348580275826
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF23,Fibroblast growth factor 23,42250,0.0173420385540136,0.00509364130816833,0.00735850159000366,0.0273255755180235,0.000664408405936579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY75,Lymphocyte antigen 75,42119,0.01321355271671,0.00389661270246156,0.0055761918198853,0.0208509136135346,0.000698283441473662
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST5,Cystatin-D,41846,0.019223949399118,0.00566966533523987,0.00811140534204782,0.0303364934561881,0.000699262724894785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3,Granulocyte colony-stimulating factor,41913,0.0163678200017717,0.00484112405141109,0.00687921686100601,0.0258564231425375,0.000724312879222696
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERC2,ERC protein 2,39649,0.0251573833143687,0.00745665115049522,0.0105423470593981,0.0397724195693393,0.000743882077798322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0261224237655041,0.00774381219295265,0.0109445518673169,0.0413002956636913,0.000745206384239046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD3,Bromodomain-containing protein 3,39575,0.0162136605423108,0.00481074630661901,0.00678459778133756,0.0256427233032841,0.000753450965262121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR2,TGF-beta receptor type-2,42181,-0.0116261123711801,0.00345281232985331,-0.0183936245376926,-0.00485860020466761,0.000761621331720321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB2A2,Mammaglobin-A,39575,-0.0106120744738871,0.00315393869658066,-0.0167937943191852,-0.00443035462858905,0.000768879499715793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A16,Protein S100-A16,41814,-0.0206194601098471,0.0061290863900691,-0.0326324694343826,-0.00860645078531168,0.000769847255792313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0115286727191627,0.00342894879542017,-0.0182494123581862,-0.00480793308013915,0.000775976853307882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSDE1,Cold shock domain-containing protein E1,39575,0.0409745345823653,0.012214778558963,0.0170335686067979,0.0649155005579327,0.000797764771682643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR2,Interferon gamma receptor 2,42016,0.0178409709617423,0.00532328477574195,0.00740733280128809,0.0282746091221965,0.000805979731321445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0183763240564095,0.00548805962634286,0.00761972718877752,0.0291329209240415,0.000815443950045579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF16,Fibroblast growth factor 16,39657,0.0157744246008583,0.00471234863819603,0.00653822126999406,0.0250106279317225,0.000818262174954791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNLY,Granulysin,42137,0.0181893305633148,0.00544023981074236,0.00752646053425977,0.0288522005923698,0.000829592116974153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0190904030781181,0.00572104518310582,-0.0303036516370055,-0.00787715451923069,0.000850064001417533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYGD,Gamma-crystallin D,39929,0.0331317442823445,0.00993006748065774,0.0136688120202553,0.0525946765444336,0.000851110488853478
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0227012379676758,0.00681369556320286,0.00934639466379822,0.0360560812715534,0.000865459972971798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.0072233760535773,0.00217701131047637,-0.011490318222111,-0.00295643388504361,0.000909422957291198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP112,Centrosomal protein of 112 kDa,39575,0.0149129223299643,0.00449719765188558,0.00609841493226852,0.02372742972766,0.00091596543885993
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN2,Prefoldin subunit 2,41839,0.018409957699108,0.00555585911752875,0.0075204738287516,0.0292994415694643,0.000923465237073831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0147902570246821,0.0044908958442188,0.00598810117001328,0.023592412879351,0.00099291621971042
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0142264156581704,0.0043237926195632,-0.0227010491925143,-0.00575178212382653,0.00100409323489614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00977419792210921,0.00297129358540383,0.0039504624947177,0.0155979333495007,0.00100611081307036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEB,Nebulin,39575,-0.0132578965273323,0.00403163431622517,-0.0211598997871336,-0.00535589326753094,0.00101051568188422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0114503195773023,0.00349142816350061,-0.0182935187777635,-0.00460712037684108,0.00104232512953336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC51B,Organic solute transporter subunit beta,39575,-0.0240939196421183,0.00734901049129958,-0.0384979802050654,-0.00968985907917107,0.00104675573115328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCC,Netrin receptor DCC,39649,0.00740888627050609,0.00226108286375747,0.00297716385754144,0.0118406086834707,0.0010535250219785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN4,CCN family member 4,42262,0.0129095444555868,0.00394241671921988,0.00518240768591586,0.0206366812252578,0.00106102874409412
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXN,Thioredoxin,39854,0.0142291445995682,0.00435035122955617,0.00570245618963811,0.0227558330094983,0.00107564943278793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0290865230225333,0.00890031720222558,-0.0465311447388955,-0.0116419013061712,0.00108629162151324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42185,-0.00966119567955554,0.00295693303250083,-0.0154567844232572,-0.00386560693585392,0.00108846924746883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.00632403822546353,0.00194029021131333,-0.0101270070396377,-0.0025210694112894,0.00111951031615264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0155237535280722,0.00476290473993848,0.00618846023779275,0.0248590468183516,0.00112023770329609
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMPER,BMP-binding endothelial regulator protein,39736,0.00761689896559693,0.00234387535067878,0.00302290327826653,0.0122108946529273,0.0011586844566183
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,39757,0.0235611933553128,0.00725325706033562,0.009344809517055,0.0377775771935706,0.00116415467616211
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKLR,Pyruvate kinase PKLR,42143,-0.0202438762495453,0.00627910798484557,-0.0325509278998426,-0.00793682459924798,0.00126710693742043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEO1,Neogenin,39934,0.00737593068046315,0.00228778448211485,0.00289187309551805,0.0118599882654082,0.00126749443597494
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NHLRC3,NHL repeat-containing protein 3,39481,0.0105218111412186,0.00327674675360454,0.00409938750415366,0.0169442347782835,0.0013263339402215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0124417509725896,0.00388140254933104,0.00483420197590071,0.0200492999692784,0.00135213030890635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD274,Programmed cell death 1 ligand 1,42016,0.0109029534358361,0.00340318994672337,0.00423270114025828,0.0175732057314139,0.00135969508788331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WNT9A,Protein Wnt-9a,41913,-0.00941249251955166,0.00293964658333665,-0.0151741998228915,-0.00365078521621183,0.00136839085995826
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0173789534058744,0.00543223148945052,0.00673177968655139,0.0280261271251974,0.00138118440657968
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYZL2,Lysozyme-like protein 2,39560,0.0117978149065656,0.00368837957629644,0.00456859093702462,0.0190270388761067,0.00138468087860256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIPF,Gastric triacylglycerol lipase,39638,0.0202803078391898,0.00635909149857372,0.00781648850198533,0.0327441271763943,0.00143074010881193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAP,Cartilage-associated protein,39649,0.0158798750048712,0.00498936837304871,0.00610071299369578,0.0256590370160467,0.00146291402454773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0269124741017001,0.00846329844664057,0.0103244091462846,0.0435005390571156,0.00147720710427079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB2,Calretinin,41839,0.00941498769205948,0.002961151612145,0.00361113053225528,0.0152188448518637,0.00147868066168744
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2,Brorin,41973,0.0131242547342494,0.00412985306165044,0.0050297427334145,0.0212187667350842,0.00148684147405983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX1,Heme oxygenase 1,42007,-0.0157641588934194,0.00496216223506279,-0.0254899968741424,-0.0060383209126963,0.00149209765440159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0113216584943332,0.00356455682561768,0.00433512711612255,0.0183081898725438,0.00149566903082973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0123927168172103,0.00391180070754955,-0.0200598462040075,-0.00472558743041324,0.00153810808348366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT1A1,Sulfotransferase 1A1,42249,-0.0409483651433035,0.0129491978560817,-0.0663287929412235,-0.0155679373453834,0.0015690766671759
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL11,C-X-C motif chemokine 11,42249,0.0248123280044571,0.00786439817500077,0.00939810758145561,0.0402265484274586,0.00160835917145975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.00882267339412581,0.00279702810945589,0.00334049829959227,0.0143048484886594,0.001612419123849
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0180772509223172,0.00577618633056605,0.00675592571440775,0.0293985761302267,0.00175412916140923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.0111126102898195,0.00355518391936831,0.0041444498078576,0.0180807707717814,0.00177736725539476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5,T-cell surface glycoprotein CD5,42239,0.0112014652041393,0.00358515387282899,0.00417456361339446,0.0182283667948841,0.00178539763663739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0084325356148761,0.00269911797324309,0.00314226438731964,0.0137228068424326,0.00178678503419413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0259500810858499,0.00830609248941365,0.00967013980659911,0.0422300223651006,0.00178736836490804
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP8,GTPase IMAP family member 8,39560,0.0158682359629418,0.00508545429353857,0.00590074554760622,0.0258357263782774,0.00181124771915896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSL,Cathepsin L1,42145,0.00769176510826388,0.00246715781186214,0.00285613579701409,0.0125273944195137,0.00182673209201584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0187615770601689,0.00601816374236228,0.0069659761251388,0.0305571779951989,0.00182852362751788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.016309527357724,0.00523307653144647,0.00605269735608892,0.0265663573593591,0.00183313974920689
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN3,Calsyntenin-3,39929,0.00953929029436137,0.00306478916731356,0.00353230352642678,0.015546277062296,0.00185944162895629
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN4,Contactin-4,42137,-0.00736819477410588,0.00236999917182396,-0.0120133931508809,-0.00272299639733091,0.0018814665126288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0103384386395433,0.00333709274784442,-0.0168791404253184,-0.00379773685376824,0.00195281779812938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR158,Probable G-protein coupled receptor 158,39934,0.0108573989420376,0.00351156046920177,0.00397474042240211,0.0177400574616731,0.00199361666039794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0115247246227277,0.0037289929792327,0.00421589838343157,0.0188335508620237,0.00200263588955913
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN4B,Sodium channel subunit beta-4,39638,0.013586042481832,0.00440291061969128,0.00495633766723711,0.0222157472964269,0.00203579030790723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM26,Tripartite motif-containing protein 26,39560,0.0179634181120217,0.00582314573360536,0.00655005247415523,0.0293767837498882,0.00204175165759503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPJ,Centromere protein J,39757,0.021951404519227,0.0071169506955648,0.00800218115591995,0.035900627882534,0.00204473121651318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00939566708980758,0.00304695101112128,0.00342364310800987,0.0153676910716053,0.002049965699573
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0196853807939843,0.00638652677830437,0.00716778830850778,0.0322029732794609,0.00205888051076766
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNXB,Tenascin-X,42137,0.00812378050911152,0.00263614188864182,0.00295694240737356,0.0132906186108495,0.00206240135331097
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLNS1A,Methylosome subunit pICln,39649,-0.01044806291175,0.00339744776292126,-0.0171070605270756,-0.0037890652964243,0.00210826856652417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.0060393598541637,0.00196407741045847,-0.0098889515786623,-0.00218976812966509,0.00211065564782842
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0165825156411267,0.00540298000405652,-0.0271723564490775,-0.00599267483317594,0.00215107044954962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0141279695185002,0.00460906429843036,0.00509420349357673,0.0231617355434237,0.00217909376338631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FEN1,Flap endonuclease 1,41843,0.0197917541585228,0.00647448916839109,0.00710175538847624,0.0324817529285693,0.00224097387921301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF9,Fibroblast growth factor 9,39539,0.0127554674989179,0.00417858471047265,0.0045654414663915,0.0209454935314443,0.00227427169996113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,41802,0.00894555413054037,0.00293587035467711,0.00319124823537324,0.0146998600257075,0.00231605481990251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL34,Interleukin-34,41814,0.0112068699784321,0.00367878410989027,0.00399645312304717,0.018417286833817,0.00232093517933781
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42145,0.0188824444794785,0.00620125804675667,0.00672797870783541,0.0310369102511216,0.00233175428598102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD6,Programmed cell death protein 6,42145,-0.021545371620558,0.00711523971434634,-0.0354912414606768,-0.00759950178043918,0.00246592488182905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CX3CL1,Fractalkine,42016,-0.0101696698779015,0.00336991488938052,-0.0167747030610873,-0.00356463669471567,0.00255109436771415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0159676106818976,0.00529592579475041,-0.0263476252396084,-0.00558759612418683,0.00257485714356093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0114587719214328,0.00380560231290623,0.0039997913881366,0.018917752454729,0.00260955743033231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F3,Tissue factor,42174,-0.00792430962787566,0.00263464309912751,-0.0130882101021656,-0.00276040915358573,0.00263684283986718
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTN3,Myeloblastin,41800,-0.0145340970696502,0.00485487618263004,-0.0240496543876051,-0.00501853975169534,0.00276117155261605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL1,Fc receptor-like protein 1,42145,0.0137631829901011,0.00461905385704769,0.00470983743028767,0.0228165285499146,0.00289085966798792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.00820241599312222,0.00275274224158201,0.00280704119962149,0.0135977907866229,0.00289116970083996
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN2,Nectin-2,42129,-0.00927585243652808,0.00311817079222926,-0.0153874671892974,-0.00316423768375872,0.00293722469098019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB1,Lamin-B1,39908,0.0183649840669444,0.00618539741025426,0.006241605142846,0.0304883629910427,0.00299312485885139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,39930,0.0150971514713367,0.00508981038626258,0.00512112311426209,0.0250731798284114,0.00302180511141682
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0117314351788384,0.0039577262264771,0.00397429177494327,0.0194885785827335,0.00304133701265304
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B2M,Beta-2-microglobulin,39979,-0.00912036025310544,0.00308704772636082,-0.0151709737967726,-0.00306974670943823,0.00313923566051045
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBD,Thrombomodulin,42145,0.00878878710291917,0.00298008272690296,0.00294782495818937,0.014629749247649,0.00319167428764101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.012845815053153,0.0043577778755529,-0.0213870596892366,-0.00430457041706927,0.00320597276449147
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0110635397830346,0.00376335701368543,-0.018439719529858,-0.00368736003621112,0.00329091302162327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAO1,Hydroxyacid oxidase 1,42262,0.0366086796735974,0.0124567368335661,0.0121934754798078,0.061023883867387,0.00329966563075536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0163321047653983,0.0055637152341977,-0.0272369866244258,-0.00542722290637081,0.00333735571045962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABO,Histo-blood group ABO system transferase,39990,0.0430618219932376,0.0146705432923739,0.0143075571401849,0.0718160868462904,0.00333936783706237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK3,Dickkopf-related protein 3,42310,-0.00870924092010775,0.00297309602709094,-0.014536509133206,-0.00288197270700951,0.00340230516197966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TERF1,Telomeric repeat-binding factor 1,39657,-0.00857756264020183,0.00294686972872148,-0.0143534273084959,-0.00280169797190774,0.00361297162749756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0153636309916149,0.00531131932862974,0.00495344510750067,0.0257738168757292,0.00382789403234319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLASP1,CLIP-associating protein 1,39560,0.0219979180396876,0.00762098625333077,0.00706078498315927,0.0369350510962159,0.00390323295282857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRC,Chymotrypsin-C,42122,0.0189730005846764,0.00658616076897495,0.00606412547748551,0.0318818756918673,0.00397369461585447
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10,Interleukin-10,41913,-0.0223003340345656,0.00775791173530773,-0.0375058410357687,-0.0070948270333624,0.00405272914291468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0138593227116986,0.00482886582550472,0.00439474569370932,0.0233238997296878,0.00411102655414473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0142992036841667,0.00498398230236016,0.00453059837154082,0.0240678089967927,0.00412506369183335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UMOD,Uromodulin,42274,0.0155370864131665,0.00542520298003512,0.00490368857229765,0.0261704842540353,0.0041913397819888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST1,Cystatin-SN,38503,0.0309614303183495,0.0108287267801337,0.0097371258292875,0.0521857348074115,0.00425606173593961
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,41920,0.00827911522931798,0.00289652253114123,0.00260193106828116,0.0139562993903548,0.0042658513434922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0292776096608071,0.0102518547536837,-0.0493712449780271,-0.00918397434358713,0.00430043165237886
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB37,Ras-related protein Rab-37,41913,0.0233887166571792,0.00819201147815695,0.00733237415999157,0.0394450591543668,0.00430946636868407
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0117778686944111,0.00413013151863148,-0.0198729264709288,-0.00368281091789339,0.00435652521711672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0109185928754534,0.00383046811105839,-0.0184263103731279,-0.003410875377779,0.0043737642383037
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LUZP2,Leucine zipper protein 2,39919,0.0129315630869672,0.00454572133657884,0.00402194926727265,0.0218411769066617,0.00445222799439199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0175997761489484,0.00620395462063955,-0.0297595272054019,-0.00544002509249487,0.00456272708314354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNU13,NHP2-like protein 1,39575,0.018099281859684,0.00639091738666929,0.00557308378181224,0.0306254799375558,0.00463374489820628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.00892686481890656,0.00315427734427379,0.00274448122412992,0.0151092484136832,0.00466199071276658
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHCY,Adenosylhomocysteinase,42145,0.0191768782523943,0.00678088959270709,0.00588633465068843,0.0324674218541002,0.00468972638792908
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0109865327348605,0.00389083269624735,0.00336050065021566,0.0186125648195053,0.00475560819990256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGES2,Prostaglandin E synthase 2,39579,0.0159259448807871,0.00565696392353971,0.00483829559064928,0.027013594170925,0.00488213685572655
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NADK,NAD kinase,42145,0.0155042943470649,0.00551125248905556,0.00470223946851603,0.0263063492256138,0.00491206888778992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST2,Bone marrow stromal antigen 2,42249,0.0144276466061698,0.00513750427786771,0.00435813822154912,0.0244971549907905,0.00498747309171195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00741977328533388,0.00264497497414276,-0.0126039242346537,-0.00223562233601408,0.00503686633753617
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTNB,Dystrobrevin beta,39900,0.0129017931076766,0.00459944614667915,0.00388687866018551,0.0219167075551678,0.00503907480805227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00890406618986854,0.00317771202734923,0.00267575061626405,0.015132381763473,0.00508544829182804
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0177086993036205,0.00632569155316946,0.00531034385940838,0.0301070547478326,0.00512560906953285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBB,Inhibin beta B chain,39736,0.0148255485999918,0.00529706626595009,0.00444329871872963,0.025207798481254,0.00513775047374887
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLO1,Lactoylglutathione lyase,41900,0.0159450122356355,0.0056994240299651,0.00477414113690387,0.0271158833343671,0.00515493330534514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDCP1,CUB domain-containing protein 1,42016,0.0157790161182218,0.00564740218597389,0.00471010783371299,0.0268479244027306,0.00521293416786536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.00884256170577116,0.00317299456098237,-0.0150616310452966,-0.00262349236624572,0.0053319631144468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00829575086415203,0.00299215036015809,-0.0141603655700619,-0.00243113615824217,0.0055703182364698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO1,R-spondin-1,42016,0.00948467200721399,0.00343720994048423,0.00274774052386491,0.0162216034905631,0.00579843310142579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0148882379383723,0.00540491659860025,0.00429460140511581,0.0254818744716288,0.0058846523374963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L,Seizure 6-like protein,42181,0.00763659799036844,0.00277439485476997,0.0021987840750193,0.0130744119057176,0.00592156984629697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOSB,Protein fosB,41839,0.010658666320237,0.00387352449742402,0.00306655830528591,0.0182507743351881,0.00593726537045556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTP1,Glutathione S-transferase P,41759,-0.0192967163155325,0.00703856913019971,-0.033092311810724,-0.00550112082034109,0.00612292793076739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRNN,Cornulin,41749,0.0186015604061772,0.00679014295234258,0.00529288021958571,0.0319102405927686,0.00616166609046612
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP8,Neutrophil collagenase,42224,-0.0197274120172523,0.00720940306943721,-0.0338578420333493,-0.00559698200115541,0.00622063996095023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL3,Fc receptor-like protein 3,41913,0.014762736006511,0.00540191553211252,0.00417498156357044,0.0253504904494515,0.00628678656978352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF1C,Kinesin-like protein KIF1C,39575,0.00964971020403405,0.0035325573728462,0.00272589775325548,0.0165735226548126,0.00631187933332292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.015063019918425,0.00551763451404313,0.00424845627090049,0.0258775835659495,0.00634218646005717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC1,Hamartin,39657,0.0204061919196852,0.00749970239291334,0.00570677522957509,0.0351056086097954,0.00651996866986578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00813949399618566,0.00299468238891002,0.00226991651392202,0.0140090714784493,0.00657836895643245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX7,Syntaxin-7,39657,0.0134855474756191,0.00497489617681181,0.00373475096906791,0.0232363439821702,0.00672410442481048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00819997584497156,0.00302843045935865,-0.0141356995453145,-0.00226425214462862,0.00678423325661024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKAP12,A-kinase anchor protein 12,39736,0.00580929771244759,0.00215587663104,0.00158377951560918,0.010034815909286,0.00705717701005024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0188823048327101,0.00702327793526839,0.00511668007958405,0.0326479295858361,0.007185567397222
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIM,Vimentin,41900,0.0311390581355224,0.0115888924455483,0.00842482894224764,0.0538532873287971,0.00721921048400375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99,CD99 antigen,42137,-0.00538558430967525,0.00200998982756711,-0.00932516437170678,-0.00144600424764372,0.00738414859433292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG4,Proteasome assembly chaperone 4,39657,-0.0151719964263857,0.00567059195178596,-0.0262863566518862,-0.00405763620088521,0.00747148974843098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD248,Endosialin,39966,0.0109276087015936,0.00409632308120393,0.00289881546243388,0.0189564019407533,0.00764891648494991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTO1,Protein LTO1 homolog,41913,0.0111002366177037,0.00416673005684095,0.00293344570629545,0.019267027529112,0.00773068317899387
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCOF1,Treacle protein,39958,0.00873955052987594,0.00328244848138649,0.00230595150635843,0.0151731495533935,0.00776696434578851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNC,Tenascin,42217,-0.0129558837915748,0.00487113989784666,-0.0225033179913542,-0.00340844959179531,0.00782964555142817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0194782575271389,0.00733450761755256,0.00510262259673588,0.0338538924575419,0.00792373486178113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0156466314914033,0.00590835184030591,-0.0272270010984029,-0.00406626188440376,0.00810108717945404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D1,DCN1-like protein 1,39586,-0.0201942748690979,0.00763999980906046,-0.0351686744948564,-0.0052198752433394,0.00822358464185768
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00793975515291127,0.00300640560824553,0.00204720016075004,0.0138323101450725,0.00827746337580428
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPS,Calcyphosin,39929,0.0253876247314985,0.00962253605461089,0.00652745406446114,0.0442477953985358,0.00834242883791509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0153715713155354,0.00583547944271302,-0.026809111023253,-0.00393403160781791,0.00844420487751128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSZ,Cathepsin Z,42168,0.00856089924908073,0.00325336303152907,0.00218430770728375,0.0149374907908777,0.00851300734042811
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0113547133964058,0.00431945362160624,0.00288858429805753,0.019820842494754,0.00857984993673812
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0113535453866335,0.00432383786889347,-0.0198282676096647,-0.00287882316360233,0.0086542269884584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42119,0.0130505800678777,0.00497791162340776,0.00329387328599844,0.0228072868497569,0.00875909759779142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP164,Centrosomal protein of 164 kDa,41913,0.0164544219812512,0.00627869515490492,0.00414817947763756,0.0287606644848649,0.00878554570225297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0137931358561769,0.00526336892769348,0.00347693275789771,0.0241093389544561,0.00878986761101296
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.00718918605843672,0.00274375766060519,-0.0125669510732229,-0.00181142104365054,0.00879767030285184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON1,Spondin-1,42144,-0.00860036899348825,0.00328715659532787,-0.0150431959203309,-0.00215754206664564,0.00889727220375647
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB2,Lamin-B2,39929,-0.00759427029219813,0.0029055183930348,-0.0132890863425463,-0.00189945424184991,0.00896755288906076
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRLB,Fc receptor-like B,41843,-0.0161816847952553,0.0062072753723273,-0.0283479445250168,-0.00401542506549375,0.00914710719882734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP2,Neuropilin-2,42137,-0.00736946947593861,0.00283618518229403,-0.0129283924332349,-0.00181054651864231,0.00937679481025307
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL4,Delta-like protein 4,39638,0.0231736158398815,0.00892193557105106,0.00568662212062138,0.0406606095591416,0.00940638768383435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TK1,"Thymidine kinase, cytosolic",39757,0.0124135416292347,0.00477945797549705,0.00304580399726052,0.021781279261209,0.00940914634225402
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0234180028299212,0.0090199984612473,-0.0410971998139659,-0.00573880584587644,0.00943743739859799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX2,Sorting nexin-2,39919,0.022421027796139,0.00864112305901736,0.005484426600465,0.039357628991813,0.00947986024340415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPO,Erythropoietin,42119,-0.0190374037869836,0.00734565948729842,-0.0334348963820885,-0.00463991119187867,0.00956186237837729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN1,Calsyntenin-1,41839,0.0132223663423303,0.00510345709002582,0.00321959044587969,0.0232251422387809,0.00958401388889129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0221729761644797,0.00856613577610315,0.00538335004331751,0.0389626022856419,0.00965333236499726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIL1,Nucleotide exchange factor SIL1,39638,0.00858829428916331,0.00331910978291843,0.0020828391146432,0.0150937494636834,0.00967935095405942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42310,0.00848055351976098,0.00328188792249877,0.00204805319166339,0.0149130538478586,0.00977508549833269
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MST1,Hepatocyte growth factor-like protein,39854,0.0176064979011602,0.00682329201719306,0.00423284554746182,0.0309801502548586,0.00988250501529137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00670726185917755,0.00260089590856862,0.00160950587838307,0.011805017839972,0.00992611944139649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0056447644300743,0.00219395380052017,0.00134461498105476,0.00994491387909383,0.010096449109891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0110591317439318,0.00429902190111036,0.00263304881775554,0.0194852146701081,0.0101081249751843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0122709273103222,0.00477144765443428,-0.0216229647130134,-0.002918889907631,0.0101294808203314
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS22,Brain-specific serine protease 4,39657,0.0090289844096127,0.00351097019772593,0.00214748282206988,0.0159104859971555,0.0101344773073332
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.038234869010292,0.0148823855577378,-0.0674043447034582,-0.00906539331712586,0.0102083586498958
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0172845571642043,0.00673181215413538,0.00409020534209899,0.0304789089863097,0.0102515928889369
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA11,Serpin A11,42310,-0.0108070129170626,0.00421266780740193,-0.0190638418195703,-0.00255018401455477,0.0103173941466383
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0100160295368364,0.00390706721534382,0.00235817779476247,0.0176738812789102,0.0103734628742271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0113408237988902,0.00442822015406274,-0.0200201353008531,-0.00266151229692719,0.0104493412390517
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00798470629945118,0.00311792829134242,0.00187356684842004,0.0140958457504823,0.0104510288969533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0134616837408625,0.00525922326738786,0.00315360613678224,0.0237697613449427,0.0104911360631226
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXTL1,Exostosin-like 1,39575,0.0122766958733381,0.00482199372513553,0.00282558817207247,0.0217278035746037,0.010910716124124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A14,Zinc transporter ZIP14,41839,-0.00861841613259361,0.00339715144952259,-0.0152768329736579,-0.00195999929152933,0.0111935534578091
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA,Lymphotoxin-alpha,42119,0.0102156684079853,0.0040330208049214,0.00231094763033934,0.0181203891856312,0.0113200912235568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2,Ataxin-2,39586,0.0271987552345493,0.0107418750313132,0.00614468017317547,0.0482528302959232,0.0113542269277698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,39638,0.0145317249466642,0.00574071687354975,0.00327991987450665,0.0257835300188217,0.0113764219997251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC4A1,Band 3 anion transport protein,39966,-0.0121616788361527,0.00481798700700022,-0.0216049333698731,-0.00271842430243227,0.0116089031460278
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB1,Carboxypeptidase B,42310,0.0157656947639422,0.00625657853016266,0.00350280084482344,0.028028588683061,0.0117514558462584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0119199215096286,0.00473235893770692,0.00264449799172302,0.0211953450275342,0.0117868585331349
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSS,Cathepsin S,39358,0.00615958037319129,0.00245146245595369,0.00135471395952206,0.0109644467868605,0.0119985245084065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS9,Galectin-9,42129,0.00793739698055898,0.00316375572121001,0.00173643576698735,0.0141383581941306,0.0121239965244667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.013668419387403,0.00545378179040667,-0.0243578316966,-0.00297900707820588,0.0122170956733667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB2,Integrin beta-2,42079,-0.00724860600431843,0.00289560281659739,-0.0129239875248493,-0.00157322448378754,0.0123153300836056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.014168436426769,0.00569560221127704,0.00300505609266603,0.025331816760872,0.0128747541544435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0196184518397829,0.00788757373590975,-0.035078096362166,-0.00415880731739976,0.0128853174509755
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22,Interleukin-22,39919,-0.0177057531511609,0.00712079820301068,-0.0316625176290619,-0.00374898867326,0.0129155303347843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBP1,Z-DNA-binding protein 1,39657,0.0104125744661624,0.00419157811345935,0.00219708136378206,0.0186280675685427,0.01300022939227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP7,GTPase IMAP family member 7,39736,-0.00808569532489116,0.00326434922969611,-0.0144838198150955,-0.00168757083468679,0.0132650346868779
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0244575725605693,0.00988484111469418,0.00508328397576867,0.0438318611453698,0.0133637875022222
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK15,Kallikrein-15,39900,0.01314461890715,0.00531817302609598,0.00272099977600187,0.0235682380382981,0.013464045097571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD1,Polycystin-1,39958,0.0067896027802904,0.00275097594747168,0.0013976899232459,0.0121815156373349,0.013598976208126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMA,Granzyme A,42296,0.00842857738699048,0.00341948274740992,0.00172639120206704,0.0151307635719139,0.0137185103236404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0217318980552287,0.00884427348156004,0.00439712203137104,0.0390666740790864,0.0140189348160724
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD46,Membrane cofactor protein,42107,0.00708709023324651,0.00288902227267967,0.00142460657879437,0.0127495738876987,0.0141752390510801
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42016,-0.00902254875777944,0.00368570735151439,-0.0162465351667476,-0.00179856234881124,0.0143785655229176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.00633923168232353,0.00259739637354548,0.00124833479017439,0.0114301285744727,0.0146753468458692
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPQ,Carboxypeptidase Q,39960,0.00923120556049643,0.00378787447118982,0.00180697159696437,0.0166554395240285,0.0148232416930818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00829405085961635,0.0034058237341265,0.0016186363407284,0.0149694653785043,0.0148941533125186
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSAP,Gamma-secretase-activating protein,41843,0.0206375534729336,0.00848355096123261,0.00400979358891773,0.0372653133569496,0.0150017222574978
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.00847106384611817,0.0034838802139157,0.00164265862684339,0.0152994690653929,0.015049383227854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN2,Neuroligin-2,39586,-0.0114957976746596,0.00473769065650737,-0.020781671361414,-0.00220992398790516,0.0152630847218708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.00968303098466593,0.00399079955576025,-0.017504998113956,-0.00186106385537585,0.0152679091126182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42070,0.0063528711899456,0.00261863887134257,0.00122033900211417,0.011485403377777,0.0152784572583851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0169284390121823,0.00699956825033991,-0.0306475927828485,-0.00320928524151604,0.0156004095343574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0119284482192825,0.00493863052832834,-0.021608164054806,-0.00224873238375896,0.0157341905987094
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.00891608859288694,0.00369543993330265,-0.0161591508621601,-0.00167302632361375,0.0158494423930206
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMB,Granzyme B,42119,0.016464085274235,0.00683348306717629,0.00307045846256945,0.0298577120859005,0.0159953153432266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0156629048972463,0.00655117405977446,-0.0285032060544043,-0.00282260374008841,0.0168258425875127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36G,Interleukin-36 gamma,39624,0.0162296645583188,0.00681244383822386,0.0028772746354,0.0295820544812375,0.0172191239294851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,39657,0.025247558190708,0.0106065564617969,0.00445870752558614,0.0460364088558299,0.0173119761733271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.00753394742705935,0.0031705208374164,-0.0137481682683955,-0.00131972658572321,0.0175037101541047
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0103877899565058,0.00438663032633279,-0.0189855853961181,-0.00178999451689357,0.0178984258055622
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00805090624884836,0.00340304641732705,-0.0147208772268094,-0.00138093527088734,0.0180056192645378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0283180734667041,0.0119804811625085,-0.0517998165452207,-0.00483633038818745,0.0181082753789376
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.00860252768472661,0.00364726103432909,0.0014538960574416,0.0157511593120116,0.0183601212055429
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1A,Interleukin-1 alpha,41913,0.0137569406999929,0.00583805926173305,0.00231434454699615,0.0251995368529897,0.0184662692223819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA8,Carbonic anhydrase-related protein,39657,0.00635781193293552,0.00270019153510677,0.00106543652412626,0.0116501873417448,0.0185611308299745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.012456665135279,0.00529507117395286,-0.0228350046362266,-0.00207832563433141,0.0186651353600467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA4,Apolipoprotein A-IV,39979,-0.00820822729376906,0.00348992387914362,-0.0150484780968906,-0.00136797649064756,0.0186907815565857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0205788317591469,0.00875852198189026,0.00341212867464202,0.0377455348436519,0.0188121899138591
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00827489710700985,0.00352255827221978,0.00137068289345907,0.0151791113205606,0.0188353998686218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH7B,Myosin-7B,39560,-0.0102024761375031,0.00435057222417837,-0.0187295976968927,-0.00167535457811355,0.0190403137324322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0158722507871151,0.00679944672330654,-0.0291991663647959,-0.00254533520943432,0.0195956371862477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0052231270187051,0.00223913117391018,0.000834429917841158,0.00961182411956905,0.0196806964865882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0164790339730226,0.00706833850061313,0.00262509051182092,0.0303329774342244,0.019747366060626
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC1,Glypican-1,42262,0.00692969645056651,0.0029794794094213,0.00108991680810077,0.0127694760930323,0.0200433667369537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.00738535435283388,0.0031800967232224,0.00115236477531798,0.0136183439303498,0.0202278839427243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGCR6,Protein DGCR6,39586,0.00984897503278989,0.00424336588364684,0.00153197790084209,0.0181659721647377,0.0203034905741924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.00836915028132409,0.00361764763204893,-0.01545973964014,-0.0012785609225082,0.0207141979984202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00778871406007952,0.00336981706566812,-0.014393555508789,-0.00118387261137001,0.0208337891921667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCN,Decorin,41900,-0.00536202841179437,0.00232153751099486,-0.00991224193334429,-0.000811814890244449,0.0209206465142558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC5D,Netrin receptor UNC5D,39657,0.00609969127689768,0.00264673176348181,0.000912097020473326,0.011287285533322,0.021206718737122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.00873865522966299,0.00379532211194337,-0.016177486569072,-0.00129982389025398,0.021326690086033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00730288206748214,0.0031741399898313,-0.0135241964475515,-0.00108156768741279,0.0214246634306184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0103332527947061,0.00449437897814629,-0.0191422355918728,-0.00152426999753935,0.021511526204331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTG,Protogenin,42262,0.00569066268400764,0.00247697836745425,0.000835785083797314,0.010545540284218,0.0216097954201334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP1,Interstitial collagenase,41693,0.0208504193155154,0.00908554323933297,0.00304275456642275,0.038658084064608,0.0217545591490302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.012515064871857,0.00547259328360408,-0.023241347707721,-0.00178878203599301,0.0222227106646059
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA1,Carbonic anhydrase 1,41890,0.0129604103392721,0.00568243221762771,0.00182284319272181,0.0240979774858224,0.0225768839436316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0133490299889102,0.00588648849228831,0.00181151254402512,0.0248865474337953,0.0233609810521382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0120280111183267,0.00530908199261064,0.00162221041280982,0.0224338118238435,0.0234944940688089
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBH,Dopamine beta-hydroxylase,39978,0.0261284049230281,0.0115401968194579,0.00350961915689071,0.0487471906891656,0.0235853995945564
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOH,Beta-2-glycoprotein 1,42137,-0.00835307958694348,0.00369078194176764,-0.0155870121928081,-0.00111914698107891,0.023637429689338
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMR1,Synaptic functional regulator FMR1,41843,0.00823359744850605,0.00363833381965586,0.00110246316198055,0.0153647317350315,0.0236509971332068
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00533522076513905,0.00236190563771339,-0.00996455581505729,-0.000705885715220816,0.0239077116778633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX9,Transcription factor SOX-9,39649,0.00628888098780764,0.00279571282844502,0.000809283844055399,0.0117684781315599,0.0245020135796108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00619899393856187,0.00277050186094157,-0.0116291775860074,-0.000768810291116384,0.0252734351222875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,41843,0.0119777981296319,0.00537038234683476,0.0014518487298358,0.0225037475294281,0.0257413263363589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRC1,Macrophage mannose receptor 1,39990,-0.00640701727704279,0.0028761988160165,-0.0120443669564351,-0.000769667597650449,0.0259267338851533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SATB1,DNA-binding protein SATB1,39934,0.00659840251213948,0.00296514264492044,0.000786722928095419,0.0124100820961835,0.0260791093562643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSC,Dipeptidyl peptidase 1,42123,0.00993970058180391,0.00447358722480701,0.00117146962118217,0.0187079315424257,0.0263090116449731
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD70,CD70 antigen,42119,0.00988733135427021,0.004453067979198,0.00115931811504212,0.0186153445934983,0.0264121158332215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRD1,Natural killer cells antigen CD94,42296,0.0105424525127924,0.00475523574516559,0.00122219045226782,0.0198627145733169,0.0266380867470316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPR,Nucleoprotein TPR,39575,0.0109705564972131,0.00495039246006278,0.00126778727549009,0.0206733257189362,0.0267052018179688
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNF,Tumor necrosis factor,41880,0.00812282769118047,0.00366971811240683,0.000930180190863088,0.0153154751914979,0.0268818767827178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.00848427025800774,0.0038408905079155,-0.0160124156535221,-0.000956124862493367,0.0271959794071756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPESP1,Sperm equatorial segment protein 1,39958,0.00749114847015184,0.00339225146434663,0.000842335600032448,0.0141399613402712,0.0272424552547633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L15,Bcl-2-like protein 15,39657,-0.0126731969696464,0.00573930107165679,-0.0239222270700937,-0.00142416686919913,0.0272547581903728
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PZP,Pregnancy zone protein,39979,0.00743229886662547,0.00336667203351202,0.000833621680941905,0.014030976052309,0.0272913486556482
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.00992611112889769,0.00450073180091772,0.00110467679909895,0.0187475454586964,0.0274434670035551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00736237461693732,0.00334048273497733,0.000815028456381759,0.0139097207774929,0.0275424507414858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THY1,Thy-1 membrane glycoprotein,42249,-0.00648695029376184,0.00294548165801713,-0.0122600943434754,-0.000713806244048274,0.0276580022783563
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE3,Eosinophil cationic protein,42081,0.0241131082885212,0.0109788837709851,0.00259449609739046,0.0456317204796519,0.0280862343254902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRUNE2,Protein prune homolog 2,39757,0.00639715303164544,0.00292555964017388,0.000663056136904643,0.0121312499263862,0.0287893299012831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB1A1,Uteroglobin,42165,0.0117941740239478,0.00540209653805303,0.00120606480936389,0.0223822832385318,0.0290338463519148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPL14,60S ribosomal protein L14,39638,0.00863007819125781,0.00395344126674285,0.000881333308441818,0.0163788230740738,0.0290620983533544
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.0144829646931174,0.00665643902430607,-0.0275295851807572,-0.00143634420547747,0.0295924302264344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0119807427961903,0.00551385016721908,-0.0227878891239397,-0.00117359646844092,0.0298126248698227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA6C,Semaphorin-6C,39657,0.00567402462204741,0.00261582579175209,0.000547006070213325,0.0108010431738815,0.0300952610056077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO1,Amphoterin-induced protein 1,39649,0.0111291341194418,0.00513181089263146,0.00107078476988415,0.0211874834689995,0.0301300495222666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00555474927556021,0.00256875325950707,-0.0105895056641941,-0.000519992886926358,0.0306059022934516
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0303122275069713,0.0140250703033694,-0.0578013653015753,-0.00282308971236729,0.030693851071384
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.018400318881121,0.00851827277647737,-0.0350961335230167,-0.00170450423922539,0.0307830262141508
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRSF1,G-rich sequence factor 1,39486,0.0182001903494726,0.00843935034237572,0.0016590636784162,0.034741317020529,0.0310597127040367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKCQ,Protein kinase C theta type,41913,0.00930434377088198,0.00431502033717382,0.000846903910021294,0.0177617836317427,0.0310805346125692
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G15,Phospholipase A2 group XV,42181,-0.00596228907564965,0.00277095081928388,-0.0113933526814461,-0.000531225469853256,0.0314375925655984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAT,Catalase,39827,0.0113615252671825,0.00529669985436639,0.000979993552624342,0.0217430569817406,0.0319726672480074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00552699083898324,0.00259174466194014,-0.0106068103763859,-0.000447171301580565,0.0329847479065454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300E,CMRF35-like molecule 2,42232,-0.00897776851566292,0.00421455668337147,-0.017238299615071,-0.000717237416254847,0.0331745286357873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUK1,Guanylate kinase,39575,-0.00867859205478726,0.00407806628564796,-0.0166716019746573,-0.000685582134917267,0.0333498083022419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA,Adenosine deaminase,42296,0.00757503577954478,0.00357921739480887,0.000559769685719402,0.0145903018733702,0.0343292631741981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,39757,0.0146425127938417,0.00693307187848222,0.00105369191201659,0.0282313336756669,0.0347102865487584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOPH1,Enolase-phosphatase E1,39919,0.0113609184827614,0.0053924513733128,0.000791713791068271,0.0219301231744545,0.035155227314448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.010543138982026,0.00502718879323346,0.000689848947288421,0.0203964290167636,0.0359969548755506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.00643813244892159,0.00307538468182546,0.000410378472543683,0.0124658864252995,0.0363283518237896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15,Interleukin-15,42119,-0.00692202234593529,0.00331822367697844,-0.013425740752813,-0.000418303939057544,0.0369916511955193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMA,Repulsive guidance molecule A,42249,-0.00674836557190628,0.00324122181939019,-0.013101160337911,-0.000395570805901513,0.037357057935103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00632851884114481,0.00304018019204875,-0.0122872720175604,-0.000369765664729266,0.0373990092865436
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD55,Complement decay-accelerating factor,41714,0.00551504196318684,0.00265535433000391,0.000310547476379185,0.0107195364499945,0.037825463918033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00516882598156123,0.00248893088227919,0.000290521452294022,0.0100471305108284,0.0378499497600078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVR,Poliovirus receptor,42249,0.00781551055588495,0.00376778178402225,0.000430658259201336,0.0152003628525686,0.0380701383072023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42119,0.00931472830861067,0.00449201591976273,0.000510377105875717,0.0181190795113456,0.0381336255591304
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO6,Unconventional myosin-VI,39934,0.0078524007407081,0.00379061952814348,0.000422786465546886,0.0152820150158693,0.0383314045003216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0089132434662555,0.0043116489660246,-0.0173640754396637,-0.000462411492847281,0.038734099442283
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBLN2,Fibulin-2,39966,-0.00670926232618461,0.00325084370865683,-0.013080915995152,-0.000337608657217231,0.0390543371292818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0130983094773985,0.00635638660585673,0.000639791729919272,0.0255568272248777,0.0393590136029425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0129918886938887,0.00631469914261514,0.000615078374363014,0.0253686990134144,0.0396707563689482
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00756584611091646,0.00367958414880138,0.000353861179265745,0.0147778310425672,0.0397896687647554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0110725126964791,0.00538827005777582,0.000511503383238486,0.0216335220097197,0.0399051006193109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.00930712770559473,0.00453729778860591,0.000414024039927142,0.0182002313712623,0.0402619991538931
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.00895946673781449,0.00436862590223792,-0.0175219735062008,-0.000396959969428156,0.0402991859254423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.0092607075254349,0.00451922986645534,0.00040301698718242,0.0181183980636874,0.040464354994767
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL1,Interferon lambda-1,41839,-0.00938179867511549,0.00457846468808127,-0.0183555894637548,-0.000408007886476196,0.0404705810270882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROCR,Endothelial protein C receptor,39575,-0.0071793015782748,0.00350932292802343,-0.0140575745172007,-0.000301028639348875,0.0408018366989241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0084857234197427,0.00415129616967639,0.000349182927176969,0.0166222639123084,0.0409616015641451
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YY1,Transcriptional repressor protein YY1,39657,0.00577577291160487,0.00282744036976499,0.000233989786865486,0.0113175560363443,0.0411001875534661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0108509922001692,0.00531338276752712,0.000436761975816094,0.0212652224245224,0.0411547074545346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA1,Apolipoprotein A-I,39979,0.00567986591917716,0.00278290680451937,0.000225368582319186,0.0111343632560351,0.0412755265847485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.014254752047949,0.00699268953522938,0.000549080558899462,0.0279604235369986,0.0415215059428058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL4,Early placenta insulin-like peptide,39919,-0.00989368568402912,0.00486881614785169,-0.0194365653338184,-0.000350806034239806,0.0421717355191406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRND,Prion-like protein doppel,39929,-0.0100532813412431,0.00495241184738543,-0.0197600085621185,-0.000346554120367631,0.0423822131267537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSB,Cathepsin B,42153,0.0103581804250623,0.00511609647703016,0.000330631330083179,0.0203857295200414,0.0429253829384532
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR5,Proline-rich protein 5,39657,0.00968119450624381,0.00478290203905166,0.000306706509702553,0.0190556825027851,0.0429812259511266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.00853075477906765,0.0042241455471059,-0.0168100800513952,-0.000251429506740095,0.0434564947967113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.00995330198014067,0.00493276817518727,-0.0196215276035077,-0.000285076356773618,0.0436326075114194
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC12A2,Solute carrier family 12 member 2,39575,-0.00539306831538634,0.00267619535802273,-0.0106384112171109,-0.000147725413661798,0.0439080537278861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.00752313894437133,0.00373566836487866,-0.0148450489395335,-0.000201228949209153,0.0440470267740488
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0154487854710923,0.00767516480240065,-0.0304921084837975,-0.000405462458386978,0.0441570940160275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.00633029072361136,0.00315387065960969,0.000148704230776364,0.0125118772164464,0.0447535738272467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OBP2B,Odorant-binding protein 2b,41979,0.0115968669235855,0.00577896711572138,0.000270091376771609,0.0229236424703994,0.044797760608397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.00677660995072538,0.00337846081017086,-0.0133983931386603,-0.000154826762790498,0.0448943237950129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGN,Mimecan,42137,-0.00874710947998403,0.00436188424118562,-0.0172964025927078,-0.000197816367260212,0.0449453903140143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NINJ1,Ninjurin-1,41843,0.0109477794233198,0.00547118862274764,0.000224249722734431,0.0216713091239052,0.045414120569505
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0092014585961617,0.0046003069607598,-0.0182180602392509,-0.000184856953072502,0.0455006904796102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI16,Peptidase inhibitor 16,39990,0.00485932845756171,0.00244368208565947,6.97115696691626e-05,0.00964894534545427,0.0467772972551207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0115783798602587,0.00582932703716155,0.000152898867422082,0.0230038608530954,0.0470280194542346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCG22,Protein PBMUCL2,39575,-0.0116749638938027,0.00588492217340733,-0.023209411353681,-0.000140516433924315,0.0472943854254823
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.00653628366060862,0.00330167599458982,-0.0130075686100047,-6.49987112125716e-05,0.0477589913216622
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSD,Cathepsin D,41225,0.0082473070586241,0.00417503652236786,6.42354747830871e-05,0.0164303786424651,0.0482461498639879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00555439626152736,0.00281627891708929,-0.0110743029390224,-3.44895840323507e-05,0.0486016281250605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00683133345998945,0.00348131528748316,7.95549652244862e-06,0.0136547114234565,0.0497543317209029
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D2,DCN1-like protein 2,39560,-0.0158584228068965,0.00809596707210584,-0.031726518268224,9.67265443089713e-06,0.0501609187744755
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0093303781419195,0.00477372377704228,-0.0186868767449224,2.61204610833669e-05,0.0506633354434158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,39657,0.0127618705703521,0.00653732500740273,-5.12864441572121e-05,0.0255750275848615,0.0509450295350785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRAS,GTPase Hras,39750,0.0195912604805416,0.0100398198940002,-8.67865116987096e-05,0.039269307472782,0.051039745426616
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.00874191145311839,0.00449236903817026,-6.31318616953255e-05,0.0175469547679321,0.0516864242150134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC2,Stanniocalcin-2,42113,0.00470424894938812,0.0024199863264553,-3.89242504642744e-05,0.00944742214924052,0.0519263698316384
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XCL1,Lymphotactin,42262,0.0106864450530224,0.0054989896525788,-9.15746660320252e-05,0.0214644647720769,0.0519947562572021
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42247,-0.00555133771017992,0.00285872191929991,-0.0111544326720077,5.17572516479017e-05,0.0521703676712679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0090526568061467,0.00466822627042123,-9.70666838789099e-05,0.0182023802961723,0.0525009628078316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0140231490640599,0.00724639658072476,-0.000179788234160583,0.0282260863622805,0.052991950371992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGN,Cingulin,39649,-0.00726638148476278,0.00378676558721801,-0.0146884420357101,0.000155679066184524,0.0550241614396096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSG1,Tryptase gamma,39657,0.00509083890126068,0.00265596283147372,-0.000114848248427822,0.0102965260509492,0.0552943864754505
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,39586,0.00863720984688876,0.00450926279154013,-0.000200945224529894,0.0174753649183074,0.0554626989795728
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,39919,0.0112233534582191,0.00586428035347614,-0.0002706360345941,0.0227173429510323,0.0556645059942999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB2,Plexin-B2,42255,-0.00471805653423234,0.00246647456784093,-0.00955234668720057,0.000116233618735881,0.0557850030222576
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN1,Contactin-1,42310,0.00514735298175626,0.00269379161959962,-0.000132478592658991,0.0104271845561715,0.0560484519202221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.00399918524939799,0.00209709572985983,-0.000111122381127276,0.00810949287992325,0.0565403757890326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO3,R-spondin-3,42262,-0.00539625251421775,0.0028331607318489,-0.0109492475486416,0.000156742520206095,0.0568432143431473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CILP,Cartilage intermediate layer protein 1,39966,0.010631170710725,0.00559056333461946,-0.000326333425129182,0.0215886748465791,0.0572450903210869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12A_IL12B,Interleukin-12,42070,0.0147430643380472,0.00776721755132021,-0.000480682062540436,0.0299668107386348,0.0577024230800899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCC1,Regulator of chromosome condensation,39919,0.00998440891131751,0.00527333596921349,-0.000351329588340926,0.0203201474109759,0.0583333358910933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.00966161770218272,0.00510969508925647,-0.000353384672759957,0.0196766200771254,0.0586717960198067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYMP,Thymidine phosphorylase,42070,-0.0126570329669994,0.00670460787378234,-0.0257980643996127,0.000483998465614043,0.0590727934192404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR101,Probable G-protein coupled receptor 101,39586,-0.0111147499129816,0.00588917593206763,-0.0226575347398341,0.000428034913870981,0.0591438548233156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.0057918028699245,0.00307165386156585,-0.0118122444385936,0.000228638698744562,0.0593799658550038
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0135102900682348,0.00716971073318098,-0.0275629231052696,0.000542342968799889,0.0595431664318124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0234162718283407,0.0124649961826999,-0.00101512068975105,0.0478476643464325,0.0603262327718997
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFLAM,Pikachurin,39930,0.00587612090128891,0.0031303263221072,-0.000259318690041204,0.012011560492619,0.0605219492475398
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0283274703255852,0.0151135766894866,-0.0579500806369789,0.00129513998580849,0.0609097830042729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGR1,Prostaglandin reductase 1,39958,0.0158576113823812,0.00846159018510514,-0.000727105380424854,0.0324423281451873,0.0609464437899657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP290,Centrosomal protein of 290 kDa,39757,0.0100562218524562,0.00537299127120102,-0.000474841039097786,0.0205872847440102,0.0612847233659166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA7A,Semaphorin-7A,42272,-0.00537832388400242,0.00287972901110427,-0.0110225927457668,0.000265944977761939,0.0618323478611317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0318293800313244,0.0170548799706712,-0.00159818471119122,0.0652569447738401,0.0620225048918686
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPEP,Aspartyl aminopeptidase,39929,-0.0107605371256472,0.00576789482641335,-0.0220656109854173,0.000544536734123009,0.0621243283136318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAP1A,Ras-related protein Rap-1A,39657,-0.0130731269702585,0.00701037719961199,-0.026813466281498,0.000667212340980987,0.0622324036200764
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0111569586667627,0.0060481344339681,-0.000697384823814755,0.0230113021573402,0.0651041626379348
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42070,0.0108077336291377,0.00586645249017124,-0.000690513251597911,0.0223059805098734,0.0654540371849336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0141230032352212,0.00766925343064789,-0.000908733488848653,0.0291547399592911,0.0655691800852037
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00625399427138298,0.00341277969846461,-0.0129430424803736,0.000435053937607659,0.0669005937232241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSP90B1,Endoplasmin,41774,0.0116981378304892,0.00639927403890202,-0.000844439285758811,0.0242407149467371,0.0675659426264176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.0108782846820037,0.00596374049836158,-0.0225672160587924,0.000810646694784945,0.0681683523127824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00602473514549688,0.00330699705923352,-0.000456979090600825,0.0125064493815946,0.0685103444969552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC2,MAM domain-containing protein 2,39958,-0.00655111309031172,0.00359793538984988,-0.0136030664544175,0.000500840273794049,0.0686638878409964
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA9,Serpin A9,42025,0.0131833189894501,0.00729589431712181,-0.00111663387210861,0.0274832718510089,0.0707923956773503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA1,GDNF family receptor alpha-1,42247,0.00519248177007576,0.00287786004442355,-0.000448123916994399,0.0108330874571459,0.0712085665631295
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERVV_1,,39575,0.00796548735803516,0.00441569699757834,-0.000689278757218392,0.0166202534732887,0.0712739835896948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0115042783705512,0.00638225329074128,-0.0240134948204041,0.00100493807930174,0.071487626932829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0107396303057912,0.00596231065677242,-0.0224257591930651,0.000946498581482784,0.0716904129701285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.0111982753300305,0.00621992600457376,-0.0233893302989951,0.000992779638934033,0.0718265155089824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRTN,Neurturin,41913,0.00898546871080921,0.00499961421904817,-0.000813775158525199,0.0187847125801436,0.0723213861884458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPG,Macrophage-capping protein,42015,0.010667366251636,0.00593963788866219,-0.000974324010141919,0.0223090565134138,0.0725229926246443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1B,Protein phosphatase 1B,39657,0.0112282441636881,0.00625330506258832,-0.00102823375898505,0.0234847220863612,0.0725902970161581
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA2,Carbonic anhydrase 2,42103,0.0120093438995346,0.00669019287618795,-0.00110343413779378,0.025122121936863,0.0726653938867438
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.00455200300804189,0.00253632740457117,-0.000419198704917617,0.00952320472100139,0.0727199977473155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPH,Hephaestin,39958,0.005063985685547,0.0028231349717539,-0.000469358859090638,0.0105973302301846,0.0728803877467237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00841997717507478,0.00469683689543771,-0.000785823139983124,0.0176257774901327,0.0730498777275291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX3,Syntaxin-3,39929,0.00692492600102652,0.00386371769850658,-0.000647960688046369,0.0144978126900994,0.0731122276203592
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEFL,Neurofilament light polypeptide,41797,-0.00853751536225496,0.00476390960761785,-0.0178747781931859,0.000799747468676023,0.0731360507962954
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBQLN3,Ubiquilin-3,39575,-0.0101782165733429,0.00569786313005998,-0.0213460283082605,0.000989595161574602,0.0740747806852403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0113032991591745,0.00634430225262267,-0.00113153325596597,0.0237381315743149,0.0748345044214831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDAN1,Codanin-1,39929,0.00394411953512665,0.00221480770096148,-0.000396903558757854,0.00828514262901116,0.0749726569837639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0125873203077333,0.00707031179294259,-0.00127049080643418,0.0264451314219008,0.075048092949981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53BP1,TP53-binding protein 1,39657,-0.0155187450714207,0.0087169190576451,-0.0326039064244051,0.00156641628156369,0.0750540652927304
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGM2,Phosphoglucomutase-2,39649,0.0109140704481164,0.00614114954310998,-0.00112258265637911,0.022950723552612,0.0755623206903796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD177,CD177 antigen,42123,-0.0230244187150985,0.0129904186840514,-0.0484856393358392,0.00243680190564217,0.0763481294448252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARTN,Artemin,41913,0.00807022663977633,0.0045607718473068,-0.000868886180944993,0.0170093394604977,0.0768355211613572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.00496933849030726,0.00281064533850396,-0.010478203353775,0.000539526373160498,0.0770763542613832
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A11,Protein S100-A11,42027,0.00821561188468337,0.00466558350734344,-0.000928931789709767,0.0173601555590765,0.0782786023942458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42185,0.00512987043194777,0.00291897669862736,-0.000591323897361844,0.0108510647612574,0.0788686282035702
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB7,Integrin beta-7,42262,-0.00816866390080697,0.00465143175872891,-0.0172854701479156,0.000948142346301691,0.0790832944488846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGR,Tyrosine-protein kinase Fgr,41839,0.0103668372416868,0.00590977350927172,-0.00121631883648575,0.0219499933198594,0.079421912456216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0135141755851251,0.0077074621689706,-0.00159245026605729,0.0286208014363075,0.0795623152794155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRL,Prolactin,42249,-0.0129896650704728,0.00741607491565032,-0.0275251719051475,0.0015458417642018,0.0798727689988565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0119366617043268,0.00682242849529385,-0.00143529814644918,0.0253086215551027,0.0802117819213272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAP,Prosaposin,39886,0.00503924819498227,0.00288919961596936,-0.000623583052317667,0.0107020794422822,0.0811571030572367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.00581886520873611,0.00334771993037367,-0.0123803962722685,0.000742665854796288,0.082210462346285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2BP,LRP2-binding protein,39649,-0.0136508433687205,0.00786156968951051,-0.0290595199601611,0.00175783322272012,0.0825206960412898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA10,Ephrin type-A receptor 10,41839,0.0114963038194846,0.00662249532487359,-0.00148378701726759,0.0244763946562369,0.0825963935068083
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B4,Protein ATP1B4,39560,-0.00734998131100057,0.00424870299193888,-0.0156774391752008,0.000977476553199636,0.0836699865981756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSMB,Beta-microseminoprotein,42103,-0.0121816145421222,0.00704184366949286,-0.0259836281343282,0.00162039905008377,0.0836727911248957
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN3,Matrilin-3,41992,0.0057519592564945,0.00332923234801754,-0.000773336145619883,0.0122772546586089,0.0840626786355942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP7,Retinoid-binding protein 7,39930,-0.0109265313414553,0.00632438023747424,-0.0233223166069048,0.00146925392399419,0.0840721212826528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB2,Lysosome membrane protein 2,41777,-0.00573809177401033,0.00332350943922462,-0.0122521702748906,0.000775986726869933,0.0842780859216008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3C,Protein FAM3C,42129,-0.00527404995187537,0.00306515540323656,-0.011281754542219,0.000733654638468276,0.0853377940565889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP3,"Fatty acid-binding protein, heart",39958,-0.00941306076868985,0.00549995056388901,-0.0201929638739123,0.00136684233653262,0.0870196614615096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMS1,PMS1 protein homolog 1,39649,0.00855434051107863,0.00500111256551686,-0.00124784011733441,0.0183565211394917,0.0872038359530397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00589977379032989,0.00345461890914335,-0.0126708268522509,0.000871279271591072,0.0876978116374915
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLHL41,Kelch-like protein 41,39934,-0.00904878374430755,0.00531357212270858,-0.0194633851048164,0.00136581761620126,0.0886035720297476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4,Interleukin-4,41913,0.0161912011516034,0.0095229253903166,-0.00247373261341709,0.034856134916624,0.0891102839878161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00816302954817284,0.00480656922636591,-0.01758390523185,0.00125784613550435,0.0894780144714438
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO6,Coronin-6,39586,-0.00672063921980765,0.00395729312765195,-0.0144769337500055,0.00103565531039018,0.0894809834674694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00457757974188313,0.0026975192636062,-0.000709558014785016,0.00986471749855128,0.0897328447062288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.00620871484009756,0.00366547163400991,-0.000975609562561856,0.013393039242757,0.0903244619133672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171B,Protein FAM171B,39919,0.00453988231687282,0.00268588993042494,-0.000724461946760063,0.0098042265805057,0.0910036228833825
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0157380580755061,0.00931657426973677,-0.00252242749317801,0.0339985436441901,0.0911991873545038
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC4,MANSC domain-containing protein 4,39575,0.0115973779426524,0.00688657206943172,-0.00190030331343381,0.0250950591987385,0.0921991447369788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0065974002546278,0.00392297640049376,-0.00109163349033997,0.0142864339995956,0.092648845377584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.00975792459926531,0.0058048561341131,-0.00161959342359637,0.021135442622127,0.0927921953886096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.00897849668463298,0.00535686251053204,-0.0194779472052758,0.00152095383600981,0.0937518122459812
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42310,-0.00604214630030606,0.00361464145838998,-0.0131268435587504,0.0010425509581383,0.0946308696737693
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTA2,"Actin, aortic smooth muscle",41900,-0.00735630705706552,0.00440197616256758,-0.015984180335698,0.00127156622156694,0.0947180656143699
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0117329043756354,0.00702535162740821,-0.0255025935653555,0.00203678481408465,0.0949318799311389
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1,DNA topoisomerase 1,39930,0.0203946676765387,0.0122157594668716,-0.00354822087852951,0.044337556231607,0.0950385443902424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK8,Kallikrein-8,41668,0.00616409484171537,0.00369677580227993,-0.0010815857307533,0.013409775414184,0.0954539705994614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0108384519702483,0.00650720943463856,-0.00191567852164324,0.0235925824621399,0.0958193237533952
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL14,C-X-C motif chemokine 14,41913,0.00957113612095025,0.00576770771563201,-0.0017335710016885,0.020875843243589,0.0970517198464985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD1,Glutamate decarboxylase 1,39560,0.00443175866135853,0.00267169527087394,-0.000804764069554394,0.00966828139227145,0.0971884453227348
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSHB,Follitropin subunit beta,39638,-0.00687150156957691,0.00415108533421954,-0.0150076288246472,0.00126462568549339,0.0978818298059765
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00655743669445709,0.00396237480115653,-0.0143236913047239,0.0012088179158097,0.0979681615388617
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00944278014472646,0.00573362634614187,-0.00179512749371161,0.0206806877831645,0.0996060125308612
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX5,Syntaxin-5,39657,0.00663007492655721,0.00403225101422914,-0.00127313706133191,0.0145332869144463,0.10015063578869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00497899902574032,0.00302818627532168,-0.000956246073890161,0.0109142441253708,0.100159564952775
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA11,Carbonic anhydrase-related protein 11,41843,-0.00504602545244274,0.00307362464776345,-0.0110703297620591,0.000978278857173617,0.100672167695501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KEL,Kell blood group glycoprotein,41839,-0.00595473532456503,0.0036451801581969,-0.013099288434631,0.00118981778550091,0.10236843215027
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.0035667099092879,0.00218763621970018,-0.000721057081324456,0.00785447689990026,0.103046692554542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42262,0.00976384027223103,0.00600579057858993,-0.00200750926180524,0.0215351898062673,0.104028527340709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACHE,Acetylcholinesterase,39736,-0.00564625092927614,0.00347474062423842,-0.0124567425527835,0.00116424069423117,0.104203281465701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSM,Oncostatin-M,42051,-0.0112525151976767,0.0069579412237158,-0.0248900799961596,0.00238504960080629,0.105854451270421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00482286220845859,0.00298389458145964,-0.00102557117120231,0.0106712955881195,0.106058473529291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.00573906744092309,0.0035576595605133,-0.00123394529768299,0.0127120801795292,0.106738034413287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.00610829437978053,0.00379199027362446,-0.00132400655652342,0.0135405953160845,0.107242869896245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00683999479120954,0.00425296518916218,-0.0151758065619674,0.00149581697954832,0.10780031363814
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMBS,Porphobilinogen deaminase,42262,0.00651783945967997,0.00405374770509889,-0.00142750604231386,0.0144631849616738,0.10788999593092
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPO,Myeloperoxidase,42137,-0.00728881907367199,0.00453688874252447,-0.01618112100902,0.00160348286167596,0.108172548482582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB8,Serpin B8,42296,0.00943936435593825,0.00589248685482766,-0.00210990987952396,0.0209886385914005,0.109193667528455
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.0058631202216293,0.0036620183547212,-0.00131443575362426,0.0130406761968829,0.10939169621359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOC,Myocilin,42137,-0.00721837076862106,0.00451105332087453,-0.0160600352775351,0.00162329374029301,0.109588214352286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.00837581946837623,0.00525284041234135,-0.0186713866765653,0.00191974773981281,0.110840906078882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1,Programmed cell death protein 1,42232,-0.00673546924611819,0.0042260323627068,-0.0150184926770235,0.00154755418478715,0.111003020904746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00950098044337484,0.00596360440207422,-0.00218768418469064,0.0211896450714403,0.111152971312761
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA4,Ephrin type-A receptor 4,39736,-0.00471987068104451,0.00296371303547715,-0.0105287482305797,0.00108900686849071,0.111288841432525
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.00818276992359885,0.00513862429994183,-0.00188893370428714,0.0182544735514848,0.111317546213915
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI2,Serpin I2,39930,0.00931829791124337,0.00585319587509787,-0.00215396600394845,0.0207905618264352,0.111412214806285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00740972477906377,0.00465662301533743,-0.0017172563309976,0.0165367058891251,0.111587328920913
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLGN,Calmegin,39649,-0.00732932071908586,0.00462177762955776,-0.0163880048730191,0.00172936343484735,0.112808110400074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR2,Toll-like receptor 2,39757,-0.00371825554940275,0.00234509138948442,-0.00831463467279222,0.000878123573986724,0.112870163568379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB5,Serpin B5,41900,0.00779154516646962,0.00491434963770459,-0.00184058012343138,0.0174236704563706,0.112883766215561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42126,0.00465261003863386,0.00293538147063933,-0.00110073764381924,0.010405957721087,0.112987357988091
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0116865592650288,0.00737722699091987,-0.0261459241672317,0.00277280563717418,0.113185286191056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC13A1,Solute carrier family 13 member 1,39919,0.00959872349557167,0.00607482976060624,-0.00230794283521658,0.0215053898263599,0.114116244276977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.00909878489032668,0.0057632854314181,-0.0021972545552528,0.0203948243359062,0.114422349092205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNIP4,Kv channel-interacting protein 4,41839,0.00808771370464255,0.00512958843597799,-0.00196627962987432,0.0181417070391594,0.11489332744117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00642369235978567,0.0040752463084631,-0.0144111751243733,0.00156379040480201,0.11499172608024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0081568230107461,0.00518103228303885,-0.0183116462855022,0.00199800026401004,0.115432295952627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN1,Transcobalamin-1,39806,-0.00567733309231142,0.00361035649295387,-0.012753631818501,0.00139896563387816,0.11585982155868
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSPN,Claspin,41820,0.0056164108282001,0.00358077916472279,-0.00140191633465657,0.0126347379910568,0.116791112448484
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST6,Cystatin-M,41864,0.0078454966607782,0.00501855320080722,-0.00199086761280394,0.0176818609343603,0.118006258863771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0129326973445419,0.00827901680968302,-0.0291595702915207,0.00329417560243678,0.118292019346467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0185218048700493,0.0119441192008946,-0.0419322785038028,0.00488866876370411,0.121000326353227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA4,Ephrin-A4,41992,-0.00504604998981542,0.00326122647523582,-0.0114380538812776,0.00134595390164679,0.121817931294604
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMCH,Pro-MCH,39575,-0.0129286724215298,0.00836179761561343,-0.0293177957481322,0.00346045090507249,0.122094896219639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42070,-0.0161910482150176,0.0105162028946826,-0.0368028058885954,0.00442070945856021,0.123674365224903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00956438021500721,0.00621465507240638,-0.00261634372690929,0.0217451041569237,0.123831225391157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNG,Uracil-DNA glycosylase,39919,0.00547546557502223,0.00356292072483867,-0.00150785904566156,0.012458790195706,0.124372375591954
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0179457345269265,0.0116857012617102,-0.00495823994602541,0.0408497089998784,0.124635673992328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0195054316403946,0.0127179928619842,-0.00542183436909448,0.0444326976498836,0.125130342417299
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.00423012712697737,0.00276353453048067,-0.00964665480671949,0.00118640055276474,0.125868202940107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2B,Sodium channel subunit beta-2,39649,-0.00435952859219364,0.00285414882647795,-0.00995366029209043,0.00123460310770314,0.126681348401925
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.00817218464811715,0.00535055292483081,-0.0186592683807855,0.00231489908455124,0.126696550206862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA2,Protein disulfide-isomerase A2,39560,0.00619217248376824,0.00405454955217607,-0.00175474463849686,0.0141390896060333,0.1267361941848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAG,Myelin-associated glycoprotein,39649,0.00751443865773358,0.00492213730288537,-0.00213295045592174,0.0171618277713889,0.126873771567132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00639780705852292,0.00419828389664983,-0.00183082937891073,0.0146264434959566,0.127555066043599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH2,Growth hormone variant,41843,0.0248493864419456,0.0163255164220871,-0.00714862574534508,0.0568473986292363,0.128003023897856
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI2,Protein-arginine deiminase type-2,41913,-0.0087491233414798,0.00575311045829502,-0.020025219839738,0.00252697315677843,0.128342817454466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_A,,39934,-0.00504785257708245,0.00332484855063737,-0.0115645557363317,0.0014688505821668,0.128986762171868
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EP300,Histone acetyltransferase p300,39657,0.0047342051804142,0.00312132869454622,-0.00138359906089639,0.0108520094217248,0.129364076713134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX2,Transcription factor SOX-2,39915,0.00376979594243669,0.00248750116766646,-0.00110570634618958,0.00864529823106296,0.129674992595079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL15,C-C motif chemokine 15,42310,-0.00664852122339242,0.00439094957938744,-0.0152547823989918,0.00195773995220697,0.130012877639332
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.00907843286855563,0.00599723246131146,-0.0208330084927261,0.00267614275561483,0.130112883017908
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.00462550642956974,0.00305812665066155,-0.0106194346648664,0.00136842180572689,0.13042243738023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI3,Elafin,41966,-0.00854985488692564,0.00566797169389601,-0.0196590794069618,0.00255936963311054,0.131462895386815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALB,Ras-related protein Ral-B,39657,0.00453111591044522,0.00300618984492029,-0.00136101618559854,0.010423248006489,0.131772066178035
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME1,Nucleoside diphosphate kinase A,39657,-0.00334445942339879,0.00222412499502026,-0.0077037444136385,0.00101482556684092,0.13268224808713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRK1,Protein BRICK1,41839,0.00683349512069679,0.00457484173459627,-0.00213319467911189,0.0158001849205055,0.135274792330127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGA4,Pepsin A-4,39990,-0.0113034366018153,0.00758838654581976,-0.0261766742316221,0.00356980102799138,0.136364896547604
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.00446576050505424,0.00299873066780917,-0.0103432726139602,0.00141175160385173,0.136454064946572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB5,Integrin beta-5,42181,0.00575266371516905,0.00387415481233285,-0.00184067971700333,0.0133460071473414,0.137598228051156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS5,Transmembrane protease serine 5,41946,0.00577554246451186,0.0038903564357057,-0.00184955614947131,0.013400641078495,0.137678930952263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLVRB,Flavin reductase,42137,-0.00951116004425788,0.00642637625472257,-0.0221068575035141,0.00308453741499837,0.138891402332432
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.00473178750271295,0.00320176600161394,-0.0110072488658763,0.00154367386045037,0.139471646231988
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK2,Protein AHNAK2,39638,0.00465530466282,0.00315221830808538,-0.00152304322102735,0.0108336525466673,0.139748541721819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDN1,Endothelin-1,39638,-0.00437827314307429,0.0029735353430819,-0.0102064024155148,0.00144985612936624,0.140937801192744
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS2,"Nitric oxide synthase, inducible",39575,-0.00601138097430432,0.00408492683886139,-0.0140178375784726,0.00199507562986401,0.141157423095041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVPL,Envoplakin,39757,0.00497052976650466,0.00338321638429147,-0.00166057434670661,0.0116016338797159,0.141814098318288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00540660283168229,0.00368237983257399,-0.00181086164016272,0.0126240673035273,0.142068560118273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUOX2,Dual oxidase 2,41900,0.0104145005611718,0.00709392939555465,-0.00348960105411535,0.0243186021764589,0.142104430567209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.0067408603709518,0.0045926351861892,-0.0157424253358826,0.00226070459397902,0.142199583552661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42119,0.00716513129840218,0.00488527065084855,-0.00240999917726098,0.0167402617740653,0.142486244858777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,39575,0.00630665088594724,0.00431241594176192,-0.00214568435990612,0.0147589861318006,0.143649225190987
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00511053510195758,0.00350153775931463,-0.0119735491102143,0.00175247890629909,0.144447935045217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0172694117551463,0.0118515770491061,-0.00595967926110156,0.0404985027713942,0.145101124975121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00418688999145003,0.00287761415550435,-0.00982701373623856,0.00145323375333849,0.145700591503511
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0155248105497925,0.010678582539907,-0.0364548323280102,0.00540521122842528,0.146022706325838
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP4,Guanylate-binding protein 4,41839,0.00717648302283963,0.0049392877659942,-0.00250452099850899,0.0168574870441883,0.146264437499077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAFB2,Scaffold attachment factor B2,39934,0.00400506457514762,0.00276053627406941,-0.00140558652202842,0.00941571567232367,0.146855308707022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0076979750380165,0.00532027990589697,-0.00272977357754157,0.0181257236535746,0.14794976066082
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.00554662273341015,0.0038550256901589,-0.0131024730861216,0.00200922761930129,0.150229971259251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00923752766838635,0.00642467948376182,-0.0218298994565595,0.00335484411978682,0.150508322847678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00725148139116766,0.00504431051560869,-0.0171383300017607,0.00263536721942536,0.150588439513581
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,39958,-0.00583178743479404,0.00405827829231645,-0.0137860128877343,0.00212243801814619,0.150742631416734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD7,T-cell antigen CD7,39636,-0.00650884235617756,0.00453909345313474,-0.0154054655243216,0.00238778081196652,0.15161427911997
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEBP1,Heme-binding protein 1,41900,-0.00752005565772572,0.00524990813321268,-0.0178098755988226,0.00276976428337114,0.152048127059322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.00539080966713097,0.00376616054337441,-0.0127724843321448,0.00199086499788288,0.152349599557245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX1,Neuronal pentraxin-1,42137,0.00601766219887666,0.00421213843538255,-0.00223812913447313,0.0142734535322264,0.153128567984992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPN3,Calpain-3,39919,-0.00563029007098103,0.00394648410543633,-0.0133653989176362,0.00210481877567417,0.153705571190715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100G,Protein S100-G,39934,0.00705543282177358,0.00495577843024866,-0.00265789290151379,0.016768758545061,0.154567226721554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP29,Dual specificity phosphatase 29,39649,-0.00969780438046216,0.00681410935679568,-0.0230534587197817,0.00365784995885737,0.154707953532917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0084725750991272,0.00596253731769274,-0.00321399804355056,0.020159148241805,0.15535445513627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL8,Interleukin-8,42035,0.009676136302561,0.00683746629654025,-0.00372529763865789,0.0230775702437799,0.15704358848679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00485737387751327,0.00344743049891989,-0.0116143376553963,0.00189958990036972,0.158868276335202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA1,Ephrin-A1,42113,-0.00416517317974495,0.00297031803026782,-0.00998699651906988,0.00165665015957998,0.160859082406587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRN,Progranulin,42077,0.00355398039340779,0.00253493766182146,-0.00141449742376226,0.00852245821057785,0.16093853795452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAG,S-arrestin,39586,-0.00739109018186078,0.00529959408252643,-0.0177782945836126,0.00299611421989103,0.163148965038071
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00621744803389674,0.00445824036600358,-0.0149555991512638,0.00252070308347028,0.163164809849279
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF174,Zinc finger protein 174,39657,0.00519779995539437,0.00372795647646001,-0.00210899473846725,0.012504594649256,0.163262313466336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR4,Toll-like receptor 4,39657,0.00400544570652688,0.00287784177940611,-0.0016351241811091,0.00964601559416287,0.16400407005415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00425680205642551,0.00306310377884933,-0.0102604854629702,0.00174688135011918,0.164642483393867
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.00396973951733338,0.0028628393919284,-0.00164142569084629,0.00958090472551305,0.165572842290803
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA1,Annexin A1,39699,0.00625019082466252,0.00451079574968951,-0.00259096884472892,0.015091350494054,0.165894736548703
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL5,Insulin-like peptide INSL5,39930,0.0143610288290817,0.0103734015395157,-0.00597083818836918,0.0346928958465326,0.166260567131713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.00869616993816425,0.00628180873560456,-0.0210085150599492,0.00361617518362068,0.166281961416996
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFL4,Insulin growth factor-like family member 4,39657,0.00998243027097926,0.00724644714551102,-0.00422060613422234,0.0241854666761809,0.168366439724121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRAXIN,Draxin,42016,-0.00590632313052201,0.00428998729469326,-0.0143146982281208,0.00250205196707678,0.168606535515974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.00372678289375281,0.00270906760045481,-0.00903655539064425,0.00158298960313862,0.16894670969992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42185,0.00412412144470824,0.00300337481069286,-0.00176249318424976,0.0100107360736662,0.169724520459673
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GKN1,Gastrokine-1,41538,0.00391791055399244,0.00285952029899449,-0.00168674923203676,0.00952257034002165,0.170670534461953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA5,Protein disulfide-isomerase A5,39560,0.00855548134650866,0.00625312736484009,-0.00370064828857791,0.0208116109815952,0.171279906957919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42070,0.00333610260695375,0.00244139613621213,-0.00144903382002203,0.00812123903392953,0.171813268104864
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN7,Tetraspanin-7,39586,-0.0134866866981679,0.0098882897505148,-0.0328677346091769,0.00589436121284108,0.172625445972115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC1,Plexin domain-containing protein 1,41843,-0.00441279244208762,0.00324407249429215,-0.0107711745309002,0.00194558964672499,0.173769801464419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00542868166991545,0.00399256431836423,-0.0132541077339093,0.00239674439407843,0.173952991993056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MELTF,Melanotransferrin,39958,0.00412771979954287,0.00304252504652272,-0.00183562929164165,0.0100910688907274,0.174911240101685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GJA8,Gap junction alpha-8 protein,39560,-0.00858905896219316,0.00633107392018958,-0.0209979638457647,0.00381984592137841,0.1749200109279
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLFM4,Olfactomedin-4,39347,-0.0169995321934411,0.0125666999172769,-0.0416302640313038,0.00763119964442154,0.176165778089362
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH12,Protocadherin-12,39934,0.00349240924704731,0.00258320914250911,-0.00157068067227055,0.00855549916636517,0.176413378121945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,39990,0.00909273598244195,0.00672574786020821,-0.00408972982356614,0.02227520178845,0.176424759387718
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00360193745614995,0.00267197947054534,-0.00883901721841881,0.00163514230611892,0.177672054847321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.0406729611996057,0.0301738059823758,-0.0998136209250623,0.018467698525851,0.177695131183922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARCL1,SPARC-like protein 1,42169,0.00369292638456051,0.00275859754893958,-0.00171392481136106,0.00909977758048209,0.180691746789962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00940946821549343,0.00704133271592653,-0.0232104803387094,0.00439154390772257,0.181472662532189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0100296524622876,0.00753464573022169,-0.00473825316894694,0.0247975580935221,0.183170416284628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.00546925408577025,0.00411083625585165,-0.00258798497569898,0.0135264931472395,0.183397459140286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00325344164095711,0.00244688462394308,-0.00804933550388554,0.00154245222197133,0.183668255943738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,41843,0.00497702636303749,0.00374796599821713,-0.00236898699346809,0.0123230397195431,0.184225012331183
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.00403837958074738,0.00304417760956239,-0.0100049676954897,0.0019282085339949,0.184666490135726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR1,TGF-beta receptor type-1,39657,-0.00295644729955208,0.00222859853289456,-0.00732450042402542,0.00141160582492126,0.18467014326238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.00751694730927221,0.00567111787560934,-0.00359844372692208,0.0186323383454665,0.185039078029738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.00675947633009046,0.0051108215179662,-0.0167766865053042,0.00325773384512328,0.18600139308299
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,39649,0.00561575018935715,0.00425128530185676,-0.00271676900228211,0.0139482693809964,0.186544226552998
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA11,Integrin alpha-11,42119,-0.00450286495508727,0.00341153458095073,-0.0111894727337507,0.00218374282357616,0.186892668899694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDI2,Protein DDI1 homolog 2,39736,0.00999416550790066,0.00759936037563373,-0.00490058082834146,0.0248889118441428,0.188492467996087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL25,Interleukin-25,39510,0.00455151129664183,0.00348518220567069,-0.00227944582647272,0.0113824684197564,0.191593427383988
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD82,CD82 antigen,39757,-0.0054810023664671,0.00419850748093843,-0.0137100770291064,0.00274807229617224,0.191761655251967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,39889,-0.00359779964636526,0.00276236234394813,-0.00901202984050359,0.00181643054777307,0.192794016467282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN6,Prefoldin subunit 6,39649,0.00853106576386579,0.00656156643899903,-0.00432960445657231,0.0213917359843039,0.193574325503167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUCL3,Mucin-like protein 3,39560,-0.00561493913637749,0.004323266970645,-0.0140885423988417,0.00285866412608671,0.194049427283664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00666731089222903,0.00514594619591787,-0.00341874365176999,0.016753365436228,0.195125640868353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G1B,Phospholipase A2,42299,-0.00581655514404246,0.00449460753888809,-0.0146259859202631,0.00299287563217819,0.19564627917317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALY,RNA-binding protein Raly,39919,0.00627600835800048,0.00486753499598081,-0.0032643602341219,0.0158163769501229,0.197299061849834
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPE4,NXPE family member 4,39575,-0.00417837778891728,0.00324215465572744,-0.0105330009141431,0.00217624533630851,0.197506710688624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO1,Roundabout homolog 1,42144,0.00308743039721927,0.0024144983202374,-0.00164498631044603,0.00781984710488458,0.201022966776749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR2,Complement receptor type 2,42217,0.00601281418263473,0.00470711023376498,-0.00321312187554462,0.0152387502408141,0.201486473906047
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00446103396677828,0.0034988963845533,-0.0113188708805028,0.0023968029469462,0.20234216583287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00793996202148735,0.00623672856650036,-0.020163950011828,0.00428402596885335,0.203010498282207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00406355618381129,0.00319542968676933,-0.0103265983698792,0.00219948600225661,0.203514631614669
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,H2AP,Huntingtin-interacting protein M,39560,-0.00642643997280733,0.00511115777055248,-0.0164443092030902,0.00359142925747553,0.208658975412988
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD9,Enhancer of filamentation 1,39657,0.00431172827804726,0.00343257753017494,-0.00241612368109561,0.0110395802371901,0.20909911216781
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF7,Fibroblast growth factor 7,39560,-0.00988562555292929,0.00788505214870911,-0.0253403277643991,0.00556907665854056,0.209971552908261
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00464964567413335,0.00371419131543733,-0.0119294606523905,0.00263016930412381,0.210647565794213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00704184752126254,0.00565745291288936,-0.0181304552305257,0.00404676018800061,0.213267565399701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0084802036612293,0.00682674752098912,-0.00490022147990939,0.021860628802368,0.214187514835929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF1,Formylglycine-generating enzyme,39657,0.00831148930292235,0.0066979980347786,-0.0048165868452437,0.0214395654510884,0.214672134056778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300C,CMRF35-like molecule 6,42249,-0.00438081724161255,0.00355089466517588,-0.0113405707853573,0.00257893630213218,0.217327717722528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0066607625043506,0.005411550141418,-0.00394587577282867,0.0172674007815299,0.218403503218392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM19,Probable RNA-binding protein 19,39575,-0.00595312835135508,0.00487299079260678,-0.0155041903048644,0.00359793360215422,0.221863212210086
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00671355487647355,0.00549598096082044,-0.0040585678067345,0.0174856775596816,0.22190829698695
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM25,RNA-binding protein 25,39560,-0.00578837537072686,0.00475030478193912,-0.0150989727433275,0.00352222200187381,0.223049940040356
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNPO1,Transportin-1,39757,0.00435878428957032,0.00359497846520565,-0.00268737350223275,0.0114049420813734,0.225360241322614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00368044134329833,0.00304470380514565,-0.0096480608013838,0.00228717811478714,0.22676442823091
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.00358519209463889,0.00296626491380529,-0.00939907132569725,0.00222868713641947,0.226816397727231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB1,Scavenger receptor class B member 1,41839,0.00675960564006108,0.00559600620768516,-0.00420856652700182,0.017727777807124,0.227094263353176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.00834944150478717,0.00691458007238048,-0.00520313543707858,0.0219020184466529,0.227256426141856
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB39B,Ras-related protein Rab-39B,39575,0.0112812316949875,0.00935608225358667,-0.00705668952204235,0.0296191529120174,0.227934307282694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,39575,0.00477564641540324,0.00396845167931434,-0.00300251887605287,0.0125538117068594,0.228846387800124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB6,Ephrin type-B receptor 6,41997,0.00397932749074714,0.00330720890913066,-0.00250280197114895,0.0104614569526432,0.228909232269203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.00467863802385796,0.00389709622911318,-0.00295967058520388,0.0123169466329198,0.229948890621499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALMS1,Alstrom syndrome protein 1,39757,-0.00539648487924884,0.00449922682569739,-0.0142149694576157,0.00342199969911805,0.230388224641409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42119,0.00442832764011023,0.00369615940777236,-0.00281614479912358,0.0116728000793441,0.230903404654572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSD1,Tryptase delta,39934,-0.00442526865672421,0.00370452232952156,-0.0116861324225865,0.00283559510913804,0.232284567033854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA5,Annexin A5,41780,-0.00365495259059482,0.00306268534899031,-0.00965781587461582,0.00234791069342618,0.232741406501243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH23,Cadherin-23,39929,-0.00323563628690972,0.00271144757612409,-0.00855007353611293,0.0020788009622935,0.232767377445602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0048050446390359,0.00404017015093604,-0.0127237781348706,0.00311368885679874,0.23434037571982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLON5,IgLON family member 5,39560,-0.0111388699320963,0.00940002689273177,-0.0295629226418505,0.00728518277765799,0.236049951818503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX18,Sorting nexin-18,39930,0.00524718397019364,0.00442990690099231,-0.00343543355575129,0.0139298014961386,0.236243682479326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPE,Coatomer subunit epsilon,41839,0.00553465928731993,0.00467274035953534,-0.00362391181736934,0.0146932303920092,0.236253534370886
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6B,Ras-related protein Rab-6B,41839,0.0056388025492365,0.00477052395194844,-0.00371142439658243,0.0149890294950554,0.237223334312739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOS,Proto-oncogene c-Fos,39539,-0.00432379904424374,0.00366223265958825,-0.0115017750570367,0.00285417696854923,0.23776919289759
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR3,Folate receptor gamma,42132,-0.0228386671297129,0.0193612440827241,-0.0607867055318521,0.0151093712724263,0.238177129057031
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTR,Methionine synthase,39575,0.00775405272935601,0.00661990271230191,-0.00522095658675573,0.0207290620454678,0.241493887549184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0175355451330497,0.0149818400018559,-0.0118288612705878,0.0468999515366872,0.241839636717638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM2,Paralemmin-2,39929,0.00458887147266076,0.00392923800131408,-0.00311243500991483,0.0122901779552363,0.242880469149262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0072574358040972,0.00622514496757085,-0.00494384833234167,0.0194587199405361,0.243705691968008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCNA,Proliferating cell nuclear antigen,39560,0.00758079852701314,0.00654129728028617,-0.00524014414234776,0.020401741196374,0.246516644972539
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00538913411938774,0.00465060107662301,-0.0145043122295688,0.00372604399079335,0.246561201270014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.00438897493250881,0.0038111950755412,-0.00308096741555195,0.0118589172805696,0.249510278061951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN4,Prefoldin subunit 4,39560,-0.00616264482251814,0.00535467529228221,-0.0166578083953913,0.00433251875035499,0.249802402245388
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00563593120351831,0.00490844790984852,-0.00398462669978479,0.0152564891068214,0.250906754708554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL24,Interleukin-24,41913,-0.00556210029262354,0.00486557079293653,-0.0150986190467791,0.00397441846153206,0.252994908097551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00524219304038052,0.00459687658066788,-0.0142520711384896,0.00376768505772852,0.254152112496902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCIN,Adseverin,39586,-0.00852581179564951,0.0074792387402256,-0.0231851197264917,0.00613349613519268,0.254340140265243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0115104590667904,0.0101122934467999,-0.0313305542225183,0.00830963608893742,0.255035129658462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00397136017525217,0.00348915882918391,-0.0108101114804526,0.00286739112994829,0.255057006528888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFRC,Transferrin receptor protein 1,42200,-0.00429712040657749,0.00378031061008543,-0.0117065292023449,0.00311228838918995,0.255679174819818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKKL1,Dickkopf-like protein 1,42070,-0.00959160519102314,0.00845224123534588,-0.0261579980123011,0.00697478763025479,0.256479228119939
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMP,Olfactory marker protein,39586,-0.00550833264818529,0.00486009538924887,-0.0150341196111131,0.00401745431474249,0.257079637386888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.00925978037898106,0.00819158922789452,-0.00679573450769219,0.0253152952656543,0.258331844263963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAVL4,ELAV-like protein 4,39586,-0.00937037995814422,0.00830897772963238,-0.0256559763082237,0.00691521639193524,0.259453686139582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPF,Centromere protein F,39757,0.0061569592452199,0.00546309842027936,-0.00455071365852765,0.0168646321489675,0.259763056258831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.00413879861718634,0.00367899573536771,-0.00307203302413438,0.0113496302585071,0.260621157294538
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.00575819043522052,0.00511933273982176,-0.00427570173483013,0.0157920826052712,0.260696474332459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PREB,Prolactin regulatory element-binding protein,41913,0.0032130109613836,0.00286121268841285,-0.00239496590790558,0.00882098783067279,0.261477173851282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00445441865386795,0.00397007479408487,-0.0033269279425384,0.0122357652502743,0.261883003645698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNB2,Ephrin-B2,39649,-0.00653134104045951,0.00585355295752836,-0.0180043048372151,0.00494162275629607,0.264535921929026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLGAP5,Disks large-associated protein 5,39934,0.00558001852772563,0.00500633460068452,-0.00423239728961603,0.0153924343450673,0.265049102411646
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00564692267076175,0.00506657275726008,-0.0155774052749915,0.004283559933468,0.265069888174606
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.006221999878992,0.00558394566154546,-0.0171665333756211,0.00472253361763711,0.265189593093903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00407306479494278,0.00366284919657681,-0.0112522492202333,0.00310611963034777,0.266165104627278
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3A,Uroplakin-3a,39586,0.00545453000293563,0.00491014828285059,-0.00416936063145153,0.0150784206373228,0.266649184885199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00405315994178291,0.00366448287549944,-0.00312922649419598,0.0112355463777618,0.268722032324245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB1,Calbindin,42070,0.00504614659806135,0.00456645616680322,-0.00390410748887296,0.0139964006849957,0.269159159971685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAND5,DAN domain family member 5,39657,0.00612441101995998,0.00554416612386476,-0.00474215458281495,0.0169909766227349,0.269331568109184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.00386491996007147,0.0035074184569396,-0.0107394601356731,0.00300962021553014,0.270512883413589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX101,Testis-expressed protein 101,39649,0.00684607561470243,0.0062322550352459,-0.00536914425437953,0.0190612954837844,0.272014113291547
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300A,CMRF35-like molecule 8,39736,0.00340357755299152,0.00310234213651116,-0.00267701303457036,0.0094841681405534,0.272621685217758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,39929,0.00427678387426925,0.003918743339591,-0.00340395307132912,0.0119575208198676,0.275135005694667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDK,Midkine,42129,0.00560674811749033,0.00515977562581593,-0.0045064121091089,0.0157199083440896,0.277221337761934
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL14,C-C motif chemokine 14,42152,0.00441764528078071,0.00407723461428575,-0.00357373456321935,0.0124090251247808,0.27861000785345
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00565954960904538,0.00522395508291102,-0.00457940235346021,0.015898501571551,0.278661404791771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR1,Cadherin-related family member 1,41839,0.00449910829545107,0.00416607061570721,-0.00366639011133506,0.0126646067022372,0.28018835949745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00452892478053278,0.00419375225369242,-0.0127486791977699,0.00369082963670437,0.280200528156024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JUN,Transcription factor AP-1,41913,-0.00525974110546905,0.00487142446172758,-0.0148077330504551,0.004288250839517,0.280289491416262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00702724517377457,0.0065184966155186,-0.019803498540191,0.00574900819264189,0.281036354359664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00226046195272719,0.00210978795868276,-0.0063956463517454,0.00187472244629102,0.284005688337391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.0034249296921482,0.00320291842679253,-0.00970264980866156,0.00285279042436516,0.284947106562559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.0035538814186451,0.00332385068605281,-0.0100686287633086,0.00296086592601841,0.285000327156739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCL2,Phosducin-like protein 2,39560,-0.00564869890978951,0.00529780811952293,-0.0160324028240545,0.00473500500447543,0.286341723878757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.00541648811374629,0.00508417781686856,-0.00454850040731609,0.0153814766348087,0.286735002613791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20,Interleukin-20,41913,0.0050081512275977,0.00470758818601663,-0.0042187216169949,0.0142350240721903,0.287417536599096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG3,Secretogranin-3,42144,-0.0035641467911371,0.00335488895644489,-0.0101397291457691,0.00301143556349489,0.288084875418953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHIT1,Chitotriosidase-1,42207,-0.0167498648220606,0.0157813822981858,-0.0476813741265048,0.0141816444823837,0.288541224470692
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM3,Paralemmin-3,39575,-0.00813473655367656,0.00768522110016431,-0.0231977699099986,0.00692829680264547,0.289854995852311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00737604174146266,0.00698752831179154,-0.00631951374964876,0.0210715972325741,0.291173409630362
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD3,Extracellular superoxide dismutase,39990,-0.00648448375275593,0.0061483135209086,-0.0185351782537368,0.00556621074822493,0.291595527809156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENND2B,DENN domain-containing protein 2B,39575,-0.00521861786365261,0.00496526022197484,-0.0149505278987233,0.00451329217141808,0.293269764632269
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MENT,Protein MENT,39736,0.00252939768460748,0.00241217054168741,-0.00219845657709985,0.00725725194631481,0.294385842157547
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00553719974765488,0.0052849213906952,-0.00482124617810771,0.0158956456734175,0.294779614600365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMMT,MICOS complex subunit MIC60,39919,0.00472410631790741,0.00451216659323846,-0.00411974020483996,0.0135679528406548,0.295135437529399
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLNL,Mesothelin-like protein,39649,0.00401479868731685,0.00383693517752887,-0.00350559426063974,0.0115351916352734,0.295419764084914
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0031821665544672,0.00304370364998889,-0.00278349259951103,0.00914782570844543,0.295814495581543
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC44A4,Choline transporter-like protein 4,39649,-0.0072675515730655,0.00696245469457115,-0.020913962774425,0.00637885962829396,0.296591372720551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXOSC10,Exosome component 10,39575,-0.00611505628960795,0.00590722395090161,-0.0176932152333751,0.00546310265415921,0.300606384986502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNN,Tenascin-N,39966,-0.00452395213179528,0.00437448638181555,-0.0130979454401538,0.00405004117656319,0.301079815735256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASQ2,Calsequestrin-2,39575,0.00498011674611001,0.00482195744992634,-0.00447091985574562,0.0144311533479656,0.301720349603549
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTNNA1,Catenin alpha-1,39586,-0.00353727464659794,0.00342783800754744,-0.0102558371413909,0.00318128784819504,0.302129571915122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0080512984888011,0.00781183486504148,-0.00725989784668019,0.0233624948242824,0.302725684996548
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42212,0.00868605643129918,0.00843923353109456,-0.00785484128964615,0.0252269541522445,0.303381874061568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00593902487651071,0.00578873786701574,-0.0172849510958616,0.00540690134284014,0.304931956638463
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.00750481760912028,0.00732138256537152,-0.0218547274372485,0.0068450922190079,0.305359262752805
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTOA,Otoancorin,39586,-0.00544568197040993,0.00532607295537814,-0.0158847849629511,0.00499342102213122,0.306587044327281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.00777371007861937,0.00762091493806016,-0.00716328319997855,0.0227107033572173,0.307723649194341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00486291884805417,0.00476809509373949,-0.00448254753567524,0.0142083852317836,0.307803788977188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5A,Cytochrome b5,39560,-0.00735882247345953,0.00722251294980411,-0.0215149478550756,0.00679730290815653,0.308285816444733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI4,Protein-arginine deiminase type-4,41814,0.00749324779854811,0.00735928484428973,-0.00693095049625977,0.021917446093356,0.308600013457614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0078526443994693,0.00771901939775856,-0.00727663362013747,0.0229819224190761,0.309027896162421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD83,CD83 antigen,42119,0.00353003758149543,0.00347736938273902,-0.00328560640867305,0.0103456815716639,0.310054409383887
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHH,Sonic hedgehog protein,39657,-0.00438147755169235,0.00432490168767128,-0.0128582848595281,0.00409532975614337,0.311043439078312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.00322370348679705,0.0031916660712631,-0.00303196201287862,0.00947936898647272,0.312495289081692
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN8,Tetraspanin-8,39930,0.00974858941207784,0.0096622463603274,-0.00918941345416386,0.0286865922783195,0.313026814358065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.00863972609381363,0.00857741688199436,-0.0254514631825226,0.00817201099489532,0.313825792651641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXK,Tyrosine-protein kinase TXK,39757,-0.00743215163711854,0.00741948872727919,-0.0219743495425858,0.00711004626834867,0.316506989644526
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RYR1,Ryanodine receptor 1,39575,-0.00341620712140231,0.00342124454820501,-0.0101218464358841,0.00328943219307951,0.318045600358069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00440759002599891,0.00442010669247057,-0.0130709991432412,0.00425581909124342,0.318704148205715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.006089034544596,0.00614078481533668,-0.00594690369346388,0.0181249727826559,0.321427853304535
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0100522831750217,0.0101435641094407,-0.0299336688295255,0.00982910247948212,0.3217062275817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAX,Apoptosis regulator BAX,41814,0.00915774085323299,0.00924176503904677,-0.00895611862329867,0.0272716003297647,0.321748547128378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL25,C-C motif chemokine 25,42296,-0.00490502172850764,0.00495162792008838,-0.0146102124518809,0.00480016899486558,0.321904444477364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00619708944539642,0.00626924729008774,-0.00609063524317555,0.0184848141339684,0.322934406429589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NENF,Neudesin,39919,-0.0112160472721924,0.0113706002553536,-0.0335024237726854,0.0110703292283007,0.323954188611165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HK2,Hexokinase-2,41900,0.002709376566458,0.00275520785310078,-0.00269083082561953,0.00810958395853553,0.325445432554947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPS10,40S ribosomal protein S10,39575,-0.00415293592712431,0.00423117704008587,-0.0124460429256926,0.00414017107144399,0.326363715689437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5,Interleukin-5,41913,0.0136703264450661,0.0139389791686818,-0.0136500727255503,0.0409907256156825,0.326745446952417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,39560,0.00331710925926246,0.00339116487993224,-0.00332957390540473,0.00996379242392965,0.32801570429568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00471294901594991,0.00482707081481822,-0.00474810978109381,0.0141740078129936,0.328904864543164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00411833598661259,0.00421930272009798,-0.00415149734477945,0.0123881693180046,0.329050469956019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.00565924629268449,0.00582359644700717,-0.00575500274344958,0.0170734953288185,0.331178233417421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6,Seizure protein 6 homolog,39649,0.003074331979822,0.00316846761051969,-0.00313586453679659,0.00928452849644059,0.331923271836735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN4,Alpha-actinin-4,41913,0.00308247707094422,0.00318311993536665,-0.0031564380023744,0.00932139214426285,0.332871057263791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR1B,Cornifin-B,39757,-0.00845976183003835,0.00875441893028454,-0.025618422933396,0.00869889927331934,0.333894071469837
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP2,Dipeptidase 2,42070,0.00292590258807588,0.00303580580352339,-0.00302427678682997,0.00887608196298173,0.335164672272897
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF3,Neurotrophin-3,42119,0.00333921152492428,0.00346831372680343,-0.00345868337961044,0.010137106429459,0.335676833503528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.0037177992759478,0.00387240311872522,-0.0113077093886492,0.00387211083675362,0.337038379104394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00737320909649057,0.00772691593195826,-0.0225179643231288,0.00777154613014761,0.339990911205707
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00421390010173672,0.00443365564283119,-0.0129038651616859,0.00447606495821241,0.341911700361257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00565958323581904,0.00595494074998587,-0.00601210063415326,0.0173312671057913,0.341929307458286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR1,Toll-like receptor 1,39657,-0.00256835677797884,0.00271327714915033,-0.00788637999031349,0.00274966643435581,0.34386922356154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3,Galectin-3,42196,0.00282721050444648,0.00298817350201401,-0.00302960955950098,0.00868403056839394,0.344097407117699
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBZ,Hemoglobin subunit zeta,39958,-0.0102538660654992,0.0108625515801969,-0.0315444671626852,0.0110367350316867,0.345207727545796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOP56,Nucleolar protein 56,39575,-0.0107032322340693,0.0113514753974633,-0.0329521240130975,0.0115456595449588,0.345756140728239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.00289001225247881,0.00308180102294468,-0.00315031775249276,0.00893034225745037,0.348380609827559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPLX2,Complexin-2,39560,-0.00291494553020526,0.00311020166674348,-0.00901094079702248,0.00318104973661197,0.348665671058159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL21R,Interleukin-21 receptor,39657,-0.00513626652004913,0.00548889089026475,-0.015894492664968,0.00562195962486978,0.349418897558155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.00672153633675944,0.00718503105943563,-0.00736112453973439,0.0208041972132533,0.3495552477148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEF,Thyrotroph embryonic factor,39575,0.00404849439130729,0.00434001045603651,-0.00445792610252427,0.0125549148851388,0.350927979866486
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH15,Cadherin-15,42230,-0.00649413932692162,0.00697307272655199,-0.0201613618709635,0.00717308321712029,0.351706242800603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM2,Isthmin-2,39966,0.00408779009115608,0.00439238549588512,-0.00452128548077875,0.0126968656630909,0.352052460095006
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.00434792035619776,0.00467847684593917,-0.00482189426184302,0.0135177349742385,0.35273061768128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00319536087251463,0.00344214581529826,-0.00355124492546997,0.00994196667049922,0.353269194646769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA1,Laminin subunit alpha-1,39575,-0.00485407320147874,0.00523763674357418,-0.0151198412188841,0.00541169481592665,0.35406747400956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLN,Mesothelin,42048,-0.00539108679571079,0.00586646791320404,-0.0168893639055907,0.00610719031416912,0.358129638353116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00328666105777982,0.00357846782876208,-0.0103004580021535,0.00372713588659385,0.358397161094579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP12,Macrophage metalloelastase,42146,-0.005038547431957,0.00551440827966787,-0.015846787660106,0.00576969279619202,0.360887660408579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL6B,Myosin light chain 6B,39649,-0.00837816223587097,0.00923352322530385,-0.0264758677574665,0.00971954328572457,0.364234376590891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42262,-0.00562215507452001,0.00619933762289137,-0.0177728568153871,0.00652854666634707,0.36447774181147
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00294615446158626,0.0032510473756394,-0.00931820731783948,0.00342589839466697,0.364837116544261
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42296,0.00225319362881333,0.00248785175309328,-0.00262299580724951,0.00712938306487617,0.365122023305912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00355942831054631,0.00393325304706603,-0.00414974766170311,0.0112686042827957,0.365504168300128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC13,Mucin-13,41839,0.00479364715930825,0.00530337231497154,-0.00560096257803597,0.0151882568966525,0.366071982999239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.00509196853365531,0.0056396486512643,-0.00596174282282272,0.0161456798901333,0.366604777175392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00447315305737962,0.00495980701662558,-0.0141943748099658,0.00524806869520653,0.367140188444742
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH4,Cadherin-4,39586,0.00424088713255815,0.00471543119885983,-0.00500135801720711,0.0134831322823234,0.368478738136651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00238938600930224,0.00266393483243755,-0.00283192626227536,0.00761069828087985,0.369771349266415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.00243565670009228,0.00272155694419948,-0.00776990831072326,0.00289859491053871,0.370829825097325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPT,Microtubule-associated protein tau,41839,0.00476130439494116,0.00532205323704405,-0.00566991994966518,0.0151925287395475,0.370997565569175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0029792520707404,0.00333402956925118,-0.00355544588499192,0.00951395002647272,0.371557811210408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAEP,Glycodelin,42016,-0.00943199287310666,0.0105642743896252,-0.030137970676772,0.0112739849305587,0.371969719251275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,39919,-0.0032025541305415,0.00359899618344556,-0.0102565866500948,0.00385147838901179,0.373567230000394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.0026910620392646,0.00304508621155339,-0.00327730693538004,0.00865943101390924,0.376853059369382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00424228626879794,0.0048011271825071,-0.0136524955465119,0.00516792300891598,0.376930376431565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CADPS,Calcium-dependent secretion activator 1,39649,0.00363339839720949,0.00412780929043196,-0.00445710781203714,0.0117239046064561,0.378756910067717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLINT1,Clathrin interactor 1,39560,0.00444630586389115,0.00507030731201663,-0.00549149646766144,0.0143841081954437,0.380543744535003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.00740771770734956,0.00849029762983732,-0.0240487010618307,0.00923326564713158,0.382959057057244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDRG1,Protein NDRG1,41839,0.00579950862937238,0.00665001256317988,-0.00723451599446019,0.0188335332532049,0.383166961577596
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00358667974191529,0.00411282322162214,-0.0044744537724641,0.0116478132562947,0.383184136963533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_E,,42119,-0.00257296381888473,0.00295667914818922,-0.0083680549493356,0.00322212731156615,0.384195178954441
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00348209328224913,0.00400172748963084,-0.0113254791619256,0.00436129259742732,0.384238817785578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42032,0.00252096027444499,0.00290150340210391,-0.00316598639367867,0.00820790694256865,0.384946770406053
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00396640514169711,0.00457246512663229,-0.00499562650650218,0.0129284367898964,0.385711724790706
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD302,CD302 antigen,42070,0.00272554208463347,0.00314234482347087,-0.00343345376936945,0.00888453793863638,0.385760611897167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00274098019556705,0.00318236386030769,-0.00349645297063602,0.00897841336177011,0.389089291071923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,39649,0.00674674492264424,0.00783531950448025,-0.00861048130613706,0.0221039711514255,0.389219134790844
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00237707338232293,0.00277232761247238,-0.0078108355027688,0.00305668873812293,0.391222967152023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRING1,SREBP regulating gene protein,39560,-0.00539328120638962,0.00629816789343221,-0.0177376902775168,0.00695112786473751,0.391836531147556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.00709379283717901,0.00829647464069967,-0.0233548831329504,0.00916729745859235,0.392549021433481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A3,Protein S100-A3,39919,0.00369038225985382,0.00431853930093355,-0.00477395476997595,0.0121547192896836,0.392821673749597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGR,Progesterone receptor,39657,0.00868069654109463,0.0101600654983196,-0.0112330318356118,0.028594424917801,0.392905364002029
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPACAM2,HEPACAM family member 2,39929,0.00377486702125532,0.00442687629093448,-0.00490181050897625,0.0124515445514869,0.393834995629033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.0035685648988704,0.00419175096671177,-0.00464726699588466,0.0117843967936255,0.394604415112281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00623953793173602,0.0073346135028357,-0.020615380397294,0.00813630453382195,0.394955910145221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN1,Neuroligin-1,39649,0.00576119505216771,0.00679706464304445,-0.00756105164819942,0.0190834417525348,0.396678883219632
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC8,Histone deacetylase 8,39657,0.00517123264494874,0.00610393317808378,-0.00679247638409547,0.017134941673993,0.396903774546635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.00336927639052409,0.00398264617450433,-0.0044367101115044,0.0111752628925526,0.397573639060114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TET2,Methylcytosine dioxygenase TET2,39750,-0.00859643580033225,0.0101791777207533,-0.0285476241330088,0.0113547525323443,0.398401586056817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,39586,0.01002366183191,0.0119110129050437,-0.0133219234619758,0.0333692471257957,0.400060605286334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00361901562091406,0.00431801793817365,-0.0120823307797344,0.0048442995379063,0.401981768071843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPN1,Epsin-1,39757,0.00367217143426021,0.00438329232802004,-0.00491908152865906,0.0122634243971795,0.402180320042994
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFD,Vascular endothelial growth factor D,42275,-0.00325665375235791,0.00388983612073625,-0.010880732549001,0.00436742504428515,0.402482803424635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF830,Zinc finger protein 830,39919,-0.00653304211264234,0.0078517835523865,-0.0219225378753199,0.00885645365003519,0.405400748111633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKIV2L,Helicase SKI2W,39575,-0.00333576962819263,0.00401034744199215,-0.0111960506144973,0.00452451135811199,0.40554520231365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADM,Pro-adrenomedullin,42262,0.0021829401764187,0.00263824101162406,-0.00298801220636446,0.00735389255920186,0.408012040332461
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP1,Retinol-binding protein 1,39649,-0.00587935164586501,0.00710739461805709,-0.0198098450972569,0.00805114180552688,0.408132421390491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT1,Diamine acetyltransferase 1,39575,-0.00402036785672192,0.00490173777923723,-0.0136277739040269,0.00558703819058305,0.412124271587821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00403172691886572,0.00491635560529109,-0.00560433006750482,0.0136677839052363,0.412197336705863
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100P,Protein S100-P,41900,-0.00442691490937391,0.00540128981640622,-0.0150134429495301,0.00615961313078229,0.412456983729653
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.00500787427497096,0.00615201756499135,-0.0070500801524121,0.017065828702354,0.415647234933844
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,39638,0.00318168566757291,0.00391753240040634,-0.00449667783722351,0.0108600491723693,0.416714040053267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00468918330048208,0.00579242948321237,-0.0160423450875783,0.00666397848661417,0.418224128639223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN1,Cerebellin-1,39586,0.00758989499426807,0.00939157081726966,-0.0108175838075805,0.0259973737961166,0.419015788669986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.00866904327805272,0.0107368403142,-0.0297132502938847,0.0123751637377793,0.419447213267197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42145,0.00374169778814344,0.0046429031837076,-0.00535839245192346,0.0128417880282103,0.420316880629399
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.00455067600317981,0.00565483820724958,-0.00653280688302936,0.015634158889389,0.420983949110831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00377737139067054,0.00470607574470589,-0.00544653706895301,0.0130012798502941,0.422186159279295
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00338525389113855,0.00422898428592166,-0.011674063091545,0.00490355530926791,0.423444952355712
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00422164092866392,0.00528799750341678,-0.00614283417803298,0.0145861160353608,0.42468820538505
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00436760569727971,0.00547099259236268,-0.0150907511783106,0.00635553978375115,0.424701805504126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROS,Uroporphyrinogen-III synthase,39649,0.00533913587298106,0.00668913423672637,-0.00777156723100263,0.0184498389769648,0.42478296156475
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00394166209529035,0.00494896942673029,-0.00575831798110101,0.0136416421716817,0.425781250498908
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.00269059262853043,0.00338047496335827,-0.00393513829965179,0.00931632355671264,0.426091505536877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00221126188094434,0.00278333097975535,-0.00766659060126482,0.00324406683937614,0.426938359740611
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP6,Guanylate-binding protein 6,39575,-0.00358851318858791,0.00453118740712554,-0.012469640506554,0.00529261412937815,0.428401887394767
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00163839765965061,0.002068867261161,-0.00569337749152617,0.00241658217222495,0.428418592223476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHODH,Dihydroorotate dehydrogenase,39575,0.00372019039936337,0.00470793320285868,-0.00550735867823964,0.0129477394769664,0.429430333299195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCB,Calcitonin gene-related peptide 2,39929,0.00324258146121332,0.00411607996405282,-0.0048249352683302,0.0113100981907568,0.430839611009467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.00520846208581283,0.00663540357312247,-0.0182138530891329,0.0077969289175072,0.432496414790971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNW1,Interferon omega-1,39575,0.00276760553006117,0.00357567986550083,-0.00424072700632046,0.0097759380664428,0.438942615459578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSE,Cathepsin E,39736,0.00416625223373913,0.00538399075363823,-0.00638636964339179,0.0147188741108701,0.439052296168761
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPB41L5,Band 4.1-like protein 5,39649,-0.00485932173471895,0.00629257947149449,-0.0171927774988481,0.00747413402941024,0.439994442360408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,39649,0.0028532992187299,0.00371366593578829,-0.00442548601541515,0.0101320844528749,0.442311051998705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0056855981358244,0.0074218990283506,-0.00886132395974278,0.0202325202313916,0.443655701767164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP7,Dipeptidyl peptidase 2,42054,-0.00484230532012601,0.00634182886252964,-0.0172722898906841,0.00758767925043208,0.445148666261746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.0021689494002024,0.00284450782312275,-0.007744184733523,0.0034062859331182,0.445774962533863
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.00545826680912947,0.00720769657132458,-0.0195853520889256,0.00866881847066671,0.448896022733475
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TUBB3,Tubulin beta-3 chain,39586,-0.00219643055126054,0.0029013776227432,-0.00788313069183722,0.00349026958931614,0.44904799043888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.0049959484049224,0.00661832872023646,-0.0179678726965859,0.00797597588674107,0.450345586484454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.00431740737323414,0.00577912052400055,-0.00700966885380694,0.0156444836002752,0.455037071640634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00222204880437811,0.00298158342143456,-0.00806595231038984,0.00362185470163363,0.456131728294144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB118,Beta-defensin 118,39586,0.00429637980677246,0.00577645993679639,-0.00702548166934846,0.0156182412828934,0.457029213596039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBN,Ameloblastin,41913,-0.00204886735763819,0.00276042837461613,-0.0074593069718858,0.00336157225660942,0.45796227359896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00441095213287683,0.00599918787829453,-0.00734745610858044,0.0161693603743341,0.462197488426058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI2B,Protein EVI2B,39560,-0.00297826624529768,0.0040540860888155,-0.0109242749793761,0.0049677424887807,0.462578628642087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00363397930557549,0.00495202285836758,-0.00607198549682497,0.013339944107976,0.463063537315043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNG,Interferon gamma,41913,0.00841652519530625,0.0115226862723949,-0.0141679398985878,0.0310009902892003,0.465139737833255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00310406958073901,0.00425003380353915,-0.00522599667419773,0.0114341358356757,0.465183494627669
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3,Interleukin-3,39560,0.0045305027487922,0.00621359628071486,-0.00764814596140894,0.0167091514589933,0.465939370080725
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RA,Interleukin-17 receptor A,42137,0.00325693240595272,0.00447583656798311,-0.00551570726729418,0.0120295720791996,0.46682814788567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMD,Osteomodulin,42185,0.00301020487451708,0.00413732053862401,-0.00509894338118597,0.0111193531302201,0.466887232800893
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF3,Fibroblast growth factor 3,39657,0.00218114651981563,0.00300297596493417,-0.00370468637145535,0.0080669794110866,0.46765289027094
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHC1,SHC-transforming protein 1,39560,-0.0085953022936017,0.0118697014106986,-0.031859917058571,0.0146693124713676,0.468996450340092
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00561354556931169,0.00782843752649365,-0.0209572831212392,0.00973019198261586,0.473345566038923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00358483777904752,0.00501494753204755,-0.00624445938376568,0.0134141349418607,0.474728950443873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPT1,Translationally-controlled tumor protein,41913,0.0046170865922379,0.00646466560234302,-0.00805365798835441,0.0172878311728302,0.475113894316798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00192786523719049,0.00270590082228652,-0.00337570037449108,0.00723143084887206,0.4761907611092
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK11,Kallikrein-11,42062,-0.00230475872366212,0.00324955567142479,-0.00867388783965471,0.00406437039233045,0.478179463649264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNNI3,"Troponin I, cardiac muscle",41900,-0.00598701008750844,0.00847507882697571,-0.0225981645883808,0.010624144413364,0.479936067794121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00382670614179182,0.00545624287146669,-0.0145209421698665,0.0068675298862829,0.483102880016624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FH,"Fumarate hydratase, mitochondrial",39586,0.00583193864659637,0.0083411909189562,-0.0105167955545578,0.0221806728477505,0.484458486417408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SBSN,Suprabasin,39954,0.00251169825755438,0.00359529122503534,-0.00453507254351488,0.00955846905862364,0.484811517331885
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL2,Interferon lambda-2,39586,-0.00413108866445339,0.00593334325765732,-0.0157604414494617,0.00749826412055496,0.486287176064411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYDC1,Pyrin domain-containing protein 1,39638,-0.00290344089561247,0.00417415362893993,-0.0110847820083347,0.00527790021710979,0.48670907256777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB44,Ras-related protein Rab-44,39919,0.00315782431077238,0.00454013463555088,-0.00574083957490734,0.0120564881964521,0.486734120237171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42145,0.00221764214034763,0.00319453045901161,-0.00404363755931512,0.00847892184001038,0.48756887585198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSBP1,Heat shock factor-binding protein 1,39638,0.00674159982408688,0.00974152237049856,-0.0123517840220903,0.0258349836702641,0.488921823139455
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00454538266090196,0.00658871873934931,-0.0083685060682227,0.0174592713900266,0.490288294652376
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.00399812679633682,0.00582389207579043,-0.0154129552648861,0.00741670167221242,0.492409659513268
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSG,Basigin,42284,-0.00144542405003848,0.00210558410374001,-0.0055723688933689,0.00268152079329193,0.492427290674059
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00556409193965381,0.0081125922553356,-0.0214647727601116,0.010336588880804,0.492816470095646
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD9,COMM domain-containing protein 9,39919,0.0027434251272725,0.00403268148140707,-0.00516063057628535,0.0106474808308304,0.496329707717335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDNRB,Endothelin receptor type B,39657,0.00301550387884588,0.00444289141784746,-0.00569256330013514,0.0117235710578269,0.497325985392169
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GM2A,Ganglioside GM2 activator,39733,0.00263057744968535,0.00389985471563009,-0.00501313779294964,0.0102742926923203,0.499987048994176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG2,Secretogranin-2,42193,0.00222349192122787,0.00332655942259114,-0.00429656454705076,0.0087435483895065,0.503885884562701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTNL10,Butyrophilin-like protein 10,39560,-0.00269945803392794,0.00404627755895782,-0.0106301620494853,0.00523124598162939,0.504692902083309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00394684714472722,0.00593432016522911,-0.00768442037912184,0.0155781146685763,0.506005335306334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00360951902963939,0.00544688782176323,-0.00706638110101655,0.0142854191602953,0.507549949985088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.00283447779577376,0.00431089747005435,-0.0112838368370803,0.00561488124553277,0.510861355697658
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJP3,Tight junction protein ZO-3,39586,-0.0027631840639064,0.00421622515475038,-0.0110269853672171,0.00550061723940436,0.512243806026244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCF2,Neutrophil cytosol factor 2,42097,0.00547072264726923,0.00837505005287919,-0.010944375456374,0.0218858207509124,0.513627705398648
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00502402185463614,0.00769454612451908,-0.0100572885494213,0.0201053322586935,0.513813239277771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBS,Cystathionine beta-synthase,39638,-0.00339859565980887,0.00523525906934236,-0.0136597034357199,0.00686251211610215,0.516239225953439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00315366436127187,0.00489031831660017,-0.00643135953926445,0.0127386882618082,0.519018568331432
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSLP,Thymic stromal lymphopoietin,41900,-0.00391179113622065,0.00607878922835954,-0.0158262180238053,0.00800263575136404,0.519901177724959
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK4,Dickkopf-related protein 4,41992,-0.00297206385887688,0.00465247285807986,-0.0120909106607134,0.00614678294295965,0.522954995594659
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2,Apoptosis regulator Bcl-2,39930,0.00343404463572449,0.00540567900950137,-0.00716108622289819,0.0140291754943472,0.525267706749223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX33,Testis-expressed protein 33,39757,-0.00247874855317368,0.00390793303002378,-0.0101382972920203,0.00518080018567293,0.525906971685189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00200764986988932,0.00316546775545771,-0.00419666693080779,0.00821196667058643,0.525940824184551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCNE1,G1/S-specific cyclin-E1,39657,0.00586610734938932,0.00928720724909481,-0.0123368188588365,0.0240690335576152,0.527639721289643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00341759791727041,0.00543417710856574,-0.0140685850500593,0.00723338921551844,0.529421924079514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WIF1,Wnt inhibitory factor 1,42262,0.00213085435622751,0.00339350114044168,-0.00452040787903819,0.00878211659149321,0.530065469331866
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00160661175480735,0.0025781333130175,-0.00344652953870696,0.00665975304832165,0.533186693505409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.002294159709577,0.00369984604490973,-0.00954585795760008,0.00495753853844607,0.535225170825456
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00413972441089751,0.00670222475724229,-0.0172760849350924,0.00899663611329738,0.536809310111307
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP73,Tumor protein p73,39649,0.00214137705840347,0.00346761596641421,-0.00465515023576838,0.00893790435257533,0.536894090797088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG2,"Arginase-2, mitochondrial",39919,-0.00262844289125577,0.00426630064041021,-0.0109903921464598,0.00573350636394823,0.537844767970652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHD,SH2 domain-containing adapter protein D,39554,-0.00510126266318588,0.00835875544899668,-0.0214844233432194,0.0112818980168476,0.541682555024131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSCA,Prostate stem cell antigen,39930,0.0160555399393879,0.0263150245342459,-0.035521908147734,0.0676329880265099,0.54178908925538
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNLZ,DNL-type zinc finger protein,39586,0.0052099917362634,0.00856177561685697,-0.0115710884727763,0.0219910719453031,0.542856772135045
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL20,C-C motif chemokine 20,42296,0.00528257067861549,0.00872339687616849,-0.0118152871986748,0.0223804285559057,0.544814685314408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBR1,T-box brain protein 1,39649,0.00293010525902973,0.00485440299125149,-0.0065845246038232,0.0124447351218827,0.546123700586003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MN1,Transcriptional activator MN1,39649,-0.0035950364939695,0.00596011758374546,-0.0152768669581106,0.0080867939701716,0.546399906920295
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELB,Transcription factor RelB,39657,0.00286021807728871,0.00475559133724976,-0.00646074094372082,0.0121811770982982,0.547557162169397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLI2,Zinc finger protein GLI2,39657,-0.00200429220365894,0.00336501748281236,-0.00859972646997117,0.00459114206265328,0.551437234794747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.00525871488288535,0.00885831253899234,-0.0121035776935396,0.0226210074593103,0.552760063514156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC123,Cell division cycle protein 123 homolog,39560,0.0037419203353019,0.00636876703558382,-0.00874086305444238,0.0162247037250462,0.556851622098144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2A,Pancreatic alpha-amylase,41665,-0.00289738458869295,0.00493595236858763,-0.0125718512311247,0.00677708205373879,0.557216496277748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIT,Citron Rho-interacting kinase,39649,0.00270979912927417,0.004635917641238,-0.00637659944755231,0.0117961977061006,0.55888062722143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,39575,0.00229428549558799,0.00393883888197685,-0.00542583871308664,0.0100144097042626,0.560256978122882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFB,Vascular endothelial growth factor B,39657,0.00174362883566309,0.00299445914274363,-0.00412551108411442,0.0076127687554406,0.560386556447748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.00216978735957427,0.00380002009169665,-0.0096178267392997,0.00527825202015117,0.568013582187491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,39586,0.00343322743651224,0.00603215218373967,-0.00838979084361752,0.015256245716642,0.569262832470141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00407537592053391,0.00718688534943574,-0.018161671205428,0.0100109193643601,0.5706868266989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG1,Arginase-1,42015,0.00288531716715482,0.00510037160530527,-0.00711141117924351,0.0128820455135532,0.57160227122742
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.00281700727227916,0.00499199602200781,-0.00696730493085614,0.0126013194754145,0.572557887847553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00351674200513413,0.00623692315913972,-0.015741111397048,0.00870762738677972,0.572861959204171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY6D,Lymphocyte antigen 6D,42041,-0.00225417958928266,0.00400556040397132,-0.0101050779810664,0.00559671880250112,0.573605936517438
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAGE2A,G antigen 2A,39560,-0.0037234065624134,0.00663107070711512,-0.016720305148359,0.00927349202353224,0.574462007637836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.015088745702434,0.0269777387709684,-0.0679651136935321,0.037787622288664,0.575965904584504
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFC1,Cryptic protein,41843,0.00269382224184596,0.00481942074328499,-0.00675224241499263,0.0121398868986845,0.576204301945548
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A14,Protein S100-A14,39934,-0.00292318207760134,0.00524720357457155,-0.0132077010837616,0.0073613369285589,0.577474669593857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALCAM,CD166 antigen,42310,-0.00110569614269904,0.00198549981372882,-0.00499727577760753,0.00278588349220945,0.577614722667437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0029852530751742,0.00536748004049751,-0.00753500780420092,0.0135055139545493,0.578101074637022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GL3,Endophilin-A3,39690,0.00479811163385625,0.00863280627828444,-0.0121221886715813,0.0217184119392938,0.578358963703479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOC,Brother of CDO,41900,-0.00130134997235484,0.00234678809306232,-0.005901054634757,0.00329835469004731,0.579229711037749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTTG1,Securin,39757,0.00231862854139275,0.0042168461862382,-0.00594638998363413,0.0105836470664196,0.582433972290545
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00261080384620885,0.00475109880920827,-0.0119229575122571,0.00670134981983936,0.582662723281631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH3,Cadherin-3,42249,0.00202658800555464,0.00371227085804256,-0.00524946287620879,0.00930263888731806,0.585132611303588
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN10,Ataxin-10,41839,0.00403276311939763,0.00738839705927221,-0.0104484951167759,0.0185140213555712,0.585196243320708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIF,Leukemia inhibitory factor,41839,0.00274195267906505,0.00504285519751646,-0.00714204350806721,0.0126259488661973,0.586636301084961
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF20,Fibroblast growth factor 20,39657,-0.00235167196997951,0.00437556714478565,-0.0109277835737594,0.00622443963380037,0.590963935059417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBX2,Chromobox protein homolog 2,39575,0.00213996996132732,0.00400011930424903,-0.00570026387500079,0.00998020379765542,0.592676922267298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12B,Interleukin-12 subunit beta,42296,0.0029513940698553,0.00552527212355581,-0.00787813929231409,0.0137809274320247,0.593237668691621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH22,Cadherin-22,39757,0.00149197157604705,0.0027931473696959,-0.00398259726855692,0.00696654042065102,0.593245452096057
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHDC3L,KH domain-containing protein 3,39560,0.00361436351247921,0.00680837143794708,-0.00973004450589707,0.0169587715308555,0.59551928212623
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2B,Alpha-amylase 2B,41300,-0.00268711065049266,0.00506386172676746,-0.0126122796349569,0.00723805833397156,0.595674393076195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL2,Podocalyxin-like protein 2,42181,0.00152732607655399,0.00288068799498604,-0.00411882239361864,0.00717347454672662,0.595985476419684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13,Interleukin-13,41913,-0.00258645917857554,0.00490366803235394,-0.0121976485219893,0.00702473016483819,0.597887161902875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBA,Lysosomal acid glucosylceramidase,39649,0.00294840690172848,0.00561086303750769,-0.00804888465178659,0.0139456984552436,0.599258785888083
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUP50,Nuclear pore complex protein Nup50,39575,-0.00168889087507338,0.00321437546472568,-0.00798906678593572,0.00461128503578895,0.599303225917918
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFA,Protransforming growth factor alpha,42119,-0.00238921436252759,0.0045593577283563,-0.0113255555101059,0.00654712678505076,0.600270210859203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX2,Neuronal pentraxin-2,39966,0.00181305670801265,0.00346390510114098,-0.00497619729022367,0.00860231070624897,0.600696330987943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00152188561962587,0.00290824366117686,-0.00417827195628076,0.00722204319553251,0.600775300278208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00212633945456042,0.0040831082982983,-0.00587655281010425,0.0101292317192251,0.602541057845162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3B,Sodium channel subunit beta-3,39586,0.00245146925757731,0.00472229637437402,-0.00680423163619577,0.0117071701513504,0.603682976831434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OCLN,Occludin,39934,-0.00232572703955503,0.00448450263952077,-0.0111153522130157,0.00646389813390568,0.604039884143973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRN1,Neuritin,39934,0.00182717337100959,0.00352334367298558,-0.00507858022804215,0.00873292697006133,0.604056298239373
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.00197983154992752,0.00382488271501626,-0.00947660167135939,0.00551693857150436,0.604734571660867
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COLEC12,Collectin-12,42123,-0.00141610646132349,0.0027585946323086,-0.00682295194064836,0.00399073901800137,0.607719487777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42057,0.00245069310905644,0.00477459738623743,-0.00690751776796891,0.0118089039860818,0.607765690852704
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRP15,RRP15-like protein,39586,0.00468852652275945,0.00924386889065207,-0.0134294565029186,0.0228065095484375,0.612021926640505
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS8,Regulator of G-protein signaling 8,41913,-0.00326841108537364,0.00644784348563752,-0.0159061843172232,0.0093693621464759,0.612233465721568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3G,Semaphorin-3G,39736,-0.00231982454441747,0.00461871577303036,-0.011372507459557,0.00673285837072202,0.615490254722796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0023479961298562,0.00469122665902634,-0.00684680812183542,0.0115428003815478,0.616727437740406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5L,CD5 antigen-like,39925,0.002433236465588,0.0048705029362573,-0.00711294928947631,0.0119794222206523,0.617376122789839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF6,Fibroblast growth factor 6,39657,0.00197798375152996,0.00396129972075994,-0.00578616370115952,0.00974213120421944,0.617558999249073
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG3,Proteoglycan 3,39966,-0.00250392863853724,0.00503513893311761,-0.0123728009474478,0.00736494367037328,0.618993566022153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL33,Interleukin-33,41913,-0.00195242767770545,0.00398030880980676,-0.0097538329449267,0.0058489775895158,0.623772892094652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00204064070155929,0.00416100316318526,-0.00611492549828382,0.0101962069014024,0.623846111122676
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.00116933904461568,0.00238797009734004,-0.00584976043540216,0.00351108234617079,0.62436886429523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00338240972948661,0.00691541150619949,-0.0169366162816376,0.0101717968226644,0.624772125754353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00272704214865733,0.00557895357514589,-0.00820770685862862,0.0136617911559433,0.62498675542423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDM3A,Lysine-specific demethylase 3A,39657,-0.00438380765581667,0.00898906002416822,-0.0220023653031864,0.013234749991553,0.625784387619311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCLRE1C,Protein artemis,39560,0.00150440171471165,0.00308881966338382,-0.00454968482552063,0.00755848825494394,0.626234451462451
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00248182346385879,0.00511933611815226,-0.0125157222554372,0.00755207532771964,0.62783215049797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00287231697007935,0.00603689831087184,-0.00896000371922946,0.0147046376593882,0.634230984914081
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00125376077790376,0.002635203577935,-0.00641875979065635,0.00391123823484884,0.63424469262044
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTF,Ciliary neurotrophic factor,39586,0.00165560344222378,0.00350254884101571,-0.00520939228616702,0.00852059917061458,0.636447086912499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00283655133194575,0.00603098265470706,-0.00898417467128009,0.0146572773351716,0.638128638232962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00145317091128185,0.00308970052541457,-0.00750898394109442,0.00460264211853071,0.638130460908003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.00330046443361496,0.00702212512263232,-0.0170638296739743,0.0104629008067444,0.638357610120211
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17F,Interleukin-17F,41913,-0.00348011064739269,0.00740541112253783,-0.0179947164475668,0.0110344951527815,0.638404449573639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00175336290467162,0.00373281209692739,-0.00906967461464932,0.00556294880530607,0.638566671123241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STEAP4,Metalloreductase STEAP4,39586,0.00346121988968919,0.00737960856601336,-0.011002812899697,0.0179252526790754,0.639061172197069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36A,Interleukin-36 alpha,39657,-0.00272504212798521,0.00582395223447349,-0.0141399885075533,0.00868990425158284,0.639863498740554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNL1,Thioredoxin-like protein 1,39570,-0.00481481055053176,0.0103103617581926,-0.0250231195965893,0.0153934984955258,0.640518061908735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TG,Thyroglobulin,39919,-0.00491429977117923,0.0105974036578073,-0.0256852109404815,0.0158566113981231,0.642852432068039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00253451827647506,0.00549263522686735,-0.0133000833211351,0.00823104676818495,0.644492470138403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD2,Bromodomain-containing protein 2,39586,-0.00163326981680357,0.00355098925861727,-0.00859320876369342,0.00532666913008628,0.645562767164313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS2,Podocin,39657,-0.0047392847096223,0.0103303272241339,-0.0249867260689248,0.0155081566496802,0.646405542846994
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APLP1,Amyloid-like protein 1,42145,-0.00234919360011961,0.00512610297851473,-0.0123963554380085,0.00769796823776926,0.646758204966322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMPD3,AMP deaminase 3,39929,-0.00316788533050597,0.00698156044603043,-0.0168517438047256,0.0105159731437137,0.6500172315618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BEX3,Protein BEX3,39560,-0.00215181310429165,0.00474583532729391,-0.0114536503457877,0.00715002413720442,0.650261920643893
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALLD,Palladin,39657,0.00174866262518741,0.00386557811698575,-0.00582787048410466,0.00932519573447948,0.651012997137101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMA1,Proteasome subunit alpha type-1,41843,0.00210638625802776,0.00466315538986806,-0.00703339830611364,0.0112461708221692,0.651486494697434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFD,Complement factor D,39979,0.000925116166708942,0.00205418878684257,-0.00310109385550249,0.00495132618892037,0.652462373479643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXDNL,Peroxidasin-like protein,39919,-0.00258902153557053,0.00578868127131402,-0.013934836827346,0.00875679375620495,0.654698901913698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCP2,Non-specific lipid-transfer protein,41843,0.00332601048143123,0.00747586818039541,-0.0113266911521438,0.0179787121150062,0.656399610103322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMH,Granzyme H,41900,-0.00352896743549881,0.00794351718344994,-0.0190982611150607,0.0120403262440631,0.656863620803979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POSTN,Periostin,39966,-0.00169714020672596,0.00382989534852878,-0.00920373508984236,0.00580945467639045,0.65768038982991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00279160775432902,0.00637002275958527,-0.0152768523631162,0.00969363685445811,0.661219918635907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00244559391102302,0.00559451865385041,-0.00851966265052378,0.0134108504725698,0.662017639559243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENG,Endoglin,42310,-0.00075734658488443,0.0017431391723812,-0.00417389936275158,0.00265920619298272,0.663951968546118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2,Interleukin-2,41913,-0.00139473867417738,0.00322693731366477,-0.00771953580896033,0.00493005846060557,0.665590365285984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANK2,Ankyrin-2,39575,-0.00298453051873508,0.00708335601576816,-0.0168679083096407,0.0108988472721705,0.67351205728798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.00341105150727987,0.00812230592176656,-0.0193307711139423,0.0125086680993826,0.674520639257483
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00318524374451706,0.00764781935611314,-0.0118044821934647,0.0181749696824988,0.677059049492413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00252412076554298,0.00608228555821454,-0.00939715892855751,0.0144454004596435,0.678151966736043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA2,GDNF family receptor alpha-2,42070,0.000871271039751267,0.00210684083709405,-0.00325813700095307,0.0050006790804556,0.679214796690156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN15,Tetraspanin-15,39575,-0.00210217939894248,0.00509639797881494,-0.0120911194374198,0.0078867606395348,0.679993226327527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR1,Interferon gamma receptor 1,42185,-0.000898298866208768,0.00218065311640903,-0.00517237897437047,0.00337578124195293,0.680389691936131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.00276676966620789,0.0068418288831541,-0.0106432149447741,0.0161767542771899,0.685932094833257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0025907403039314,0.00646817018773681,-0.0152683538718955,0.0100868732640327,0.688768724109255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK1,Cyclin-dependent kinase 1,39560,0.00147359965443814,0.00370179643283961,-0.00578192135392749,0.00872912066280378,0.690581253854519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.00205704923917445,0.00522646016399295,-0.00818681268225173,0.0123009111606006,0.69389479467755
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC2,Plexin domain-containing protein 2,39929,-0.00108191034609184,0.0027771059695546,-0.00652503804641885,0.00436121735423517,0.696853027916223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9orf40,Uncharacterized protein C9orf40,39930,-0.00304766428958753,0.00787518561693766,-0.0184830280987853,0.0123876995196103,0.698766535721445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD2,Leiomodin-2,39586,-0.00241092632503969,0.00623296926742239,-0.0146275460891876,0.00980569343910819,0.698910128366491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00188125670757034,0.004891161859737,-0.00770542053751418,0.0114679339526549,0.700523704810013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QSOX1,Sulfhydryl oxidase 1,39767,0.00155433771312301,0.00404578507204069,-0.00637540102807675,0.00948407645432277,0.700847225915208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42118,-0.00186334501150473,0.0048958939772503,-0.0114592972069153,0.00773260718390586,0.703510948042749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.00192025742871065,0.00506594959255846,-0.0118495186301252,0.00800900377270392,0.704655459824209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00105096488111166,0.00278568110597711,-0.00440897008660348,0.00651089984882681,0.705975933065553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA6,Carbonic anhydrase 6,42103,-0.00236526111813543,0.00631712485038331,-0.0147468258248867,0.0100163035886159,0.708097364409459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.00230794237105957,0.00616977940609682,-0.0097848252648902,0.0144007100070093,0.708356559286952
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESR1,Estrogen receptor,39657,0.00214093486231117,0.00579451308638687,-0.00921631078700709,0.0134981805116294,0.711779861322312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTKN2,Rhotekin-2,39575,-0.00190329398887689,0.00516052178005845,-0.0120179166777915,0.00821132870003768,0.712270405000117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00168057929037728,0.00457874253727162,-0.0072937560826751,0.0106549146634297,0.71359659156115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00187089614544989,0.00512990379266699,-0.00818371528817742,0.0119255075790772,0.715338239442868
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRC1,Protein regulator of cytokinesis 1,39919,0.00161377250374692,0.00446185257120077,-0.00713145853580659,0.0103590035433004,0.717596306494649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBN2,Fibrillin-2,39649,-0.00216841047222474,0.00607918499497844,-0.0140836130623825,0.00974679211793301,0.7213275047234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00147166637846095,0.00414061569369469,-0.00664394038118064,0.00958727313810254,0.722278887968396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YAP1,Transcriptional coactivator YAP1,39929,-0.000993527452778691,0.00279637291879545,-0.00647441837361777,0.00448736346806039,0.72237785734714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL2,Fc receptor-like protein 2,42229,-0.00178935566833928,0.00504705328697982,-0.0116815801108197,0.00810286877414116,0.722943667433595
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42129,0.0026727743757976,0.00769841893405699,-0.0124161267349541,0.0177616754865493,0.728457856707292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0012441665702125,0.00360001351134576,-0.00830019305245018,0.00581185991202519,0.729648415049542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00168463807698354,0.00490198033482305,-0.0112925195332367,0.00792324337926964,0.731104971523212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,41900,0.00179577488602375,0.00523194655112065,-0.00845884035417272,0.0120503901262202,0.731428867830007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL11,Interleukin-11,41913,0.002105731929894,0.00614729904289313,-0.00994297419417653,0.0141544380539645,0.731945534229938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL28,C-C motif chemokine 28,42075,0.00200083739859751,0.00593474485223925,-0.00963126251179142,0.0136329373089864,0.736016931020108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPGN,Epigen,39919,-0.00157747210459881,0.00468499543948768,-0.0107600631659947,0.00760511895679704,0.736343811752374
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00124748922500746,0.00371246320773147,-0.00602893866214622,0.00852391711216114,0.736856612401861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D17,TBC1 domain family member 17,41839,0.00145645251551334,0.00433763881613321,-0.00704531956410776,0.00995822459513444,0.737049021621428
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL9,Interleukin-9,39757,-0.00188200992050669,0.00568970247462297,-0.0130338267707677,0.00926980692975433,0.740820845406787
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00239952063123946,0.00732455591047226,-0.0167556502157651,0.0119566089532862,0.743220669700551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC16A1,Monocarboxylate transporter 1,41839,0.00179289434952633,0.00555251130169978,-0.00909002780180524,0.0126758165008579,0.746777651073284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM2,Junctional adhesion molecule B,42249,-0.000888860973523274,0.00275349841728817,-0.00628571787140809,0.00450799592436154,0.746842942654808
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42281,0.00167983136027483,0.00525123166178983,-0.00861258269683324,0.0119722454173829,0.749054457793324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYY,Peptide YY,39575,-0.00323307567117722,0.0101430781922322,-0.0231135089279523,0.0166473575855978,0.749924442398756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTN,Neuroplastin,41843,-0.00249251442368543,0.00788757368937419,-0.0179521588548588,0.012967130007488,0.752003529499224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD10,Frizzled-10,39649,-0.00187448156563883,0.00603595707495309,-0.0137049574325469,0.00995599430126923,0.756146699209026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPBGL,Trophoblast glycoprotein-like,39649,-0.00127402616444785,0.0041126345436061,-0.00933478986991581,0.0067867375410201,0.756731471327356
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPA33,Cell surface A33 antigen,42070,-0.00416199181566369,0.0134966497126012,-0.0306154252523621,0.0222914416210348,0.757803887486541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0012173751416764,0.00396914500631172,-0.00656214907069457,0.00899689935404738,0.759070005564693
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00124508551142682,0.00409361401867094,-0.00677839796516822,0.00926856898802186,0.761016959763093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00124296327016792,0.00409153132451364,-0.00677643812587881,0.00926236466621465,0.761294209062657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.00100312163596076,0.00331922941280812,-0.00550256801314314,0.00750881128506467,0.762492645650886
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC9,Histone deacetylase 9,39586,-0.00204083860246859,0.00676296948898535,-0.0152962588008799,0.0112145815959427,0.762835672702461
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPEP,Glutamyl aminopeptidase,39575,0.00129715570436983,0.00430044985348945,-0.00713172600846949,0.00972603741720915,0.762937897954431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.0012891192374545,0.0042740141041677,-0.0070879484067142,0.0096661868816232,0.762948968255883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00212866035907604,0.00709126232866618,-0.0117702138051097,0.0160275345232617,0.764044802083747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAU,Urokinase-type plasminogen activator,42137,-0.000860398395713278,0.00288081166031401,-0.00650678924992874,0.00478599245850218,0.765200042141214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42262,-0.00110383905046826,0.0037058790231266,-0.0083673619357964,0.00615968383485989,0.765813327338789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.00083717936259181,0.00282100657268167,-0.00469199351986426,0.00636635224504788,0.766649522875823
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHP1,Calcineurin B homologous protein 1,39586,0.00220283858548292,0.00748150210896924,-0.0124609055480968,0.0168665827190626,0.768428789443467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00106275773481286,0.00362380306281851,-0.00603989626831142,0.00816541173793715,0.769320270695905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00197489128162047,0.00691469898153316,-0.0155277012854255,0.0115779187221845,0.775183994163683
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00185456669083691,0.00651336069458618,-0.0146207536522258,0.010911620270552,0.775854325897354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD5,Sushi domain-containing protein 5,39695,0.000992102972448287,0.00349451411181319,-0.00585714468670557,0.00784135063160215,0.776490029795882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00144114745151689,0.00511049693168926,-0.0114577214376278,0.00857542653459406,0.777950654050137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSF,Cathepsin F,42181,-0.00112274157352385,0.00406455121528982,-0.0090892619554919,0.0068437788084442,0.782377397599751
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00205777543458238,0.00757258379499582,-0.0169000396727742,0.0127844888036094,0.785826900144039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42145,0.000479645109783611,0.00177016710640179,-0.00298988241876391,0.00394917263833113,0.786425651961116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200,OX-2 membrane glycoprotein,42119,0.000735706105128598,0.00274002888226129,-0.00463475050410354,0.00610616271436073,0.788316226330869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP2,Guanylate-binding protein 2,41913,0.00164161133733559,0.00611969063306393,-0.0103529823034697,0.0136362049781409,0.788510502549635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.00227422023388943,0.00849612263322895,-0.0143781801272393,0.0189266205950182,0.788952664663665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.00233518331855964,0.00876452476861726,-0.0195136518650495,0.0148432852279302,0.789908605510395
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00140769255392363,0.00543834495049343,-0.0120668486568908,0.00925146354904349,0.795759095667506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB2,Beta-crystallin B2,39929,-0.00182008977638025,0.00708656272504537,-0.0157097527174692,0.0120695731647087,0.79730945896352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31,Interleukin-31,39657,0.00144007813142181,0.00563652749689503,-0.00960751576249244,0.0124876720253361,0.798349182662974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00122046999716166,0.00487833693857707,-0.0083410704024494,0.0107820103967727,0.802451472726733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00160986727707684,0.00644280364355887,-0.0142377624184522,0.0110180278642986,0.802692095163489
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.000930471876598178,0.00373531104379614,-0.00825168152243861,0.00639073776924226,0.803286051394274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.00260752618704905,0.0106036995505223,-0.0233907773060727,0.0181757249319746,0.805757823086273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR3,Small proline-rich protein 3,39929,-0.00156566889543098,0.00638484160319375,-0.0140799584376907,0.0109486206468288,0.80629319613328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGB,Secretogranin-1,42210,-0.00104098151446879,0.00426366212932835,-0.00939775928795235,0.00731579625901477,0.807116803043744
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00190261498616359,0.00780521716055262,-0.0133956106485196,0.0172008406208467,0.807419713592039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00078294844997804,0.00321594922407389,-0.00552031202920679,0.00708620892916287,0.807655191174217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00170970084265763,0.00706986415796571,-0.0121472329069551,0.0155666345922704,0.808916862993056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTLA,B- and T-lymphocyte attenuator,39560,0.00209841923057391,0.00869374789592647,-0.014941326645442,0.0191381651065898,0.809272048237931
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.00081859431053898,0.00339438975411937,-0.00583440960753498,0.00747159822861294,0.809434727389149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.000531578980728221,0.00223118019286195,-0.00490469215873764,0.0038415341972812,0.811690765162738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00148592472450643,0.00627841989062964,-0.0137916277101405,0.0108197782611277,0.812915151268748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.000915157023658954,0.00387155866592665,-0.00667309796155728,0.00850341200887519,0.813142504414509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00137246154159738,0.00580982608183371,-0.0127597206619914,0.0100147975787967,0.813257764967634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.000668449768400156,0.00285651698737728,-0.00626722306365962,0.00493032352685931,0.814981777045448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00133289127762066,0.00569762240689959,-0.00983444863990253,0.0125002311951439,0.815037360407209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.00083906837878368,0.003608916011999,-0.00623440700473437,0.00791254376230173,0.81615419059755
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAPPA,Pappalysin-1,41913,-0.00110791036820204,0.00478667289911169,-0.0104897892504609,0.00827396851405687,0.8169631143695
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH4,Myosin-4,39575,-0.00106522197375537,0.00464358123519046,-0.0101666411947287,0.00803619724721793,0.818564915278062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000657179336236312,0.00288627905640389,-0.00631428628678795,0.00499992761431532,0.819890671903036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAP1,Antigen peptide transporter 1,39757,-0.00134008051991944,0.00591164018929171,-0.0129268952909312,0.0102467342510923,0.820672796876788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42145,-0.00175387566242971,0.00774027519707813,-0.0169248150487028,0.0134170637238434,0.820745314486565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD6,MICOS complex subunit MIC25,39919,0.000660779534444005,0.00293740918268549,-0.00509654246361956,0.00641810153250757,0.822019759033739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKZF2,Zinc finger protein Helios,41843,0.0019931681307362,0.00895330770584784,-0.0155553149727256,0.019541651234198,0.823836200416237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.00118915401473155,0.00543675482674735,-0.00946688544569326,0.0118451934751564,0.826868237963621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRX,Cone-rod homeobox protein,41900,-0.00236503999842121,0.0108546944549041,-0.0236402411300333,0.0189101611331909,0.8275245769553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC1A4,Neutral amino acid transporter A,39649,-0.0011072566290688,0.00514093192761551,-0.0111834832071952,0.00896896994905759,0.829474626141341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.0019951547163083,0.00928654727309127,-0.0201967873715672,0.0162064779389506,0.829893300502725
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00142769356685981,0.00668557331798147,-0.0145314172701035,0.0116760301363839,0.830903199066741
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000648571869107029,0.00306202878593298,-0.00665014828953568,0.00535300455132162,0.832258159454202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO1,Alpha-enolase,42119,-0.00168015914884866,0.00793522541724773,-0.0172332009666542,0.0138728826689569,0.83231754358522
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTH3,Cytohesin-3,39560,-0.00155526501032571,0.00741638253761649,-0.016091374784054,0.0129808447634026,0.833900504023463
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.00158270942029574,0.00757167140468843,-0.0132577665328936,0.0164231853734851,0.83442826406742
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RUVBL1,RuvB-like 1,41843,-0.00204404360032618,0.00996839084483299,-0.0215820896561988,0.0174940024555465,0.83753424806422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0009871306207084,0.00491243471753162,-0.00864124142565358,0.0106155026670704,0.840744362935789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSTB,Cystatin-B,41959,-0.000877742645319908,0.00437832770354875,-0.00945926494427545,0.00770377965363564,0.841112624525906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00076595943893754,0.00384577332898095,-0.00677175628586512,0.0083036751637402,0.842133534077564
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.000817828899331294,0.00413367867279134,-0.00891983909800233,0.00728418129933974,0.843169087386331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN2,Contactin-2,42262,0.000872767390835635,0.00443830702888366,-0.00782631438577634,0.0095718491674476,0.844108894417424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00102287216588643,0.00522714489861808,-0.0112680761671779,0.009222331835405,0.844860681150144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.000715249249763492,0.00367198270602571,-0.00791233535357389,0.00648183685404691,0.845563790535663
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00122721710636068,0.00634762243317464,-0.0112141228626616,0.013668557075383,0.846700227307735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.000970389504647647,0.00507516840799603,-0.00897694057502457,0.0109177195843199,0.848369765656135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.000728594169441763,0.00381316460039199,-0.00820239678621006,0.00674520844732654,0.848470988657003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHB,Lutropin subunit beta,41843,0.00168418235221604,0.00891165745774594,-0.015782666264966,0.0191510309693981,0.850106346375456
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.000757875033485747,0.00404239419142266,-0.00716521758170266,0.00868096764867416,0.851286394053792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42100,0.000327376169960729,0.00175549063734052,-0.00311338547922669,0.00376813781914815,0.852065680247521
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDSN,Corneodesmosin,42246,0.000816344822647477,0.00441441435867408,-0.00783590732035372,0.00946859696564868,0.853288967121839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP1,Caspase-1,41839,-0.00127209147530698,0.00693996395025998,-0.0148744208178165,0.0123302378672026,0.854565884176575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.000654356683393459,0.00359682165343708,-0.00770412712413014,0.00639541375734322,0.855643299141654
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGEA3,Melanoma-associated antigen 3,39757,-0.00158837302497801,0.00873129893876614,-0.0187017189449596,0.0155249728950036,0.855651049629356
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42145,-0.000525895806287938,0.0028974030238471,-0.00620480573302825,0.00515301412045237,0.855973201413671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRXN3,Neurexin-3,39649,0.000659293645017823,0.00363901160057779,-0.00647316909211464,0.00779175638215029,0.856234463609683
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSND,Barttin,39560,0.000610652806774172,0.00340448505295521,-0.00606213789701805,0.00728344351056639,0.857652733342862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPTC,Opticin,42070,0.000800325111458673,0.00458008673799136,-0.00817664489500439,0.00977729511792173,0.861286432556934
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1,Huntingtin-interacting protein 1,39575,-0.000577156447313878,0.00333874043655612,-0.00712108770296388,0.00596677480833613,0.862759534691359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.000869519753844249,0.00503560446851857,-0.0107393045121406,0.00900026500445214,0.862910563142644
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.000604064658259362,0.00350311777882838,-0.00626204618824426,0.00747017550476298,0.863097715205801
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.000597886826485689,0.0034854248883885,-0.00623354595475577,0.00742931960772714,0.863803011098816
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4C,Semaphorin-4C,42070,0.000477786047096392,0.00281031041431569,-0.00503042236496235,0.00598599445915514,0.865003377715621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,41839,-0.000668187472298809,0.00401568266224649,-0.00853892549030193,0.00720255054570432,0.867849050148483
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX2,Peroxiredoxin-2,39819,-0.00101221619002972,0.00610931835565711,-0.0129864801671176,0.0109620477870582,0.868408638041017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.000821596219239489,0.00503478669179682,-0.00904658569668227,0.0106897781351613,0.870376632512967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REST,RE1-silencing transcription factor,39560,0.00056194469864457,0.00347314113969794,-0.0062454119351634,0.00736930133245254,0.871468498113263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESPL1,Separin,39560,0.000869322581776318,0.00541500956921064,-0.00974409617387654,0.0114827413374292,0.872459117786157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB6,Heat shock protein beta-6,42262,-0.000655270894727379,0.0041017011316485,-0.00869460511275845,0.00738406332330369,0.873075737919951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCARE,Photoreceptor cilium actin regulator,39586,-0.00133206991074107,0.00843817971670912,-0.0178709021554909,0.0152067623340088,0.874568258136532
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRV1,Acrosomal protein SP-10,39657,0.00169643777123777,0.0107763585916713,-0.019425225068438,0.0228181006109135,0.874915015353271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.000574187395651827,0.00369313957798576,-0.00666436617720026,0.00781274096850391,0.876450463489461
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB116,Beta-defensin 116,39586,-0.00117968801026669,0.00761061861153902,-0.0160965004888832,0.0137371244683498,0.87681980126115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSTN,Osteocrin,39649,-0.000625113866800415,0.00409423921248585,-0.00864982272327267,0.00739959498967184,0.878652376710297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC1,Syndecan-1,42145,0.000621413202020858,0.0040827240670021,-0.00738072596930326,0.00862355237334497,0.879027095266198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.000628115751488776,0.00424438561139296,-0.00769088004684143,0.00894711154981898,0.882354925670691
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00071353696642697,0.00486223456311752,-0.0102435167101373,0.00881644277728337,0.883331346408437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000648075608240399,0.0044638935245204,-0.00810115569981958,0.00939730691630038,0.884570091279047
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN1,Prorelaxin H1,39934,0.000629958412551304,0.00449003539191619,-0.00817051095560443,0.00943042778070704,0.888424323027399
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.000556202076558794,0.00401519926106492,-0.00731358847512845,0.00842599262824604,0.889828646558877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLMP,CXADR-like membrane protein,42262,-0.00030854844220128,0.00223185692899227,-0.00468298802302613,0.00406589113862357,0.890046923694961
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.000619260508696898,0.00451349480491464,-0.0082271893089358,0.0094657103263296,0.890873171507248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42137,0.000716112122238425,0.00525772909967466,-0.0095890369131239,0.0110212611576008,0.891663784315898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORN4,MORN repeat-containing protein 4,39560,-0.00106366242265757,0.00794111491697304,-0.0166282476599247,0.0145009228146096,0.893449542511225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF75D,Zinc finger protein 75D,39757,-0.000781513198733531,0.00619779985519981,-0.0129292009149252,0.0113661745174581,0.899658789722121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN7,Septin-7,39757,0.000676685761350373,0.00539141841943176,-0.00989049434073587,0.0112438658634366,0.900120772870136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD4,Sushi domain-containing protein 4,39919,0.000489064892155686,0.00389829708350624,-0.00715159739151654,0.00812972717582791,0.90016475765273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCLN,Nicalin,41913,0.000645503266798854,0.00516744259646922,-0.00948268422228081,0.0107736907558785,0.90059086391594
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.000341766329494743,0.00278413331616955,-0.00579866762918707,0.00511513497019758,0.902302912717683
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.000532747769570823,0.00437525276998006,-0.00910824319873174,0.0080427476595901,0.903087855437139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.000557047907981542,0.00462861490327711,-0.00962913311840468,0.0085150373024416,0.904209045469364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.000831425463610902,0.00701059119089106,-0.0145721841977574,0.0129093332705356,0.905597864456984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD8,Frizzled-8,39586,0.000515979272261197,0.00436527181021593,-0.00803995347576202,0.00907191202028442,0.905910598705176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MKI67,Proliferation marker protein Ki-67,39657,0.00048725918882644,0.00412637470456848,-0.00760043523212779,0.00857495360978067,0.906003177055809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00204102438236245,0.0174310072093247,-0.0321237497479139,0.0362057985126388,0.906789548031975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCP11,T-complex protein 11 homolog,39757,0.000674228772328151,0.00586063846640921,-0.0108126226218339,0.0121610801664902,0.908412657593852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.000966439689759761,0.00866847440098133,-0.0160237701361636,0.0179566495156832,0.911230599593409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM132A,Transmembrane protein 132A,39638,0.000704890639320848,0.00635151345870427,-0.0117440757397395,0.0131538570183812,0.911634264695821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX1B,Syntaxin-1B,39649,0.000445058446122275,0.00406312650818377,-0.00751866950991792,0.00840878640216247,0.912779393847136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.000455039672753907,0.00424833572738262,-0.00878177769842384,0.00787169835291602,0.914703528869116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMI,N-myc-interactor,39875,0.00076770200517237,0.00737255332352997,-0.0136825025089464,0.0152179065192911,0.917068248105858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRAL,GDNF family receptor alpha-like,39574,-0.000662361820552137,0.0064180414266539,-0.0132417230167938,0.0119169993756895,0.917803659280621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEL1L,Protein sel-1 homolog 1,39638,-0.000312303786712978,0.003181338067016,-0.00654772639806433,0.00592311882463838,0.921801125912561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZU1,Azurocidin,41751,0.000743874802370633,0.00759001319366405,-0.0141325510572109,0.0156203006619522,0.921928188873243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK1,Kallikrein-1,42016,-0.00126451409270712,0.0129064168200197,-0.0265610910599458,0.0240320628745316,0.921953122255971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00164555799733874,0.0168193547956441,-0.0313203774021237,0.0346114933968012,0.922063325849415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.000341784147160988,0.00358524918276856,-0.00736887254538737,0.0066853042510654,0.924053936075129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD33,Myeloid cell surface antigen CD33,42181,0.000750898736614798,0.00801159532522285,-0.014951828100822,0.0164536255740516,0.925327806801379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,39560,-0.000411223004477664,0.00442696224402671,-0.00908806900277002,0.00826562299381469,0.925992202724041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42137,0.000247079019260548,0.00271783940789634,-0.00507988622021628,0.00557404425873738,0.927565379536298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP1,Dipeptidase 1,41997,-0.000417971534057815,0.00463480905453138,-0.00950219728093932,0.00866625421282369,0.928144761825214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.000483715609881833,0.0054489012322069,-0.0111635620250074,0.0101961308052437,0.929263865292329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF12,Fibroblast growth factor 12,39657,0.000402213828179255,0.00459633141284795,-0.00860659574100272,0.00941102339736123,0.93026964706819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAN,Versican core protein,42249,-0.000263272954055651,0.00303232118598554,-0.0062066224785873,0.005680076570476,0.930814073492289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD59,CD59 glycoprotein,41638,0.000204247409599168,0.00238311689720086,-0.00446666170891452,0.00487515652811285,0.931701450781915
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00034625105815474,0.00413544373619117,-0.00845172078108943,0.00775921866477995,0.933274474602237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.000385426422826184,0.0047241251935652,-0.0088738589565616,0.00964471180221397,0.934976758253595
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM1,Myomesin-1,39586,0.000384180685605336,0.00496393669862242,-0.00934513524369461,0.0101134966149053,0.938311239733108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSB,Lupus La protein,41839,0.000455733655192083,0.0059303737561518,-0.0111677989068654,0.0120792662172496,0.938746123685392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,39743,-0.000403756640415032,0.00543054856694268,-0.0110476318316227,0.0102401185507926,0.940733908082051
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.000310036520735035,0.00432820255524998,-0.00817324048755493,0.008793313529025,0.942896304927537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP4,Caspase-4,39757,-0.00118661906908734,0.0168177166843859,-0.0341493437704838,0.0317761056323091,0.94375105762093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAX,Integrin alpha-X,39757,-0.000367898621390923,0.00523303349037307,-0.0106246442625221,0.00988884701974029,0.943953653175911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.000471627949685324,0.00692453697117592,-0.0131004645138195,0.0140437204131901,0.945699572637305
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIP,Gastric inhibitory polypeptide,39638,-0.000344551394914802,0.00512512424047149,-0.0103897949062389,0.00970069211640932,0.946401483452068
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.000192619971272801,0.00292892808582986,-0.00554807907695372,0.00593331901949932,0.947566350832151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC25A,M-phase inducer phosphatase 1,39560,0.000264897272643946,0.00406413183791362,-0.00770080112966676,0.00823059567495465,0.948032430189822
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.000176759084680956,0.00283750696408365,-0.0057382727342849,0.00538475456492299,0.950329993593515
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD2,Glutamate decarboxylase 2,39657,-0.000282869764640956,0.00459317744303826,-0.00928549755299594,0.00871975802371403,0.950894620830236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLLT1,Protein ENL,39560,-0.000402138489546555,0.00673182194292346,-0.0135965094976765,0.0127922325185834,0.952366234071956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZPR1,Zinc finger protein ZPR1,39586,-0.000568597187922379,0.00976819543864903,-0.0197142602476745,0.0185770658718297,0.95358318614956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000194305636416671,0.00340422341021805,-0.00647797224761071,0.00686658352044405,0.954484248601026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST7,Cystatin-F,42148,-0.000530537543533005,0.00951563263332343,-0.0191811775048469,0.0181201024177809,0.955538354787589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK12,Kallikrein-12,41843,0.000719815081433414,0.0134370492521064,-0.0256168014526951,0.0270564316155619,0.957279020164651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA3,GDNF family receptor alpha-3,41989,-0.000140398547701874,0.00280630059403073,-0.0056407477120021,0.00535995061659835,0.960099418524983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.000378759383443753,0.0075749399162144,-0.0144681228523365,0.015225641619224,0.960121994132084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.000159353201094834,0.0032866383317822,-0.00628245792919828,0.00660116433138794,0.961330468686415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.000463432301458246,0.00965642627507612,-0.0184631631976909,0.0193900278006074,0.961723402686459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",39575,0.000208090284322378,0.00471898997847278,-0.00904113007348427,0.00945731064212903,0.964828395912264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP15,Matrix metalloproteinase-15,39958,0.00021238991573512,0.00492032233471703,-0.00943144186031027,0.00985622169178051,0.965570083016189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.000247912660897178,0.00641644078533257,-0.0123283112783547,0.012824136600149,0.969180414544298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMMR,Hyaluronan mediated motility receptor,39541,-0.000173390543415103,0.00490573656235914,-0.00978863420563903,0.00944185311880882,0.97180572705921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP350,Centrosome-associated protein 350,39560,-0.000128955547934963,0.0037088886902541,-0.00739837738083301,0.00714046628496308,0.97226431590289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN3,CCN family member 3,42299,0.000116937753996661,0.00342563598902393,-0.00659730878449024,0.00683118429248357,0.972769141925927
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,39757,0.000267690095425355,0.00800365013500943,-0.0154194641691931,0.0159548443600438,0.973319524466381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PITHD1,PITH domain-containing protein 1,39539,-0.000217111248616458,0.00783489112353072,-0.0155734978507367,0.0151392753535037,0.97789330031642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAGLN3,Transgelin-3,39560,-0.000156991272873036,0.0060891000368748,-0.0120916273451476,0.0117776447994016,0.979431413861922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,6.79516527191695e-05,0.00367100917270887,-0.00712722632579021,0.00726312963122855,0.985232049287839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-8.86070323733342e-05,0.00510273676935264,-0.0100899711003045,0.00991275703555784,0.98614605580146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOBR,Apolipoprotein B receptor,39638,-7.28897537065913e-05,0.00434642337301572,-0.0085918795648174,0.00844610005740421,0.986620363256407
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42310,-3.17338973791083e-05,0.00230503660855291,-0.00454960565014281,0.00448613785538459,0.989015911888298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,41843,-5.99127514210132e-05,0.00485019101645518,-0.00956628714367317,0.00944646164083115,0.990144441523323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-5.31892106608735e-05,0.00561424771296851,-0.0110571147280792,0.0109507363067574,0.992441151413434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171A2,Protein FAM171A2,39934,-0.000132876342658597,0.0158239413350033,-0.0311478013592651,0.0308820486739479,0.99330025336157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,39586,-8.01338164711822e-05,0.0110134603116616,-0.0216665160273279,0.0215062483943856,0.994194784017567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,41913,-2.85368071442794e-05,0.00447409644835767,-0.00879776584592531,0.00874069223163676,0.99491104044343
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,1.44821761137298e-05,0.00392877865197538,-0.00768592398175802,0.00771488833398548,0.99705892941031
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASA1,Ras GTPase-activating protein 1,41839,7.64436528603705e-07,0.00328349776350553,-0.00643489117994223,0.00643642005299944,0.999814246689141
